Pathology In Depth

Library › Inflammatory and infectious skin pathology: normal skin and reaction patterns, interface, vesiculobullous, granulomatous, vasculitic and panniculitic dermatoses, skin infections and cutaneous lymphoid infiltrates

Inflammatory and infectious skin pathology: normal skin and reaction patterns, interface, vesiculobullous, granulomatous, vasculitic and panniculitic dermatoses, skin infections and cutaneous lymphoid infiltrates

Last reviewed 2026-11-17 by a board-certified pathologist. 322 references.

Normal Skin, Biopsy Handling and the Reaction-Pattern Approach; Spongiotic, Psoriasiform, Keratinization and Pigmentary Disorders

Definition and scope. No WHO classification or CAP protocol governs inflammatory skin disease. Inflammatory dermatoses are classified by reaction pattern and by the skin compartment the process involves: epidermis and superficial dermis, full-thickness dermis, deep dermis, subcutis, follicles or the dermoepidermal junction (Llamas-Velasco et al. 2026).

Related page: Interface and Lichenoid Dermatoses, Cutaneous Lupus and Dermatomyositis, Graft-versus-Host Disease, and Sclerosing Dermal Disorders (vacuolar and lichenoid interface dermatitis, lupus, graft-versus-host disease, lichen sclerosus and morphea) Related page: Vesiculobullous and Pustular Dermatoses: Pemphigus, Pemphigoid, Dermatitis Herpetiformis, Epidermolysis Bullosa, Porphyria and Direct Immunofluorescence (split level, direct immunofluorescence patterns, Darier and Hailey–Hailey disease, pustular dermatoses) Related page: Granulomatous, Vasculitic, Neutrophilic and Eosinophilic Dermatoses: Sarcoidosis, Granuloma Annulare, Cutaneous Vasculitis and Vasculopathy, Sweet Syndrome, Pyoderma Gangrenosum and Wells Syndrome (granulomatous, vasculitic and eosinophilic dermal patterns) Related page: Dermal Deposits and Degenerative, Metabolic, Nutritional and Physical-Agent Disorders of Skin: Elastic Tissue and Perforating Disorders, Mucinoses, Calcinosis and Calciphylaxis, Amyloid, Gout, Pigments, Fillers, Xanthomas and Deficiency Dermatoses (nutritional dermatoses with upper epidermal pallor, deposits and physical-agent reactions) Related page: Follicular Disorders, Alopecia, Nail Unit Pathology and Panniculitis: Rosacea, Folliculitis, Hidradenitis Suppurativa, Scarring and Non-scarring Alopecia, Hair Shaft and Nail Disorders, Septal and Lobular Panniculitis (horizontal and vertical sectioning of scalp biopsies, alopecia and panniculitis) Related page: Skin Infections and Infestations: Bacterial, Mycobacterial, Spirochetal, Fungal, Viral, Protozoal and Parasitic Infections of Skin (dermatophytosis, secondary syphilis and the infection special-stain table) Related page: Cutaneous Lymphoid and Hematolymphoid Infiltrates: Histologic Approach, Early Mycosis Fungoides and Its Mimics, CD30-Positive Lymphoproliferative Disorders, Rare Cutaneous T-Cell Lymphomas and Reactive Lymphoid Proliferations (early mycosis fungoides in the psoriasiform and spongiotic differential) Related page: ANCA, Anti-GBM and Organ-Specific Autoantibodies: Kidney, Liver, Thyroid, Pancreas and Nervous System (bullous disease serology behind eosinophilic spongiosis)

Epidermal layers and resident cells of normal skin

  • Stratum basale. The deepest layer consists of cuboidal or columnar cells (Dermitzakis et al. 2024).
  • Stratum spinosum. This is the thickest epidermal layer. Adjacent keratinocytes are bound by desmosomes (Dermitzakis et al. 2024).
  • Stratum granulosum. Differentiating keratinocytes of the granular layer express filaggrin (Dermitzakis et al. 2024). Filaggrin is expressed in keratohyalin granules and crosslinks keratin filaments in the horny layer (Metze et al. 2021).
  • Stratum lucidum. This layer lies between the granular layer and the stratum corneum and is present only in thick skin of the fingertips, palms and soles (Dermitzakis et al. 2024).
  • Stratum corneum. The normal cornified layer has a basket-weave pattern. Epidermal turnover takes about 4 weeks, and parakeratosis reflects accelerated turnover (Tirumalae 2013).
  • Melanocytes. Melanocytes derive from the neural crest (Faria et al. 2014). In normal skin, Melan-A-positive melanocytes align along the basal layer (Özgün Geçer and Kaya 2025).
  • Merkel cells. Merkel cells lie in the basal layer and lower epidermis at the dermoepidermal junction, are closely associated with afferent neurons and mediate light touch (Dermitzakis et al. 2024).
  • Langerhans cells. Langerhans cells are antigen-presenting cells that appear in fetal epidermis by week 6 of gestation and are self-renewing after birth (Dermitzakis et al. 2024).
  • Adnexa. The density and size of hair follicles and of sebaceous, eccrine and apocrine glands vary between skin areas. Eccrine glands are distributed over the whole body except the lips and the auditory canal (Dermitzakis et al. 2024).

Site-specific normal histology that alters interpretation

Site or setting Finding that changes interpretation Source
Palms and soles Stratum lucidum present; biopsy of palmar psoriasis more often shows superimposed eczematous change than an elbow biopsy Dermitzakis et al. 2024; Llamas-Velasco et al. 2026
Volar-appearing skin with hair follicles Compact orthokeratosis, uneven acanthosis and vertical papillary dermal collagen in follicle-bearing skin ("hairy palm" sign) indicate lichen simplex chronicus Tirumalae 2013
Shin compared with scalp and genital skin Lichen simplex chronicus is an acceptable diagnosis on the shin; on the scalp or genital skin other entities are excluded first Llamas-Velasco et al. 2026
Acral, genital and flexural skin Architectural and cytologic features that are concerning elsewhere can be characteristic of "special site" nevi Llamas-Velasco et al. 2026
Scalp Hair bulbs lie typically more than 5 mm deep; biopsies that do not reach subcutis cannot assess the bulb Llamas-Velasco et al. 2026
Oral and genital mucosa Discoid lupus of mucosa lacks follicular plugging; anesthetic should not be injected into the lesion; DIF biopsies are taken from normal-appearing mucosa 3–4 mm from an erosion Abu-Dayeh et al. 2026; Llamas-Velasco et al. 2026

Toker cells of the nipple. Toker cells are clear cells resident in the epidermis of the nipple. They were present in 31 of 40 mastectomy nipples, usually around duct openings (Currie and Going 2009). Like Paget cells they have abundant pale or clear cytoplasm, but they lack cytologic atypia and mitoses. Toker cell hyperplasia is a benign mimic of mammary Paget disease, and both Toker cells and Paget cells express TRPS1, so TRPS1 does not separate them (Rutland et al. 2026).

Skin biopsy techniques and selection by suspected disease

  • Punch biopsy. A punch gives a full-thickness cylinder and suits inflammatory dermatoses that involve the dermis or superficial subcutis. A 4-mm punch is the standard for most inflammatory conditions. A 2–3-mm punch is used in cosmetically sensitive areas and in children but can be insufficient for alopecia and panniculitis (Llamas-Velasco et al. 2026).
  • Shave and saucerization. Shave biopsy is for superficial and exophytic lesions confined to the epidermis or superficial dermis and is not recommended when dermal invasion is suspected or tumor thickness is needed. A deep shave (saucerization) extends into the reticular dermis (Llamas-Velasco et al. 2026).
  • Incisional (wedge) and excisional biopsy. Deep incisional biopsy is used when complete removal is not possible. For panniculitis, a deep incisional biopsy including subcutis is preferred. A punch for panniculitis is at least 6 mm, and a punch-on-punch technique is an option (Llamas-Velasco et al. 2026).
  • Timing. Active, untreated lesions are the most informative. Topical corticosteroids are often stopped 2–3 weeks before biopsy because they reduce the infiltrate and obscure features of bullous pemphigoid and drug eruptions (Llamas-Velasco et al. 2026).
Suspected diagnosis Biopsy site and technique Caveat Source
Autoimmune bullous disease, routine histology Edge of an early vesicle or bulla including adjacent intact skin Blister roof alone is not submitted Llamas-Velasco et al. 2026
Autoimmune bullous disease, vasculitis and lupus, DIF Perilesional normal-appearing skin, <1 cm from a blister Necrotic or eroded skin avoided; saline or Michel medium; formalin excluded Llamas-Velasco et al. 2026
Cutaneous leukocytoclastic vasculitis Early purpuric lesion, within 24–48 h, for DIF and for nuclear dust; established lesion for H&E Late lesions show reparative change Llamas-Velasco et al. 2026
Lupus erythematosus and scarring alopecia Established active lesion older than 6 months Old burnt-out lesions avoided Llamas-Velasco et al. 2026
Panniculitis Deepest active nodule with subcutis Punch ≥6 mm or deep incision Llamas-Velasco et al. 2026
Epidermolysis bullosa Fresh blister <24 h old; fresh or induced blister for immunofluorescence mapping Broken blisters avoided Llamas-Velasco et al. 2026
Stevens–Johnson syndrome and TEN Early lesion including full epidermal thickness Late lesions mimic other entities Llamas-Velasco et al. 2026
Porphyria cutanea tarda Intact blister on sun-exposed skin Features are lost in old blisters Llamas-Velasco et al. 2026
Morphea Inflammatory border with adjacent indurated skin Lilac ring and sclerotic area in one specimen Llamas-Velasco et al. 2026
Vitiligo and hypopigmentation Normal and affected skin from the lesion edge, or two samples Comparison within one specimen Llamas-Velasco et al. 2026
Calciphylaxis Deep biopsy with ample fat Superficial samples miss the vessels; histology in Dermal Deposits and Degenerative, Metabolic, Nutritional and Physical-Agent Disorders of Skin: Elastic Tissue and Perforating Disorders, Mucinoses, Calcinosis and Calciphylaxis, Amyloid, Gout, Pigments, Fillers, Xanthomas and Deficiency Dermatoses Llamas-Velasco et al. 2026
Bacterial, mycobacterial or fungal infection Active untreated lesion; fresh sterile tissue for culture Edge of a necrotic area gives the best culture yield Llamas-Velasco et al. 2026

Fixation, transport and laboratory handling of skin biopsies

  • Formalin. Routine fixation is 10% neutral buffered formalin in a container holding at least 10 times the tissue volume (tissue-to-fixative ratio 1:10 to 1:20). Optimal fixation is reached within 24 h, with an adequate window of about 8–48 h (Llamas-Velasco et al. 2026).
  • Handling before fixation. Specimens on dry gauze desiccate. Saline-moistened gauze preserves tissue for a short period, preferably at 4 °C (Llamas-Velasco et al. 2026).
  • Direct immunofluorescence (DIF). Tissue for DIF goes in normal saline at 4 °C when the laboratory can process it rapidly. When transport is delayed, Michel transport medium preserves immunoreactants for longer. Saline is superior to liquid nitrogen or Michel medium if the sample reaches the laboratory within 48 h. DIF tissue is never placed in formalin (Llamas-Velasco et al. 2026).
  • Other fixatives. Electron microscopy requires immediate glutaraldehyde fixation. Skin for small fiber neuropathy is frozen immediately or transported fresh on saline-moistened gauze (Llamas-Velasco et al. 2026).
  • Separate containers. Specimens from different anatomic sites are submitted in separate labeled containers because normal histology varies by site (Llamas-Velasco et al. 2026).
  • Shave specimens. Thin shaves curl. Placing them flat on dry paper before formalin preserves orientation (Llamas-Velasco et al. 2026).
  • Sectioning. Vertical sections are the standard for most dermatoses. Transverse (horizontal) sections assess more follicular units in one plane in alopecia. The HoVert technique sections transversely and then vertically sections the upper 1 mm; the Tyler technique sections vertically and then transversely sections one half (Llamas-Velasco et al. 2026). Alopecia sectioning is detailed in Follicular Disorders, Alopecia, Nail Unit Pathology and Panniculitis: Rosacea, Folliculitis, Hidradenitis Suppurativa, Scarring and Non-scarring Alopecia, Hair Shaft and Nail Disorders, Septal and Lobular Panniculitis.
  • Levels. A 4-mm punch yields more than 1,200 serial 3-µm sections. A slide of 22 sections represents only 0.066 mm of the sample. Small, focal findings such as porokeratosis and Fox–Fordyce disease are missed when only one to three sections are examined (Llamas-Velasco et al. 2026).
Histochemical stain Main use in inflammatory dermatopathology Source
PAS and PAS-diastase Fungi, basement membrane thickening, glycogen; diastase separates glycogen from diastase-resistant material Llamas-Velasco et al. 2026
Alcian blue and colloidal iron Dermal mucin in lupus erythematosus, dermatomyositis and scleromyxedema Llamas-Velasco et al. 2026
Verhoeff–Van Gieson and orcein Elastic fibers in pseudoxanthoma elasticum, anetoderma and solar elastosis Llamas-Velasco et al. 2026
Masson trichrome Collagen and fibrosis in morphea, scars and sclerosing disorders Llamas-Velasco et al. 2026
Congo red Amyloid Llamas-Velasco et al. 2026
Von Kossa and alizarin red Calcium in calcinosis cutis and calciphylaxis Llamas-Velasco et al. 2026
Perls (Prussian blue) Hemosiderin in pigmented purpuric dermatoses, stasis dermatitis and hemorrhage Llamas-Velasco et al. 2026
Fontana–Masson Melanin in pigmentary disorders Llamas-Velasco et al. 2026

Stains for organisms are tabulated in Skin Infections and Infestations: Bacterial, Mycobacterial, Spirochetal, Fungal, Viral, Protozoal and Parasitic Infections of Skin.

Artifacts in skin biopsies

Artifact Cause Histologic appearance and mimic Source
Crush Forceps pressure, especially on the mid-portion of a punch Distorted, unrecognizable cells; can mimic fibrotic tumors or scleroderma Llamas-Velasco et al. 2026
Handling separation Rough handling of the fresh specimen Artifactual dermoepidermal separation Llamas-Velasco et al. 2026
Thermal coagulation Electrosurgery or laser Nuclear enlargement or elongation that simulates neoplasia; margins may be unassessable Llamas-Velasco et al. 2026
Anesthetic injection Fluid injected into the lesion Separated collagen that resembles dermal edema, without lymphatic dilatation Llamas-Velasco et al. 2026
Topical anesthetic (lidocaine–prilocaine cream) Application before biopsy Vacuolar change and acantholysis Llamas-Velasco et al. 2026
Formalin pigment Prolonged fixation at high temperature and humidity Black pigment resembling hemozoin in hemorrhagic areas Llamas-Velasco et al. 2026
Silver nitrate Hemostatic sticks at a prior biopsy site Black pigment in ulcerated re-excision sites Llamas-Velasco et al. 2026
Monsel solution (20% aqueous ferric subsulfate) Topical hemostatic agent Ferrugination (ferric salts deposited in fibrin, dermal collagen and striated muscle), siderophages and occasional foreign-body reaction Abdul Rahman et al. 2020
Anticoagulant-related hemorrhage Anticoagulant therapy Disproportionate erythrocyte extravasation with sparse infiltrate and no fibrin; mimics vasculitis Llamas-Velasco et al. 2026
Excess marking ink Overapplied ink Ink penetrates tissue and obscures structure and immunostaining Llamas-Velasco et al. 2026

Reaction-pattern approach by skin compartment

The required biopsy compartment follows the level of the disease process (Llamas-Velasco et al. 2026).

Compartment the biopsy must include Representative diseases Detailed in Source
Epidermis and superficial dermis Psoriasis, lichen planus, pityriasis lichenoides, superficial dermatophyte infection, viral exanthems, superficial interface dermatitis Interface and Lichenoid Dermatoses, Cutaneous Lupus and Dermatomyositis, Graft-versus-Host Disease, and Sclerosing Dermal Disorders; Skin Infections and Infestations: Bacterial, Mycobacterial, Spirochetal, Fungal, Viral, Protozoal and Parasitic Infections of Skin Llamas-Velasco et al. 2026
Lesional edge with adjacent normal skin Blistering diseases for routine histology, interface dermatitis, porokeratosis, annular lesions, vasculitis, ulcers Vesiculobullous and Pustular Dermatoses: Pemphigus, Pemphigoid, Dermatitis Herpetiformis, Epidermolysis Bullosa, Porphyria and Direct Immunofluorescence; Interface and Lichenoid Dermatoses, Cutaneous Lupus and Dermatomyositis, Graft-versus-Host Disease, and Sclerosing Dermal Disorders Llamas-Velasco et al. 2026
Perilesional normal-appearing skin DIF for autoimmune blistering disease, lupus erythematosus, vasculitis and dermatitis herpetiformis Vesiculobullous and Pustular Dermatoses: Pemphigus, Pemphigoid, Dermatitis Herpetiformis, Epidermolysis Bullosa, Porphyria and Direct Immunofluorescence Llamas-Velasco et al. 2026
Full-thickness dermis Granuloma annulare, sarcoidosis, necrobiosis lipoidica, interstitial granulomatous dermatitis, urticaria and urticarial vasculitis, drug eruptions Granulomatous, Vasculitic, Neutrophilic and Eosinophilic Dermatoses: Sarcoidosis, Granuloma Annulare, Cutaneous Vasculitis and Vasculopathy, Sweet Syndrome, Pyoderma Gangrenosum and Wells Syndrome Llamas-Velasco et al. 2026
Deep dermis Morphea, scleromyxedema, deep granulomatous dermatitis, perforating disorders Interface and Lichenoid Dermatoses, Cutaneous Lupus and Dermatomyositis, Graft-versus-Host Disease, and Sclerosing Dermal Disorders; Dermal Deposits and Degenerative, Metabolic, Nutritional and Physical-Agent Disorders of Skin: Elastic Tissue and Perforating Disorders, Mucinoses, Calcinosis and Calciphylaxis, Amyloid, Gout, Pigments, Fillers, Xanthomas and Deficiency Dermatoses Llamas-Velasco et al. 2026
Deep dermis and superficial subcutis Medium-vessel vasculitis, cutaneous polyarteritis nodosa, livedoid vasculopathy, deep fungal and mycobacterial infection, lupus panniculitis, morphea profunda Granulomatous, Vasculitic, Neutrophilic and Eosinophilic Dermatoses: Sarcoidosis, Granuloma Annulare, Cutaneous Vasculitis and Vasculopathy, Sweet Syndrome, Pyoderma Gangrenosum and Wells Syndrome; Skin Infections and Infestations: Bacterial, Mycobacterial, Spirochetal, Fungal, Viral, Protozoal and Parasitic Infections of Skin Llamas-Velasco et al. 2026
Generous subcutis Panniculitis, erythema nodosum, subcutaneous panniculitis-like T-cell lymphoma, pancreatic and alpha-1 antitrypsin panniculitis, calciphylaxis Follicular Disorders, Alopecia, Nail Unit Pathology and Panniculitis: Rosacea, Folliculitis, Hidradenitis Suppurativa, Scarring and Non-scarring Alopecia, Hair Shaft and Nail Disorders, Septal and Lobular Panniculitis; Cutaneous Lymphoid and Hematolymphoid Infiltrates: Histologic Approach, Early Mycosis Fungoides and Its Mimics, CD30-Positive Lymphoproliferative Disorders, Rare Cutaneous T-Cell Lymphomas and Reactive Lymphoid Proliferations; Dermal Deposits and Degenerative, Metabolic, Nutritional and Physical-Agent Disorders of Skin: Elastic Tissue and Perforating Disorders, Mucinoses, Calcinosis and Calciphylaxis, Amyloid, Gout, Pigments, Fillers, Xanthomas and Deficiency Dermatoses Llamas-Velasco et al. 2026
Follicle-bearing skin into subcutis Alopecia, folliculitis decalvans, dissecting cellulitis, hidradenitis suppurativa, folliculotropic mycosis fungoides Follicular Disorders, Alopecia, Nail Unit Pathology and Panniculitis: Rosacea, Folliculitis, Hidradenitis Suppurativa, Scarring and Non-scarring Alopecia, Hair Shaft and Nail Disorders, Septal and Lobular Panniculitis Llamas-Velasco et al. 2026
Epidermal pattern Defining finding Source
Spongiotic Intercellular edema of the epidermis that can enlarge into spongiotic vesicles Tokura et al. 2025
Psoriasiform Elongated rete ridges of roughly equal length alternating with long dermal papillae; it can combine with spongiotic or lichenoid change Tirumalae 2013
Interface Basal vacuolar change and apoptotic keratinocytes with lymphocytes at the dermoepidermal junction Kechichian et al. 2024
  • "Invisible" dermatoses. Biopsies with subtle findings account for up to 10% of skin biopsies. Tinea incognita and urticaria are overlooked unless the requisition prompts a search for fungi or subtle dermal edema (Llamas-Velasco et al. 2026).
  • Descriptive reports. A pattern such as "psoriasiform spongiotic dermatitis with lymphocytes" conveys more than "chronic dermatitis". Acute, subacute and chronic are clinical terms (Tirumalae 2013).

Spongiotic reaction patterns

Spongiosis is intercellular epidermal edema. Accumulating fluid forms spongiotic vesicles (Tokura et al. 2025).

Spongiotic pattern Definition Representative diseases Source
Neutrophilic Neutrophils in foci of spongiosis Pustular psoriasis, IgA pemphigus, infantile acropustulosis, AGEP, palmoplantar pustulosis, dermatophytosis and candidosis, glucagonoma syndrome Balan et al. 2021
Eosinophilic Numerous eosinophils in spongiotic foci Pemphigus precursor lesions, pemphigus herpetiformis and vegetans, bullous pemphigoid, herpes gestationis, allergic contact and atopic dermatitis, arthropod bites, drug reactions, incontinentia pigmenti, id reaction Balan et al. 2021
Miliarial Edema centered on the acrosyringium Miliaria Balan et al. 2021
Follicular Edema of the follicular infundibulum Infundibulofolliculitis, follicular atopic dermatitis, eosinophilic folliculitis, follicular mucinosis Balan et al. 2021
Pityriasiform Small vesicles containing lymphocytes, histiocytes and Langerhans cells Pityriasis rosea, pityriasiform drug reaction, erythema annulare centrifugum, allergic contact and nummular dermatitis Balan et al. 2021
Haphazard No particular pattern Irritant and allergic contact dermatitis, nummular, seborrheic and atopic dermatitis, id reaction, spongiotic drug reactions, mycosis fungoides Balan et al. 2021
Spongiosis with subepidermal edema Epidermal spongiosis with papillary dermal edema Arthropod bites, id reaction, dermal-type allergic contact dermatitis, prebullous pemphigoid, Sweet syndrome, Wells syndrome, polymorphic light eruption Balan et al. 2021
  • Evolution. In acute eczema, spongiosis progresses to vesicles. Chronic eczema shows lichenification, acanthosis and hyperkeratosis, with dermal fibrosis and hyperpigmentation from epidermal melanogenesis and dermal pigment deposition (Tokura et al. 2025).
  • Histologically indistinguishable spongiotic dermatitides. Allergic contact dermatitis, nummular dermatitis, id reaction, dyshidrotic dermatitis (pompholyx) and photoallergic dermatitis are histologically indistinguishable. Clinical distribution separates them: the site of contact, coin-shaped lesions, the sides of the digits and palms and soles, and sun-exposed sites such as the V of the neck. Actinic reticuloid is photoallergic dermatitis with superimposed lichen simplex chronicus-like change (Tirumalae 2013).
  • Irritant contact dermatitis. Severe irritant reactions can show confluent epidermal necrosis, foci of ballooning, basal vacuolar change and occasional necrotic keratinocytes with a mild perivascular infiltrate, which mimics toxic epidermal necrolysis. Prior irritant exposure, restriction to exposed sites and linear streaking separate it (Akanksha et al. 2025).
  • Eosinophils. Eosinophils in a spongiotic or psoriasiform dermatitis favor allergic contact dermatitis or a drug eruption but are not required for either diagnosis (Tirumalae 2013).
  • Pompholyx versus palmoplantar pustulosis. Spongiotic vesicles indicate dyshidrotic eczema. Neutrophilic microabscesses suggest palmoplantar pustulosis and are seen only in pustulovesicles or immature pustules (Tokura et al. 2025).
  • Spongiotic vesicles in a psoriasiform dermatitis. Vesicles indicate allergic contact or nummular dermatitis or seborrheic dermatitis. Psoriasis does not form spongiotic vesicles (Tirumalae 2013).

Eosinophilic spongiosis and its differential diagnosis

Eosinophilic spongiosis is intraepidermal eosinophils in spongiotic zones, with or without vesicles (Morais et al. 2019).

Disease Clue Source
Pemphigus (vulgaris, foliaceus, vegetans) Pre-acantholytic change that can precede typical lesions; in pemphigus vegetans it accompanies suprabasal acantholysis and epidermal hyperplasia Morais et al. 2019
Pemphigus herpetiformis Eosinophilic spongiosis present in 100% of 27 cases, with or without acantholysis; intercellular IgG on DIF Morais et al. 2019
Bullous pemphigoid Prominent in the pre-bullous urticarial or eczematous phase, even without subepidermal detachment; linear IgG at the basement membrane zone on DIF Morais et al. 2019
Pemphigoid gestationis Eosinophilic spongiosis in urticarial lesions of pregnancy supports pemphigoid gestationis over polymorphic eruption of pregnancy Morais et al. 2019
Allergic contact, atopic and nummular dermatitis Eosinophilic spongiosis beside other eczematous change, with lymphocytes as the main cells Morais et al. 2019
Arthropod bite, urticaria, drug reaction Prominent dermal edema and mixed infiltrate in bite reactions and urticarial lesions Morais et al. 2019
Scabies Mite in the stratum corneum Morais et al. 2019
Incontinentia pigmenti, vesicular stage Eosinophilic spongiosis with dyskeratotic keratinocytes Morais et al. 2019
Eosinophilic pustular folliculitis (Ofuji) Eosinophilic spongiosis of the follicular infundibulum and sebaceous duct Morais et al. 2019
  • Frequency. Among 150 patients with eosinophilic spongiosis, 24% had an autoimmune bullous disease, most often bullous pemphigoid (Morais et al. 2019).
  • Workup. When eosinophilic spongiosis is the only abnormality, immunofluorescence separates eczema from early autoimmune bullous disease and is repeated if the first study is negative (Morais et al. 2019).

Seborrheic dermatitis and pityriasis rosea

  • Seborrheic dermatitis histology. Focal parakeratosis, neutrophilic scale at dilated follicular openings, psoriasiform acanthosis and mild to moderate spongiosis are the key features (Navarro Triviño et al. 2025; Tirumalae 2013). Chronic lesions overlap histologically with psoriasis (Navarro Triviño et al. 2025).
  • Scalp psoriasis versus seborrheic dermatitis. Papillomatosis, sebaceous gland atrophy and necrotic keratinocytes favor scalp psoriasis (Tirumalae 2013).
  • Seborrheic dermatitis associations. Malassezia overgrowth is part of the pathogenesis. Seborrheic dermatitis affects 20%–83% of people living with HIV and 52%–59% of patients with Parkinson disease (Navarro Triviño et al. 2025).
  • Pityriasis rosea histology. The epidermis shows focal mounds of parakeratosis with lymphocyte exocytosis, variable spongiosis, mild acanthosis and a thinned granular layer. The dermis shows extravasated erythrocytes and a perivascular infiltrate of lymphocytes, eosinophils and monocytes. The herald patch can show more parakeratosis and focal keratinocyte necrosis (Mashoudy et al. 2025).
  • Pityriasis rosea differential. Absence of acantholysis and of significant dyskeratosis separates pityriasis rosea from pemphigus and Grover disease (Mashoudy et al. 2025). Pityriasis rosea and erythema annulare centrifugum are histologically identical and are separated clinically (Tirumalae 2013).
  • Pityriasis rosea etiology. HHV-7 DNA is frequently detected in blood and saliva, and HHV-6 and HHV-7 reactivation are implicated in the herald patch and in recurrence (Mashoudy et al. 2025).

Venous stasis change

Incontinentia pigmenti

  • Genetics. Incontinentia pigmenti is caused by heterozygous mutations in IKBKG (formerly NEMO) at Xq28, a regulatory subunit of the NF-κB pathway. A recurrent deletion of exons 4–10 accounts for 70%–80% of affected individuals. Hemizygous complete loss-of-function variants are usually lethal in utero for males (Niedźwiedź et al. 2026).
  • Stages. Cutaneous lesions follow Blaschko lines through four overlapping stages: vesicular (I), verrucous (II), hyperpigmented (III) and hypopigmented or atrophic (IV) (Niedźwiedź et al. 2026).
  • Histology of the vesicular stage. Eosinophilic spongiosis, intraepidermal vesicles, dyskeratotic keratinocytes and early pigment incontinence are present. Peripheral eosinophilia and a Blaschko-linear eruption in a female neonate separate it from neonatal herpes simplex, bullous impetigo, staphylococcal scalded skin syndrome and epidermolysis bullosa (Niedźwiedź et al. 2026).

Psoriasis: histology and clinical variants

  • Established plaque. Hyperkeratosis, confluent parakeratosis, neutrophils in the stratum corneum (Munro microabscesses), neutrophils in the superficial spinous layer (spongiform pustules of Kogoj), regular acanthosis, hypogranulosis, thinning of the suprapapillary plates, dilated papillary dermal capillaries and a perivascular lymphocytic infiltrate (Saal et al. 2025).
  • Evenly elongated rete. Evenly elongated thin rete ridges with equally long dermal papillae indicate psoriasis. Other psoriasiform dermatoses show rete of uneven length with thick suprapapillary plates (Tirumalae 2013).
  • Treated lesions. Dilated, tortuous papillary capillaries are the most reliable sign of psoriasis in treated lesions and persist after the granular layer and suprapapillary plates return to normal (Tirumalae 2013).
  • Upper epidermal pallor. Pallor in psoriasis is mediated by neutrophils migrating to the stratum corneum (Tirumalae 2013).
  • Eosinophils and plasma. Significant numbers of eosinophils are not a feature of psoriasis, even when a drug triggers it. Abundant plasma in the scale crust argues against psoriasis except on volar skin (Tirumalae 2013).
  • Guttate and eruptive psoriasis. Mounds of parakeratosis with neutrophils alternate vertically with orthokeratosis, and extravasated erythrocytes indicate acuteness (Tirumalae 2013). Guttate psoriasis affects children and adolescents after streptococcal infection, viral illness or stress, and 40% of patients develop chronic plaque psoriasis (Saal et al. 2025).
  • Pustular psoriasis. Sterile coalescing pustules are localized or generalized. Abrupt withdrawal of systemic corticosteroids can trigger it (Saal et al. 2025). Neutrophils among keratinocytes at the periphery of the pustule and tortuous dermal vessels support the diagnosis (Tirumalae 2013).
  • Erythroderma. The stratum corneum is absent in erythroderma from markedly accelerated turnover, seen in psoriasis, mycosis fungoides and pityriasis rubra pilaris (Tirumalae 2013).
  • Koebnerization. Patients predisposed to psoriasis can show psoriatic change within other dermatoses, including mycosis fungoides (Tirumalae 2013).

Psoriasiform dermatoses: differential diagnosis

Disease Distinguishing histologic finding Source
Psoriasis Evenly elongated rete, confluent parakeratosis with neutrophils, hypogranulosis, tortuous papillary capillaries Tirumalae 2013; Saal et al. 2025
Pityriasis rubra pilaris Checkerboard parakeratosis (staggered vertically and horizontally), parakeratosis at follicular ostia and between follicles Tirumalae 2013
Seborrheic dermatitis Scale crust at dilated infundibular ostia, spongiosis, spongiotic vesicles Tirumalae 2013
Allergic contact and nummular dermatitis Spongiotic vesicles early, psoriasiform hyperplasia in subacute and chronic phases, eosinophils Tirumalae 2013
Lichen simplex chronicus Vertical streaks of papillary dermal collagen, uneven acanthosis, compact orthokeratosis Tirumalae 2013
Dermatophytosis Neutrophils in parakeratosis beneath basket-weave orthokeratosis, hyphae in the "sandwich" between them; fungal stains in every psoriasiform dermatitis Tirumalae 2013
Secondary syphilis Histiocytes and plasma cells, ill-formed granulomas, superficial and deep infiltrate; plasma cells absent in early lesions; spirochete stains Tirumalae 2013
Mycosis fungoides Epidermal lymphocytes disproportionate to spongiosis, basal linear and pagetoid lymphocytes, papillae stuffed with lymphocytes, wiry papillary collagen, no dermal edema Tirumalae 2013
Pityriasis lichenoides chronica Confluent parakeratosis, thin wiry papillary collagen Tirumalae 2013
Lichen striatus Psoriasiform lichenoid pattern with deep periadnexal, especially perieccrine, lymphocytes Tirumalae 2013
Inflammatory linear verrucous epidermal nevus Sharply defined thick zones of parakeratosis alternating with orthokeratosis, mild papillomatosis Tirumalae 2013
Bowen disease Crowded atypical parakeratotic nuclei and striking keratinocyte atypia Tirumalae 2013
Pellagra, acrodermatitis enteropathica, glucagonoma syndrome Marked pallor of upper epidermal keratinocytes Tirumalae 2013
Netherton syndrome Regular psoriasiform hyperplasia with focal parakeratosis and thin granular layer; loss of LEKTI on immunohistochemistry Metze et al. 2021

Pityriasis rubra pilaris

  • Checkerboard parakeratosis. Parakeratosis alternates with orthokeratosis in vertical and horizontal directions. It is often difficult to identify, even on multiple sections (Tirumalae 2013).
  • Other features. Confluent parakeratosis, upper epidermal pallor, follicular plugging and broad compact orthohyperkeratosis are seen in established lesions (Hoffmann et al. 2025).
  • Acantholytic dyskeratosis. Prominent acantholytic dyskeratosis occurs mainly early in the disease, mimics Grover disease and leads to misdiagnosis. Acantholysis is reported to be more prominent when pityriasis rubra pilaris begins on the trunk (Hoffmann et al. 2025).

Lichen simplex chronicus and prurigo nodularis

  • Lichen simplex chronicus. Vertical streaks of papillary dermal collagen with uneven psoriasiform acanthosis and compact orthokeratosis are diagnostic. The biopsy resembles volar skin except for pilosebaceous units. Its changes can be superimposed on any chronic pruritic dermatitis, including psoriasis (Tirumalae 2013).
  • Scalp lichen simplex chronicus. Horizontal sections show the outer root sheath forming jagged acanthotic projections ("gear wheel" sign) and hair shafts split in two ("hamburger" sign), with interfollicular hypergranulosis and small sebaceous glands (Agrawal et al. 2020).
  • Distinction from hypertrophic lichen planus. Lichen simplex chronicus shows regular thickened rete with hypergranulosis that is not wedge-shaped; hypertrophic lichen planus shows wedge-shaped hypergranulosis (Scotti et al. 2025).
  • Prurigo nodularis. Epidermal acanthosis and dermal fibrosis are the defining histologic features. Intraepidermal nerve fiber density is reduced, and the dermis shows neuronal hyperplasia with PGP9.5- and NGF receptor-immunoreactive fibers. Hypertrophic lichen planus is in the differential diagnosis (Serra-Baldrich et al. 2026), and its wedge-shaped hypergranulosis and lichenoid infiltrate separate it (Scotti et al. 2025).

Keratinization disorders: ichthyoses, porokeratosis and acanthosis nigricans

Histologic patterns of the ichthyoses include orthohyperkeratosis with a reduced or well-developed granular layer, ortho- and parakeratosis with a preserved or prominent granular layer, and epidermolytic ichthyosis (Metze et al. 2021).

Ichthyosis Gene and inheritance Histology Source
Ichthyosis vulgaris FLG (filaggrin) loss of function, autosomal semidominant; most frequent ichthyosis (prevalence 1:100 to 1:250) Markedly reduced, often absent stratum granulosum with mild compact orthohyperkeratosis Metze et al. 2021
X-linked recessive ichthyosis Steroid sulfatase deficiency Almost identical to autosomal recessive congenital ichthyosis: compact orthohyperkeratosis, slightly widened granular layer, acanthosis, papillomatosis Metze et al. 2021
Autosomal recessive congenital ichthyosis (lamellar ichthyosis, congenital ichthyosiform erythroderma, harlequin ichthyosis) TGM1 in 30%–40%; ABCA12 in harlequin ichthyosis and milder forms Compact orthohyperkeratosis, slightly widened granular layer, acanthosis, papillomatosis; forms are not separable histologically except harlequin ichthyosis Metze et al. 2021
Epidermolytic ichthyosis KRT1 or KRT10 (keratinopathic); palmoplantar keratoderma with KRT1 only Suprabasal vacuolization with hypereosinophilic granules (epidermolytic hyperkeratosis) Metze et al. 2021
Netherton syndrome SPINK5 (LEKTI), autosomal recessive Psoriasiform hyperplasia; absent LEKTI on immunohistochemistry Metze et al. 2021
  • Incidental epidermolytic hyperkeratosis. Small circumscribed foci of epidermolytic hyperkeratosis occur in normal skin near epithelial or melanocytic tumors and in cysts, scars and inflammatory dermatoses. The same pattern occurs in superficial epidermolytic ichthyosis (KRT2) and in epidermal nevi from mosaicism (Metze et al. 2021).
  • Filaggrin. Filaggrin deficiency predisposes to atopic dermatitis, and FLG mutations can coexist with X-linked ichthyosis (Metze et al. 2021).
  • Porokeratosis. The cornoid lamella is a column of parakeratosis over a small vertical zone of dyskeratotic and vacuolated cells, with an atrophic or thin granular layer beneath it (Anderska et al. 2024). Mutations in the mevalonate pathway (mevalonate decarboxylase, mevalonate kinase, phosphomevalonate kinase and farnesyl diphosphate synthase) cause porokeratosis. The lifetime incidence of skin cancer within the lesions ranges from 6.4% to 19% by type of porokeratosis, and squamous cell carcinoma is the most common (Anderska et al. 2024). The active border is the biopsy site of choice, and its lines may require perpendicular sectioning (Llamas-Velasco et al. 2026).
  • Acanthosis nigricans. All forms show papillomatosis, hyperkeratosis and hyperpigmentation of the basal layer. The clinical darkening reflects hyperkeratosis and thickening more than melanin. Types are benign, obesity-associated, syndromic, malignant, acral, unilateral, medication-induced and mixed. Acanthosis nigricans is a clinical surrogate of hyperinsulinemia and insulin resistance (Phiske 2014).
  • Darier and Hailey–Hailey disease. Darier disease (ATP2A2) and Hailey–Hailey disease (ATP2C1) are acantholytic genodermatoses (Ettinger et al. 2025; Porro et al. 2024) taught in Vesiculobullous and Pustular Dermatoses: Pemphigus, Pemphigoid, Dermatitis Herpetiformis, Epidermolysis Bullosa, Porphyria and Direct Immunofluorescence.

Pigmentary disorders: vitiligo, melasma and postinflammatory hyperpigmentation

  • Vitiligo. The main finding is total absence of functioning melanocytes in the lesion, with CD4-positive and CD8-positive T lymphocytes at the edges (Faria et al. 2014). Melan-A immunostaining shows no basal melanocytes in lesional skin, while normal skin shows numerous Melan-A-positive melanocytes along the basal layer. Lesional skin has significantly lower Melan-A expression and more CD8-positive T cells than control skin, and Melan-A-positive melanocytes can persist in some long-standing lesions (Özgün Geçer and Kaya 2025). Biopsy of normal and affected skin from the lesion edge allows comparison (Llamas-Velasco et al. 2026).
  • Melasma. Findings are epidermal hyperpigmentation, basement membrane disruption, dermal melanophages, solar elastosis and increased vascularity with mast cells. Melanophages are more common in dermal and mixed types (Zhang et al. 2025).
  • Postinflammatory hyperpigmentation. Epidermal postinflammatory hyperpigmentation shows melanin in basal and suprabasal keratinocytes. Dermal postinflammatory hyperpigmentation shows dermal melanophages, with or without residual inflammation (Zhang et al. 2025).
  • Café-au-lait macule and lentigo. Café-au-lait macules and solar lentigines are taught in WHO Pathway Classification of Melanocytic Tumors, Lentigines and Melanocytic Nevi, and melanoma in Cutaneous Melanoma: Subtypes, AJCC 8th Edition Staging, CAP Reporting, Sentinel Lymph Node and Metastatic Melanoma.
Hypopigmented mimic of vitiligo Histologic finding Source
Nevus depigmentosus Normal number of melanocytes with decreased melanin from defective melanosome formation and transfer Ju and Bae 2026
Piebaldism (KIT loss of function, autosomal dominant) Depigmented skin completely deficient in melanocytes Ju and Bae 2026
Hypopigmented parapsoriasis Mild spongiosis, focal exocytosis, CD8-positive T cells predominating over CD4-positive cells Ju and Bae 2026
Hypopigmented mycosis fungoides Epidermotropism of atypical cerebriform lymphocytes, predominantly CD8-positive Ju and Bae 2026
Clear cell papulosis Large intraepidermal clear cells along the basal layer, positive for EMA, CEA, CAM 5.2 and GCDFP-15 Ju and Bae 2026

Mucosal and genital dermatopathology: Zoon balanitis and vulvitis, genital melanosis

  • Zoon balanitis epidermis. Early lesions show epidermal thickening, acanthosis and parakeratosis, followed by atrophy, erosions and spongiosis of the lower spinous layer. Later lesions show subepidermal clefts, necrotic keratinocytes and lozenge keratinocytes (elongated keratinocytes in the lower spinous layer arranged parallel to the surface) (Dayal and Sahu 2016).
  • Zoon balanitis dermis. A band-like infiltrate replaces an early patchy lichenoid infiltrate. Plasma cells usually exceed 50% of the cells, with siderophages, hemosiderin and extravasated erythrocytes. Dilated proliferated vessels with a vertical or oblique orientation are characteristic (Dayal and Sahu 2016).
  • Zoon balanitis setting. It presents as a solitary persistent erythematous plaque on the glans, mainly in uncircumcised middle-aged to older men. Circumcision is the definitive treatment. Erythroplasia of Queyrat is the main clinical mimic (Dayal and Sahu 2016).
  • Zoon vulvitis. Histology shows a dense lichenoid infiltrate of the upper and mid dermis composed largely of plasma cells (>50%), with vascular proliferation, hemosiderin and extravasated erythrocytes. Erosive lichen planus is the main differential (Damiani et al. 2017).
  • Genital melanosis. Genital melanosis is benign hyperpigmentation of basal keratinocytes of the mucosa, with sparse basal dendritic melanocytes (Dika et al. 2023).
  • Lichen sclerosus. Genital and extragenital lichen sclerosus, its squamous carcinoma risk and differentiated VIN are taught in Interface and Lichenoid Dermatoses, Cutaneous Lupus and Dermatomyositis, Graft-versus-Host Disease, and Sclerosing Dermal Disorders. Lichen sclerosus, irritant dermatitis and psoriasis are the common genital conditions of children (Plantier and Lewis 2026).

Interface and Lichenoid Dermatoses, Cutaneous Lupus and Dermatomyositis, Graft-versus-Host Disease, and Sclerosing Dermal Disorders

Definition and standards. Interface dermatitis is lymphocyte-mediated injury of the basal layer with vacuolar change and apoptotic keratinocytes at the dermoepidermal junction (Kechichian et al. 2024). In the lichenoid pattern a dense band-like lymphocytic infiltrate obscures the junction (Scotti et al. 2025). No WHO classification or CAP protocol governs these disorders. Three consensus documents apply: the 1993 clinical classification of erythema multiforme, Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) by body surface area of detachment (Bastuji-Garin et al. 1993), the National Institutes of Health (NIH) 2014 consensus criteria for chronic graft-versus-host disease (GVHD) (Jagasia et al. 2015), and the Lerner histologic grades of acute cutaneous GVHD as tabulated by Villarreal et al. 2016. Previous rule (NIH 2005): the 2005 consensus proposed criteria for diagnosing and scoring chronic GVHD and divided chronic GVHD into classic chronic GVHD and an overlap syndrome with acute and chronic features together. The 2014 consensus keeps that framework, clarifies the overlap definition and revises the diagnostic criteria for mouth, eyes, genitalia and lungs (Jagasia et al. 2015).

Related page: Normal Skin, Biopsy Handling and the Reaction-Pattern Approach; Spongiotic, Psoriasiform, Keratinization and Pigmentary Disorders (biopsy timing for lupus and Stevens–Johnson syndrome, DIF transport, lichen simplex chronicus) Related page: Vesiculobullous and Pustular Dermatoses: Pemphigus, Pemphigoid, Dermatitis Herpetiformis, Epidermolysis Bullosa, Porphyria and Direct Immunofluorescence (bullous pemphigoid and paraneoplastic pemphigus with interface change, split levels and DIF patterns) Related page: Skin Infections and Infestations: Bacterial, Mycobacterial, Spirochetal, Fungal, Viral, Protozoal and Parasitic Infections of Skin (staphylococcal scalded skin syndrome and herpesvirus infection) Related page: Follicular Disorders, Alopecia, Nail Unit Pathology and Panniculitis: Rosacea, Folliculitis, Hidradenitis Suppurativa, Scarring and Non-scarring Alopecia, Hair Shaft and Nail Disorders, Septal and Lobular Panniculitis (lichen planopilaris, discoid lupus of the scalp, lupus panniculitis) Related page: Cutaneous Lymphoid and Hematolymphoid Infiltrates: Histologic Approach, Early Mycosis Fungoides and Its Mimics, CD30-Positive Lymphoproliferative Disorders, Rare Cutaneous T-Cell Lymphomas and Reactive Lymphoid Proliferations (lichenoid and hypopigmented mycosis fungoides, lymphomatoid papulosis and pityriasis lichenoides overlap) Related page: Autoantibody Testing in Systemic Autoimmune Rheumatic Diseases: ANA, ENA, Anti-dsDNA, Myositis Antibodies, Rheumatoid Factor and Anti-CCP (ANA, anti-Ro/SSA, lupus serology and dermatomyositis-specific antibodies) Related page: Esophagitis and Non-Neoplastic Diseases of the Esophagus (lichen planus esophagitis and GVHD of the esophagus) Related page: Oral Brush Cytology (oral lichen planus on brush cytology) Related page: Small Intestinal Mucosal Disease: Celiac Disease and Its Mimics, Infections, Drug Injury and Immune Enteropathies (GVHD of the intestine) Related page: Hepatic Vascular Disorders and Liver Transplant Pathology: Outflow Obstruction, Porto-Sinusoidal Vascular Disorder, Rejection and Donor Biopsy (GVHD of the liver)

Interface dermatitis: vacuolar and lichenoid patterns

Pattern Disease Key histologic features Source
Vacuolar Erythema multiforme Mild to moderate lymphocytic infiltrate entering the basal layer, basal vacuolar change, scattered apoptotic keratinocytes reaching suprabasal layers Kechichian et al. 2024
Vacuolar SJS and TEN Early vacuolar or lichenoid interface with necrotic keratinocytes; later full-thickness epidermal necrosis, orthokeratotic stratum corneum, sparse dermal inflammation Frantz et al. 2021
Vacuolar Fixed drug eruption Vacuolar interface dermatitis with superficial and deep perivascular eosinophils and lymphocytes, scattered necrotic keratinocytes, pigment incontinence Anderson and Lee 2021
Vacuolar Acute GVHD Basal vacuolar degeneration, dyskeratotic keratinocytes, mild superficial perivascular mononuclear infiltrate; injury begins at rete tips and follicles Villarreal et al. 2016
Vacuolar Lupus erythematosus Vacuolar interface change, basement membrane thickening, superficial and deep perivascular and periadnexal infiltrate, dermal mucin, follicular plugging Abu-Dayeh et al. 2026
Vacuolar Dermatomyositis Basal vacuolar change with mild to moderate mononuclear infiltrate and increased dermal mucin Kutwin et al. 2026
Vacuolar Pityriasis lichenoides et varioliformis acuta Basal vacuolar degeneration, lymphocyte exocytosis, intraepidermal erythrocytes, necrotic keratinocytes Thesiya et al. 2026
Lichenoid Lichen planus Band-like lymphocytes obscuring the junction, wedge-shaped hypergranulosis, compact orthokeratosis, Civatte bodies Scotti et al. 2025
Lichenoid Lichenoid drug eruption Lichenoid infiltrate, often focal, with eosinophils in about one-third and focal parakeratosis Promsena et al. 2025
Lichenoid Lichen planus-like keratosis Solitary lesion with acanthosis, hyperkeratosis and a dense subepidermal lymphoplasmacytic lichenoid infiltrate Bhatnagar et al. 2023
Lichenoid Lichen nitidus Circumscribed papillary dermal infiltrate of lymphocytes, epithelioid cells and Langhans giant cells ("ball in claw") Kumar et al. 2026
Lichenoid and spongiotic Lichen striatus Spongiotic, lichenoid or psoriasiform pattern with superficial and deep periadnexal lymphocytes Fortarezza et al. 2026

Lichen planus and its variants

  • Classic lichen planus. A dense lichenoid infiltrate with multiple apoptotic (colloid-hyaline, Civatte) bodies at the dermoepidermal junction is typical. Epidermal changes are compact orthokeratosis, hypergranulosis and elongated rete ridges (Scotti et al. 2025). Wedge-shaped hypergranulosis, saw-toothing of rete ridges, basal vacuolar degeneration and cytoid bodies are described in lichen planus of the lip (Garg et al. 2025). Max-Joseph spaces and saw-toothing are present in some cases (AlSulami et al. 2025).
  • Direct immunofluorescence. Shaggy fibrinogen and linear fibrin at the basement membrane and cytoid bodies are the DIF findings (Garg et al. 2025). Fibrin along the basement membrane with immunoglobulin and complement in colloid bodies favors hypertrophic lichen planus, and a lupus band favors discoid lupus (Abu-Dayeh et al. 2026).
Variant Distinguishing feature Source
Hypertrophic lichen planus Wedge-shaped hypergranulosis, irregular thickened rete, well-differentiated squamous epithelium confined to the superficial dermis; differential with squamous cell carcinoma, keratoacanthoma and lichen simplex chronicus Scotti et al. 2025
Bullous lichen planus Epithelial or subepithelial clefts with Civatte bodies Babu et al. 2019
Ulcerative (plantar) lichen planus Plantar ulcers; apoptotic keratinocytes, melanin incontinence, Max-Joseph spaces and saw-toothing in some cases AlSulami et al. 2025
Lichen planus pigmentosus and actinic lichen planus Grayish-brown patches of the face, neck and upper body; sun-exposed patches in darker phototypes Scotti et al. 2025
Lichen planopilaris Follicular lichen planus with perifollicular erythema and scarring alopecia Scotti et al. 2025
Lupus erythematosus–lichen planus overlap Combined histologic and immunologic features of both diseases in one specimen Abu-Dayeh et al. 2026
Lichen planus of the lip Histology mirrors cutaneous lichen planus: subepidermal lymphocytic band, melanophages and colloid bodies; shaggy fibrinogen on DIF Garg et al. 2025

Lichen planus-like keratosis

Lichenoid drug eruption and fixed drug eruption

  • Lichenoid drug eruption cohort. In a 17-year series of biopsy-confirmed cases, a lichenoid infiltrate was present in all cases and was focal in 58.8%. Parakeratosis was present in 17.7%. Necrotic keratinocytes were found in the basal layer in 82.4% and in the spinous layer in 38.2%. Eosinophils were present in a third of biopsies (Promsena et al. 2025).
  • Culprits and latency. Calcium channel blockers (42.5%) and statins (25.8%) were the most common culprits. The median latency was 10.1 months (Promsena et al. 2025).
  • Distinction from lichen planus. Eosinophils, plasma cells and focal parakeratosis are reported clues to lichenoid drug eruption. In this series, eosinophils were present in 32.6% and plasma cells in 8.8% of 34 biopsies, and no deep perivascular infiltrate was found (Promsena et al. 2025).
  • Fixed drug eruption histology. Vacuolar interface dermatitis with superficial and deep perivascular eosinophils and lymphocytes, scattered necrotic keratinocytes and pigment incontinence are seen. Lesions that recur at the same site show papillary dermal fibrosis and many melanophages (Anderson and Lee 2021).
  • Generalized bullous fixed drug eruption. A subepidermal blister or denuded epidermis with vacuolar change and necrotic keratinocytes is seen. Pigment incontinence was present in 100% of generalized bullous fixed drug eruptions compared with 33.3% of SJS/TEN, but the two cannot always be separated histologically (Anderson and Lee 2021).
  • Fixed drug eruption sites. In one series, 89% of women had limb lesions and 90% of men had genital lesions. Oral lesions accompanied 68.8% of genital fixed drug eruptions (Anderson and Lee 2021).

Lichen nitidus and lichen striatus

  • Lichen nitidus. Multiple discrete shiny skin-colored papules of 1–2 mm affect flexor arms, genitalia, chest, abdomen and dorsal hands. A dense, sharply circumscribed papillary dermal infiltrate of lymphocytes, epithelioid cells and Langhans giant cells forms the "ball in claw" configuration (Kumar et al. 2026).
  • Lichen striatus. Histology varies among spongiotic, lichenoid and psoriasiform patterns, often with vacuolar interface change, necrotic keratinocytes and superficial and deep perivascular and periadnexal lymphocytes. The epidermotropic lymphocytes are predominantly CD8-positive (Fortarezza et al. 2026). Deep periadnexal lymphocytes, especially around eccrine glands, are characteristic (Tirumalae 2013).
  • Lichen striatus versus folliculotropic mycosis fungoides. Spongiosis and necrotic keratinocytes favor lichen striatus. Atypical cerebriform lymphocytes, follicular mucinosis, basaloid adnexal hyperplasia and monoclonal TCR rearrangement favor folliculotropic mycosis fungoides (Fortarezza et al. 2026).

Erythema multiforme, Stevens–Johnson syndrome and toxic epidermal necrolysis

Clinical classification by body surface area of detachment (Bastuji-Garin et al. 1993)

Category Epidermal detachment (% body surface area) Lesion pattern
Bullous erythema multiforme Below 10% Localized typical targets or raised atypical targets
Stevens–Johnson syndrome Below 10% Widespread erythematous or purpuric macules or flat atypical targets
Overlap SJS–TEN Between 10% and 30% Widespread purpuric macules or flat atypical targets
TEN with spots Above 30% Widespread purpuric macules or flat atypical targets
TEN without spots Above 10% Large epidermal sheets without any purpuric macule or target
Feature Erythema multiforme SJS and TEN Source
Usual trigger Infection; herpes simplex virus is the most common agent, and Mycoplasma pneumoniae induces more diffuse lesions with more mucositis Drugs; no agent is identified in 15%–30% Kechichian et al. 2024; Frantz et al. 2021
Timing HSV lesions do not always precede erythema multiforme; recurrences can occur monthly Onset typically 4 days to 4 weeks after starting a drug, within 8 weeks Kechichian et al. 2024; Frantz et al. 2021
Target lesions Typical or atypical raised acral targets Flat targets Kechichian et al. 2024
Histology Interface dermatitis with lymphocytes in the basal layer, basal vacuolar change and scattered apoptotic keratinocytes in suprabasal layers Early vacuolar or lichenoid interface with necrotic keratinocytes; full-thickness epidermal necrosis, orthokeratotic stratum corneum and sparse dermal inflammation are typical but nonspecific Kechichian et al. 2024; Frantz et al. 2021
Direct immunofluorescence Nonspecific: apoptotic bodies, granular C3 at the junction and in papillary dermal vessels Used to exclude autoimmune blistering mimics Kechichian et al. 2024
  • Erythema multiforme major and SJS/TEN. Erythema multiforme major has histology identical to SJS/TEN, and the distinction rests on clinical correlation. The two were once placed on one spectrum and are now considered distinct diseases (Frantz et al. 2021).
  • Nomenclature proposal. A newer system groups SJS, SJS/TEN overlap and TEN as drug-induced epidermal necrolysis (Frantz et al. 2021).

Frozen section in suspected TEN versus staphylococcal scalded skin syndrome

  • Indication for frozen section. Frozen section of a skin biopsy separates staphylococcal scalded skin syndrome (SSSS) from SJS/TEN rapidly and guides urgent management (Alani et al. 2025).
  • SSSS. The frozen section shows a subcorneal split, an epidermis without necrosis, absent stratum corneum and scattered acantholytic cells in the granular layer (Alani et al. 2025).
  • TEN. Full-thickness epidermal necrosis with sparse dermal inflammation is typical (Frantz et al. 2021). Exfoliative toxin pathogenesis, impetigo and the epidemiology of SSSS are taught in Skin Infections and Infestations: Bacterial, Mycobacterial, Spirochetal, Fungal, Viral, Protozoal and Parasitic Infections of Skin.

Cutaneous graft-versus-host disease

  • Acute GVHD clinical setting. Acute cutaneous GVHD presents about 2–3 weeks after hematopoietic stem cell transplantation as a pruritic, painful morbilliform eruption, starting on the pinnae and neck and spreading to the cheeks, upper trunk, palms and soles. Its onset correlates with engraftment of donor cells (Villarreal et al. 2016).
  • Acute GVHD histology. Dyskeratotic keratinocytes, lymphocyte exocytosis, basal cell necrosis, depletion of Langerhans cells and satellite lymphocytes next to dyskeratotic keratinocytes are seen. Epithelial damage begins at the tips of rete ridges and in hair follicles. Not all findings are present in every biopsy, and histology is not always pathognomonic. Biopsy is indicated when infection or drug reaction is in the differential (Villarreal et al. 2016).
  • Engraftment syndrome. Fever, a morbilliform eruption, diarrhea and hepatic dysfunction can mimic acute GVHD. Engraftment syndrome begins several days before engraftment (absolute neutrophil count above 500/µL for 3 consecutive days), typically 1–3 weeks after transplantation, frequently involves the lungs and is often self-limited (Yan et al. 2025).
  • Histologic overlap with other post-transplant eruptions. Subtle interface dermatitis, basal vacuolar change, dyskeratosis and a superficial lymphocytic infiltrate occur in acute GVHD, drug eruptions and the eruption of lymphocyte recovery. Follicular involvement by the interface dermatitis and the absence of many eosinophils favor acute GVHD, but no combination of dyskeratosis, basal vacuolization, satellitosis, adnexal necrotic cells and eosinophil count is an optimal test. FISH can show that the interface lymphocytes are of donor origin only in sex-mismatched transplants (Yan et al. 2025).
  • Elafin immunohistochemistry. In 68 rash episodes after stem cell transplantation, epidermal elafin staining was positive in all acute GVHD episodes (sensitivity 100%) and in 9 of 23 non-GVHD episodes, 6 of them engraftment syndrome (specificity 58.3%). Elafin therefore does not separate GVHD from engraftment syndrome (Mahabal et al. 2026).
  • Acute versus chronic GVHD (NIH 2014). Clinical features decide whether GVHD is acute or chronic, independent of the time after transplantation. Classic acute GVHD occurs within 100 days of transplantation or donor lymphocyte infusion. Persistent, recurrent or late-onset acute GVHD has the same features beyond 100 days (Jagasia et al. 2015).

Histologic grades of acute cutaneous GVHD (Lerner) and clinical skin stages, as tabulated by Villarreal et al. 2016

Grade or stage Lerner histologic grade Clinical skin stage
0 Normal skin No GVHD rash
1 Mild vacuolization of epidermal cells Maculopapular rash <25% of body surface area
2 Diffuse vacuolization of basal cells with scattered dyskeratotic bodies Maculopapular rash 25%–50% of body surface area
3 Subepidermal cleft formation Maculopapular rash >50% of body surface area
4 Complete epidermal separation Generalized erythroderma with bullae
  • Chronic lichenoid GVHD. Histology resembles classic lichen planus: hyperkeratosis, hypergranulosis, acanthosis and dyskeratotic keratinocytes with basal vacuolization, with a moderate to marked band-like infiltrate along the junction (Villarreal et al. 2016).
  • Chronic sclerotic GVHD. Sclerosis can affect every skin level. Lichen sclerosus-like lesions show epidermal atrophy, edema and homogenized upper dermal collagen. Morphea-like lesions show pandermal, patchy or deep dermal sclerosis, and panniculitis with fibrosis and fasciitis is frequent. Sclerotic GVHD is preceded by lichenoid lesions in only 40% of cases and usually occurs after day 500 (Villarreal et al. 2016).

NIH 2014 skin manifestations of chronic GVHD (Jagasia et al. 2015)

Category Skin manifestations Diagnostic weight
Diagnostic Poikiloderma; lichen planus-like features; deep sclerotic features; morphea-like superficial sclerotic features; lichen sclerosus-like features Sufficient alone to establish chronic GVHD
Distinctive Depigmentation; papulosquamous lesions Require biopsy or other confirmation in skin or another organ
Other features Sweat impairment, ichthyosis, keratosis pilaris, hypopigmentation, hyperpigmentation Not used to establish the diagnosis
Common to acute and chronic GVHD Erythema, maculopapular rash, pruritus Not used to establish the diagnosis
  • Diagnostic rule. Chronic GVHD requires at least one diagnostic manifestation, or one distinctive manifestation plus a pertinent biopsy, laboratory test, specialist evaluation or imaging in the same or another organ, with infection and other causes excluded (Jagasia et al. 2015).
  • Changes from NIH 2005. The 2014 document clarifies the "overlap" subcategory as one or more acute GVHD features in a patient with chronic GVHD. In the mouth, isolated hyperkeratotic plaques without lichen planus-like change (leukoplakia) are no longer a diagnostic criterion, and asymptomatic lichen planus-like features are scored 0 (Jagasia et al. 2015).

Cutaneous lupus erythematosus

Cutaneous lupus erythematosus (CLE) is divided into acute, subacute and chronic subtypes (Fijałkowska et al. 2024). All subtypes share epidermal vacuolization and apoptosis, interface dermatitis, periappendageal inflammation, follicular plugging, basement membrane thickening and dermal mucin to varying degrees (Jarrett and Werth 2019).

Subtype Clinical features Histology and DIF Source
Acute CLE Malar rash, transient, non-scarring, photosensitive, often with active SLE Vacuolar interface dermatitis, mild lymphocytic infiltrate and dermal edema Fijałkowska et al. 2024
Subacute CLE Annular or papulosquamous lesions on sun-exposed upper trunk and arms; anti-Ro/SSA; heals without scarring Vacuolar interface dermatitis with many cytoid bodies; deeper perivascular and perieccrine infiltrate than acute CLE; less dermal infiltrate than discoid lupus and few periadnexal infiltrates; lupus band test positive in 65%–80% Fijałkowska et al. 2024
Discoid lupus (chronic CLE) Scaly plaques with follicular hyperkeratosis that heal with scarring and scarring alopecia Vacuolar interface change, thickened basement membrane, superficial and deep perivascular and periadnexal infiltrate, dermal mucin, follicular plugging; continuous granular IgG, IgA, IgM and C3 at the basement membrane zone Jarrett and Werth 2019; Abu-Dayeh et al. 2026
Hypertrophic discoid lupus Mimics keratoacanthoma, hypertrophic lichen planus and squamous cell carcinoma Irregular epidermal proliferation with vacuolar change; lupus band test positive in 50%–90% Fijałkowska et al. 2024
Lupus tumidus Edematous urticarial plaques in sun-exposed sites; no epidermal change and no scarring Superficial and deep perivascular and periadnexal lymphocytes with prominent mucin Fijałkowska et al. 2024
Lupus panniculitis Deep nodules that heal with lipoatrophy Lymphocytes, hyaline fat necrosis and nuclear dust in fat lobules; lupus band test positive in 70%–90% Fijałkowska et al. 2024

Dermatomyositis in skin

  • Histology. Vacuolar change of the basal layer with a mild to moderate mononuclear infiltrate (interface dermatitis) and increased dermal mucin are the hallmark findings (Kutwin et al. 2026). In most cases the skin histology of dermatomyositis and cutaneous lupus is indistinguishable (Fijałkowska et al. 2024).
  • Juvenile dermatomyositis. Biopsies most often show interface dermatitis and cutaneous microangiopathy (Kutwin et al. 2026).
  • Clinical signs and antibodies. Heliotrope rash, Gottron papules and the V and shawl signs separate dermatomyositis from lupus clinically (Fijałkowska et al. 2024). Dermatomyositis-specific antibodies (anti-TIF1-γ, anti-MDA5) are taught in Autoantibody Testing in Systemic Autoimmune Rheumatic Diseases: ANA, ENA, Anti-dsDNA, Myositis Antibodies, Rheumatoid Factor and Anti-CCP.

Pityriasis lichenoides

  • Spectrum. Pityriasis lichenoides comprises pityriasis lichenoides et varioliformis acuta (PLEVA, Mucha–Habermann disease), pityriasis lichenoides chronica (PLC) and the febrile ulceronecrotic variant. PLEVA lesions are erythematous or necrotic papules in different stages that heal with varioliform scars (Thesiya et al. 2026).
  • PLEVA histology. Mild acanthosis, focal spongiosis, basal vacuolar degeneration, lymphocyte exocytosis, erythrocytes within the epidermis, scattered necrotic keratinocytes and a dense superficial perivascular lichenoid lymphocytic infiltrate are seen. Absence of a plasma cell-rich infiltrate argues against syphilis, and absence of parakeratosis with a preserved granular layer argues against guttate psoriasis (Thesiya et al. 2026).
  • PLC histology. Confluent parakeratosis and thin, wiry papillary dermal collagen are seen (Tirumalae 2013).
  • Lymphomatoid papulosis overlap. T-cell clonality and overlap with lymphomatoid papulosis are taught in Cutaneous Lymphoid and Hematolymphoid Infiltrates: Histologic Approach, Early Mycosis Fungoides and Its Mimics, CD30-Positive Lymphoproliferative Disorders, Rare Cutaneous T-Cell Lymphomas and Reactive Lymphoid Proliferations.

Poikiloderma and erythema dyschromicum perstans

  • Poikiloderma. Poikiloderma is the combination of atrophy, pigmentary change and telangiectasia, and it is a diagnostic feature of chronic cutaneous GVHD (Jagasia et al. 2015).
  • Erythema dyschromicum perstans. It presents as asymptomatic, slowly progressive ashy-gray macular hyperpigmentation. Numata et al. regard erythema dyschromicum perstans and ashy dermatosis as two distinct entities, although a few cases fit both (Numata et al. 2015).
  • Erythema dyschromicum perstans histology. Degeneration of the basal epidermis and pigment incontinence with melanophages result from a T-cell-mediated interface dermatitis that targets basal keratinocytes (Golani et al. 2025). The epidermis can be atrophic, with a superficial perivascular lymphocytic infiltrate (Ravić Nikolić et al. 2022). Lichen planus, postinflammatory hyperpigmentation and discoid lupus are the histologic differentials (Golani et al. 2025).

Lichen sclerosus of genital and extragenital skin

  • Histology. Typical lichen sclerosus shows hyperorthokeratosis, epithelial atrophy, superficial dermal sclerosis containing melanophages and a band-like lymphocytic infiltrate beneath the sclerosis. Epidermal atrophy, basal apoptotic keratinocytes, a band-like infiltrate, ectatic vessels and melanophages are seen in 40%–90% of cases (Plantier and Lewis 2026). The homogenized, hyalinized collagen has a glassy appearance (Sever et al. 2025).
  • Early lichen sclerosus. Early lesions show parakeratotic scale, irregular epidermal thickening, a subepithelial infiltrate and beginning collagen homogenization (Sever et al. 2025). Basement membrane zone change can precede overt sclerosis and overlap with other interface dermatitides (Abu-Dayeh et al. 2026).
  • Variants. Perifollicular lichen sclerosus shows sclerosis only around the follicular ostium with underlying lymphocytes. Syringitis shows acrosyringeal acanthosis, neutrophils in the sweat duct epithelium and basement membrane thickening (Plantier and Lewis 2026).
  • Distribution. The incidence of lichen sclerosus is bimodal, with a first peak in girls aged 5–9 years and a second in postmenopausal women (Sever et al. 2025). In 130 prepubertal girls with vulvar complaints, 18% had lichen sclerosus (Plantier and Lewis 2026). Extragenital involvement occurs in about 15%–20% of cases (Sever et al. 2025).
  • Differentiated VIN and squamous cell carcinoma. Differentiated VIN is an HPV-independent high-grade lesion associated with lichen sclerosus and is a high-risk precursor of vulvar squamous cell carcinoma. The absolute risk of vulvar squamous cell carcinoma after a solitary differentiated VIN is about 33%–43% (Sever et al. 2025). In a cohort cited by Vasconcellos et al. 2024, the cumulative probability of progression of vulvar lichen sclerosus to neoplasia rose from about 1% at 2 years to almost 37% at 25 years.
  • Male genital lichen sclerosus. Male genital lichen sclerosus carries a risk of penile squamous cell carcinoma, reported as up to 30% in one case-based review (Couto et al. 2026).
  • Lichen sclerosus mimics. Lichen sclerosus-like chronic GVHD shows the same epidermal atrophy and upper dermal homogenization (Villarreal et al. 2016). Extramammary Paget disease is taught in Cutaneous Adnexal Neoplasms: Follicular, Sebaceous, Apocrine and Eccrine Tumors, Adnexal Carcinomas, Paget Disease and Associated Syndromes.

Sclerosing dermal disorders: morphea, eosinophilic fasciitis and nephrogenic systemic fibrosis

Disorder Level and histology Associations and key tests Source
Morphea (including morphea profunda) Epidermal atrophy, superficial and deep dermal sclerosis, atrophic eccrine glands with loss of periadnexal fat, perivascular lymphoplasmacytic infiltrate at the dermal–subcutaneous junction Biopsy of the inflammatory border with adjacent indurated skin; Masson trichrome for collagen Stephens et al. 2022; Llamas-Velasco et al. 2026
Radiation-induced morphea Early perivascular and periadnexal lymphocytes; later thickened sclerotic collagen, compressed eccrine coils with loss of periadnexal fat, rare atypical radiation fibroblasts and plasma cells Prior radiotherapy; reported after breast cancer treatment Yee et al. 2026
Systemic sclerosis Cutaneous fibrosis extending to subcutaneous and fascial tissue Anti-Scl-70; Raynaud phenomenon in about 95%; decreased CD34-positive dermal dendrocytes support scleroderma Dang et al. 2025; Ju and Bae 2026
Eosinophilic fasciitis Fascial thickening with lymphocytes and macrophages; eosinophils not required Peripheral eosinophilia, hypergammaglobulinemia, groove sign, T2 fascial hyperintensity on MRI Dang et al. 2025
Nephrogenic systemic fibrosis Dermal spindle cells dual positive for CD34 and procollagen; thick collagen bundles separated by clefts; extension into subcutis, fascia and muscle Severe renal insufficiency and gadolinium-based contrast agents; deep biopsy mandatory Waikhom and Taraphder 2011; Zou and Ma 2011

Eosinophilic fasciitis criteria (Pinal-Fernandez 2014, as tabulated by Dang et al. 2025)

Criterion type Criteria
Major (1) Swelling, induration and thickening of skin and subcutaneous tissue, diffuse or localized to the limbs; (2) fascial thickening with lymphocytic and macrophage infiltration on biopsy, eosinophils not required
Minor (1) Peripheral eosinophilia; (2) hypergammaglobulinemia (>1.5 g/L); (3) muscle weakness with or without elevated aldolase; (4) groove sign or peau d'orange; (5) high T2 signal in the fascia on MRI
Diagnosis After exclusion of systemic sclerosis: both major criteria, or one major plus at least two minor criteria
  • Morphea profunda versus eosinophilic fasciitis. Absence of fascial thickening on a wedge biopsy argues against eosinophilic fasciitis in deep morphea (Stephens et al. 2022). Eosinophilia is frequent in the acute phase, declines in chronic cases and does not exclude active disease when absent (Dang et al. 2025).
  • Nephrogenic systemic fibrosis evolution. Biopsies within 20 weeks of onset show more dermal spindle cells, and later biopsies show large collagen bundles with elastic fibers. CD34-positive dendritic cells and CD68-positive macrophages decrease with time (Waikhom and Taraphder 2011). Restricted use of gadolinium-enhanced MRI in severe renal failure has virtually eliminated the disease. Circulating fibrocytes are proposed to link gadolinium deposition to fibrosis (Zou and Ma 2011).

Radiation dermatitis

  • Chronic radiation dermatitis histology. Ulceration, prominent telangiectasia, atypical stellate fibroblasts, epidermal atrophy and absence of inflammation are characteristic. Dermal sclerosis with dilated superficial vessels is seen in fluoroscopy-induced disease (Lyons et al. 2015).
  • Clinical course. Chronic radiation dermatitis appears months to years after exposure, with ulceration, late dermal necrosis and secondary skin cancers (Lyons et al. 2015).
  • Dose thresholds. Skin injury rises with dose: transient ischemia at 2 Gy, permanent erythema at 7 Gy, telangiectasia at 12 Gy, dermal necrosis at 18 Gy and secondary ulceration at 20 Gy (Lyons et al. 2015).

Keloid versus hypertrophic scar

Feature Keloid Hypertrophic scar Source
Growth Extends beyond the borders of the original wound; no regression Confined to the wound; plateaus after months of growth and then regresses Limandjaja et al. 2021
Keloidal collagen Present constitutively and abundantly; the strongest keloid parameter Absent or negligible, rarely present Limandjaja et al. 2021
Dermal nodules and α-SMA Smaller nodules if any; α-SMA limited and strongest at the scar margins Strong diffuse α-SMA concentrated in larger dermal nodules Limandjaja et al. 2021
Vessels Small aggregating subepidermal vessels Prominent vertically oriented vessels Limandjaja et al. 2021
Other markers Tongue-like advancing edge beneath normal epidermis, horizontal fascia-like band, horizontal cellular fibrous band in the upper reticular dermis; thickened epidermis with abnormal involucrin; higher p16 Normal or increased epidermal involucrin Limandjaja et al. 2021

Vesiculobullous and Pustular Dermatoses: Pemphigus, Pemphigoid, Dermatitis Herpetiformis, Epidermolysis Bullosa, Porphyria and Direct Immunofluorescence

Definition and classification. Autoimmune blistering diseases (AIBD) are divided into the pemphigus group, with intraepidermal split formation, acantholysis and autoantibodies against desmosomal proteins, the pemphigoid group, with autoantibodies against structural proteins of the basement membrane zone (BMZ) and subepidermal splitting, and dermatitis herpetiformis, with autoantibodies against transglutaminases 2 and 3 (van Beek et al. 2024). No WHO classification or CAP protocol applies. Diagnosis combines the clinical picture, lesional histopathology, direct immunofluorescence (DIF) of a perilesional biopsy and serology (Di Lernia et al. 2020). DIF of a perilesional biopsy is the diagnostic gold standard, with a sensitivity of about 91% and a specificity of about 98% across studies (van Beek et al. 2024).

Related page: Normal Skin, Biopsy Handling and the Reaction-Pattern Approach; Spongiotic, Psoriasiform, Keratinization and Pigmentary Disorders (biopsy site selection, Michel transport medium and saline transport for DIF, eosinophilic spongiosis and pustular psoriasis) Related page: Interface and Lichenoid Dermatoses, Cutaneous Lupus and Dermatomyositis, Graft-versus-Host Disease, and Sclerosing Dermal Disorders (erythema multiforme, Stevens–Johnson syndrome and toxic epidermal necrolysis, bullous lichen planus) Related page: Skin Infections and Infestations: Bacterial, Mycobacterial, Spirochetal, Fungal, Viral, Protozoal and Parasitic Infections of Skin (impetigo, staphylococcal scalded skin syndrome and herpesvirus vesicles) Related page: ANCA, Anti-GBM and Organ-Specific Autoantibodies: Kidney, Liver, Thyroid, Pancreas and Nervous System (desmoglein 1 and 3, BP180 and BP230 ELISA and indirect immunofluorescence substrates) Related page: Melanoma, Merkel Cell Carcinoma and Skin FNA (Tzanck smear in vesiculobullous lesions) Related page: Oral Brush Cytology (oral pemphigus and herpes simplex on brush cytology) Related page: Small Intestinal Mucosal Disease: Celiac Disease and Its Mimics, Infections, Drug Injury and Immune Enteropathies (celiac disease in dermatitis herpetiformis) Related page: Porphyrias and Vitamin Testing (porphyria cutanea tarda biochemistry and UROD) Related page: Follicular Disorders, Alopecia, Nail Unit Pathology and Panniculitis: Rosacea, Folliculitis, Hidradenitis Suppurativa, Scarring and Non-scarring Alopecia, Hair Shaft and Nail Disorders, Septal and Lobular Panniculitis (eosinophilic pustular folliculitis and other follicular pustules)

Current consensus documents for blistering diseases and their previous versions

Topic Current document Previous rule Source
Pemphigus vulgaris and foliaceus EADV S2k guideline, 2020 EDF and EADV S2 guideline for diagnosis and treatment, 2015; the 2020 update was issued after rituximab was approved as first-line treatment for moderate and severe pemphigus vulgaris in Europe and the United States Joly et al. 2020; Hertl et al. 2015
Dermatitis herpetiformis EADV S2k guideline, 2021 No European consensus on management existed before 2021 Görög et al. 2021
AIBD in children and adolescents European S2k guideline, 2026 No guideline for AIBD in children existed before 2026 Nanda et al. 2026
Inherited epidermolysis bullosa (EB) Consensus reclassification, 2020 2014 international consensus classification Has et al. 2020

The 2026 pediatric guideline states that the diagnostic approach in children does not differ from that in adults. Linear IgA disease is the most common AIBD in children (42%–83%) (Nanda et al. 2026).

Approach to a blister by split level, inflammatory cells and direct immunofluorescence

Lesional histopathology separates intraepidermal acantholytic splits from subepidermal splits. Histopathology alone does not separate the pemphigoid diseases from dermatitis herpetiformis (van Beek et al. 2024). DIF then narrows the diagnosis by immunoreactant and binding pattern, and serology identifies the target antigen (Witte et al. 2018).

Disease Split level and lesional histology Dominant cells DIF of perilesional skin Target antigen Source
Pemphigus vulgaris Suprabasal acantholysis; basal keratinocytes stay attached to the BMZ ("tombstone" row) Few cells; eosinophils may be present in the cavity Intercellular net-like IgG and/or C3 Desmoglein 3, plus desmoglein 1 with skin lesions van Beek et al. 2024; Di Lernia et al. 2020; Witte et al. 2018
Pemphigus foliaceus Subcorneal split with acantholysis Few cells Intercellular IgG and/or C3 Desmoglein 1 van Beek et al. 2024; Di Lernia et al. 2020
Paraneoplastic pemphigus Acantholysis with dyskeratosis, vacuolar degeneration of the BMZ and lichenoid infiltrate of the upper dermis Lymphocytes Intercellular plus linear BMZ IgG and/or C3 Envoplakin and periplakin most often; also desmoplakins, plectin, BP230, desmogleins and desmocollins van Beek et al. 2024; Witte et al. 2018
IgA pemphigus, subcorneal pustular dermatosis type Subcorneal pustules with mild acantholysis Neutrophils Intercellular IgA in the upper epidermis Desmocollin 1 Porro et al. 2014
IgA pemphigus, intraepidermal neutrophilic type Suprabasal pustules in the lower or entire epidermis Neutrophils Intercellular IgA in the lower or entire epidermis Undetermined in most cases; rare cases desmoglein 1 or 3 Porro et al. 2014
Bullous pemphigoid Subepidermal blister; eosinophilic spongiosis in the non-bullous phase Eosinophils, lymphocytes; neutrophil-rich patterns also occur Linear IgG and/or C3, n-serrated BP180 (NC16A domain), BP230 van Beek et al. 2024; Di Lernia et al. 2020
Pemphigoid gestationis Split often absent early Eosinophils Linear C3; IgG in about one-third BP180 NC16A van Beek et al. 2024
Mucous membrane pemphigoid Subepithelial split with fewer inflammatory cells than bullous pemphigoid Mixed Linear IgG, IgA and/or C3; positive in 60%–90% of first biopsies BP180 (often C-terminal), laminin 332, α6β4 integrin, type VII collagen van Beek et al. 2024; Kamaguchi and Iwata 2019; Witte et al. 2018
Linear IgA disease Subepidermal split with neutrophils along the BMZ and in dermal papillae Neutrophils, some eosinophils Linear IgA at the BMZ LAD-1 (shed BP180 ectodomain); type VII collagen in some cases van Beek et al. 2024; Witte et al. 2018
Epidermolysis bullosa acquisita Subepidermal split; histology cannot separate it from other pemphigoid diseases Few cells (mechanobullous) or neutrophils (inflammatory) Linear IgG, IgA or C3, u-serrated Type VII collagen (NC1 domain) van Beek et al. 2024; Koga et al. 2018
Anti-p200 pemphigoid Resembles bullous pemphigoid Eosinophils and neutrophils Linear IgG and/or C3, n-serrated Laminin γ1 in 70%–90%; laminin β4 also reported van Beek et al. 2024
Dermatitis herpetiformis Neutrophilic microabscesses, nuclear dust and fibrin in dermal papillae; subepidermal split Neutrophils, variable eosinophils Granular IgA at the tips of dermal papillae and/or along the BMZ Epidermal transglutaminase (TG3) van Beek et al. 2024; Witte et al. 2018
Hailey–Hailey disease Suprabasal acantholysis of the epidermis sparing adnexal epithelium ("dilapidated brick wall") Few cells Negative None (ATP2C1 variant) Porro et al. 2024
Porphyria cutanea tarda Cell-poor subepidermal blister, festooned dermal papillae, caterpillar bodies, thickened vessel walls Few cells Immunoglobulin and complement along the BMZ and around vessels None (UROD deficiency) Leasure et al. 2022; Cohen 2023

DIF on frozen sections shows intercellular net-like deposits in the pemphigus group, linear deposits of IgG, IgA and/or C3 (rarely IgE or IgM) at the BMZ in the pemphigoid group, and granular IgA in dermatitis herpetiformis (van Beek et al. 2024). In pemphigus vulgaris, complement may be absent because IgG4, the dominant subclass, does not fix complement (Di Lernia et al. 2020). In a 10-year Brazilian series, intercellular IgG was found in 91.5% and intercellular C3 in 79.5% of 142 patients with pemphigus vulgaris, and intercellular IgG in 94% of 117 patients with pemphigus foliaceus (Arbache et al. 2014). Shaggy fibrinogen along the BMZ with cytoid bodies is the DIF pattern of lichen planus (Garg et al. 2025), taught in Interface and Lichenoid Dermatoses, Cutaneous Lupus and Dermatomyositis, Graft-versus-Host Disease, and Sclerosing Dermal Disorders.

Serration pattern analysis of linear basement membrane deposits

Linear BMZ staining is subdivided into n-serrated and u-serrated patterns on 6-µm cryosections at 400–600-fold magnification. The u-serrated pattern has arches closed at the bottom ("growing grass") and is pathognomonic for antibodies to type VII collagen, which occur in epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Every other pemphigoid disease shows the n-serrated pattern, with arches closed at the top (Witte et al. 2018; van Beek et al. 2024). The pattern cannot be read in about one-quarter of samples or in mucosal biopsies (van Beek et al. 2024).

Salt-split skin: roof and floor binding

Incubation of normal human skin in 1 M NaCl splits the lamina lucida. Indirect immunofluorescence on this substrate is the most sensitive tissue test for pemphigoid autoantibodies and separates epidermal ("roof") from dermal ("floor") binding (Witte et al. 2018; van Beek et al. 2024).

Binding side Antigens Diseases Source
Roof (epidermal side) BP180, BP230 Bullous pemphigoid, pemphigoid gestationis, linear IgA disease (lamina lucida type), anti-BP180 mucous membrane pemphigoid Witte et al. 2018
Floor (dermal side) Type VII collagen, laminin 332, laminin γ1 (p200) Epidermolysis bullosa acquisita, anti-laminin 332 mucous membrane pemphigoid, anti-p200 pemphigoid, linear IgA disease with type VII collagen antibodies Witte et al. 2018; van Beek et al. 2024

Monkey esophagus is the most sensitive substrate for pemphigus antibodies, and monkey or rat bladder epithelium detects the plakin antibodies of paraneoplastic pemphigus. In dermatitis herpetiformis, IgA binds the endomysium of monkey esophagus (van Beek et al. 2024). The complement binding test adds a complement source to salt-split skin and detects the complement-fixing IgG1 and IgG3 antibodies of pemphigoid gestationis (Witte et al. 2018). Antibody assays and ELISA performance are taught in ANCA, Anti-GBM and Organ-Specific Autoantibodies: Kidney, Liver, Thyroid, Pancreas and Nervous System.

Biopsy for histology and direct immunofluorescence

Biopsy site selection and transport for histology and DIF are taught in Normal Skin, Biopsy Handling and the Reaction-Pattern Approach; Spongiotic, Psoriasiform, Keratinization and Pigmentary Disorders. A non-lesional buccal mucosal biopsy is as sensitive as a perilesional one in pemphigus vulgaris and mucous membrane pemphigoid; perilesional mucosa does slightly better in oral pemphigus vulgaris, and the gingiva is avoided (van Beek et al. 2024; Mahmood 2024). In mucous membrane pemphigoid, a repeat biopsy increases DIF sensitivity (van Beek et al. 2024). Immunohistochemistry for C3d or C4d on lesional biopsies shows linear BMZ staining in pemphigoid diseases but has low sensitivity and specificity, and it serves only when DIF and serology are unavailable (van Beek et al. 2024).

Pemphigus vulgaris, pemphigus vegetans and pemphigus herpetiformis

  • Clinical forms and antigens. Pemphigus vulgaris usually begins in the oral mucosa (Di Lernia et al. 2020). By extent of skin involvement it is divided into a mucosal-dominant type with predominant desmoglein 3 antibodies, a mucocutaneous type with desmoglein 3 and desmoglein 1 antibodies, and a cutaneous type with predominant desmoglein 1 and pathogenically weak desmoglein 3 antibodies (Witte et al. 2018). Pemphigus vulgaris is 4 to 9 times more common than pemphigus foliaceus, and its incidence in Central Europe and the United States is 1–7 per million per year (Witte et al. 2018).
  • Histology. An early intact blister, or the active border of an erosion, shows suprabasal acantholysis with a few eosinophils in the cavity and minimal surrounding inflammation. Eosinophilic spongiosis without acantholysis can be the only change in early lesions (Di Lernia et al. 2020). Acantholysis in pemphigus vulgaris involves all epithelia, including adnexal epithelium (Porro et al. 2024).
  • Pemphigus vegetans is a variant of pemphigus vulgaris with IgG to desmoglein 3, desmoglein 1 and desmocollin 3 (Di Lernia et al. 2020). The Hallopeau type begins with pustules and the Neumann type with flaccid vesicles, and both evolve into vegetating plaques, mainly in flexures. Biopsies show papillomatosis, acanthosis and suprabasal acantholysis, with eosinophilic spongiosis and intraepidermal eosinophilic microabscesses. DIF shows intercellular IgG and C3 (Marhraoui et al. 2026; Haldankar et al. 2026).
  • Pemphigus herpetiformis presents with grouped vesicles and pustules in a herpetiform pattern. Its histology varies between biopsies and includes subcorneal pustules or intraepidermal vesicles with neutrophils and/or eosinophils and neutrophilic or eosinophilic spongiosis, often with little acantholysis. DIF shows intercellular IgG and C3 (Porro et al. 2014). Its antibodies target desmoglein 1, less often desmoglein 3, and desmocollins (Di Lernia et al. 2020).
  • Tzanck smear. Scrapings from the base of a blister show acantholytic keratinocytes, but acantholytic cells also occur secondary to inflammation or ballooning, and the smear does not replace histology (Di Lernia et al. 2020). Cytologic features are taught in Melanoma, Merkel Cell Carcinoma and Skin FNA.

Pemphigus foliaceus and pemphigus erythematosus

Pemphigus foliaceus presents with flaccid superficial erosions with scale in seborrheic areas, and mucous membranes are spared (Witte et al. 2018). Lesional histology shows a subcorneal split with acantholysis (van Beek et al. 2024). Antibodies target desmoglein 1, and their levels correlate with disease activity (Witte et al. 2018). Fogo selvagem is the endemic form, and pemphigus erythematosus is a variant with desmoglein 1 antibodies (Di Lernia et al. 2020). Pemphigus erythematosus favors seborrheic areas. Biopsies show acantholysis in the granular layer, and DIF shows intercellular IgG and C3, sometimes with a lupus band pattern and a positive ANA (Kirmani and Shegog 2025). Staphylococcal scalded skin syndrome and bullous impetigo are taught in Skin Infections and Infestations: Bacterial, Mycobacterial, Spirochetal, Fungal, Viral, Protozoal and Parasitic Infections of Skin.

Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome)

  • Definition and associations. Paraneoplastic pemphigus (PNP) was described by Anhalt in 1990 in patients with lymphoproliferative disease. The term paraneoplastic autoimmune multiorgan syndrome reflects its non-cutaneous involvement (Porro et al. 2014). The most frequent associated neoplasms are B-cell lymphoma, Castleman disease, chronic lymphocytic leukemia, thymoma and Waldenström macroglobulinemia, and bronchiolitis obliterans occurs in many patients (Witte et al. 2018). The neoplasm may become manifest only during the course of the disease (van Beek et al. 2024).
  • Clinical forms. Painful progressive stomatitis is the typical first manifestation. Skin lesions are pemphigus-like, bullous pemphigoid-like, erythema multiforme-like, graft-versus-host disease-like or lichen planus-like (Porro et al. 2014).
  • Histology and DIF. Lesions show acantholysis, dyskeratosis, vacuolar degeneration of the BMZ and a lichenoid infiltrate in the upper dermis. DIF often shows linear IgG at the dermal–epidermal junction in addition to intercellular staining (van Beek et al. 2024).
  • Serology. Antibodies against envoplakin (210 kDa) and periplakin (190 kDa) are the most frequent (Witte et al. 2018; Porro et al. 2014). Rat bladder epithelium is the classic indirect immunofluorescence substrate (van Beek et al. 2024).

IgA pemphigus and subcorneal pustular dermatosis

  • IgA pemphigus is a vesiculopustular eruption with neutrophil infiltration, mild acantholysis and tissue-bound and circulating IgA against keratinocyte cell-surface components. DIF of perilesional skin shows intercellular IgA in all cases, and IgG or C3 is weaker when present. The subcorneal pustular dermatosis (SPD) type targets desmocollin 1 and shows subcorneal pustules with IgA limited to the upper epidermis. The intraepidermal neutrophilic (IEN) type shows suprabasal pustules in the lower or entire epidermis and a "sunflower-like" clinical configuration. The axillae and groin are sites of predilection. IgA monoclonal gammopathy, myeloma and B-cell lymphoma are reported associations, especially with the SPD type (Porro et al. 2014).
  • Subcorneal pustular dermatosis (Sneddon–Wilkinson disease) is a chronic relapsing eruption, most often in women aged 50–80 years, of flaccid pustules that become annular or serpiginous over 24–48 hours, often with a hypopyon sign. Subcorneal accumulation of neutrophils is the salient histologic feature. Associations include IgA paraproteinemia, multiple myeloma, rheumatoid arthritis and Sjögren syndrome (Xu and Tan 2023).

Acantholytic genodermatoses and Grover disease

Disorder Gene and protein Clinical features Histology Source
Hailey–Hailey disease (familial benign pemphigus) ATP2C1 (chromosome 3q21–q24), transmembrane protein hSPCA1; autosomal dominant with complete penetrance; sporadic in 15%–30% Recurrent vesicles, erosions and maceration of intertriginous sites; onset in the 2nd to 4th decades; prevalence about 1 in 50,000 Suprabasal acantholysis with loosely joined keratinocytes ("dilapidated brick wall") and few dyskeratotic cells; adnexal epithelium spared; DIF negative Porro et al. 2024
Darier disease ATP2A2, sarco/endoplasmic reticulum calcium ATPase SERCA2; autosomal dominant Greasy hyperkeratotic papules in seborrheic areas from puberty; nail changes; prevalence 1 in 100,000 to 1 in 30,000 Suprabasal clefts with acantholysis and dyskeratotic cells (corps ronds and grains); corps ronds lie in the granular layer and have eccentric, sometimes pyknotic nuclei Ettinger et al. 2025
Grover disease (transient acantholytic dermatosis) Acquired Intensely pruritic papulovesicles of the trunk, mostly in white men in the fifth decade, often in winter; lesions resolve in weeks to months Shares the histologic patterns of Darier disease; clinical features separate them Ettinger et al. 2025

Bullous pemphigoid

  • Epidemiology and clinical forms. Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease. It affects the elderly, presents with itch and localized or generalized tense blisters, and is significantly associated with neurological disorders. A subset of patients has only excoriations, prurigo-like lesions or eczematous and urticarial lesions (Borradori et al. 2022). About 20% of patients present with non-bullous variants. The incidence is about 20 per million per year in Central Europe and reaches 150–180 per million per year above age 80. Mucosal lesions occur in 15%–20% (Witte et al. 2018).
  • Histology. An early bulla shows a subepidermal blister containing a fibrin net with eosinophils and/or neutrophils and a dermal infiltrate of eosinophils and neutrophils. The non-bullous phase may show only subepidermal clefts and eosinophilic spongiosis (Di Lernia et al. 2020). Lymphocyte-rich eosinophil-dominated and neutrophil-rich patterns both occur (van Beek et al. 2024).
  • Immunopathology. DIF shows fine, linear, continuous IgG and/or C3 along the dermal–epidermal junction, occasionally with IgA or IgE (Di Lernia et al. 2020), in an n-serrated pattern (van Beek et al. 2024). BP180 is a transmembrane collagen (type XVII collagen) whose 16th non-collagenous domain, NC16A, is immunodominant. BP230 is an intracellular plakin of the hemidesmosome. ELISA performance is taught in ANCA, Anti-GBM and Organ-Specific Autoantibodies: Kidney, Liver, Thyroid, Pancreas and Nervous System (Witte et al. 2018).
  • Drug-associated bullous pemphigoid. DPP-4 inhibitors are associated with bullous pemphigoid (odds ratio 1.92 in one analysis and 2.77 in a large UK case-control study), as are immune checkpoint inhibitors (Lovegrove et al. 2025).
  • Diagnostic criteria. The diagnosis rests on a compatible clinical picture plus linear IgG and/or C3 on DIF, roof binding on salt-split skin, BP180 or BP230 antibodies, or subepidermal blisters with eosinophilic–lymphocytic or neutrophilic infiltrates (van Beek et al. 2024).

Pemphigoid gestationis and mucous membrane pemphigoid

  • Pemphigoid gestationis (formerly herpes gestationis) usually starts in the third trimester with urticarial erythema around the umbilicus and few small blisters, and it recurs earlier and more severely in later pregnancies. BP180 NC16A antibodies are found in more than 95% of patients, and BP230 reactivity in only 10% (Witte et al. 2018). DIF shows mainly linear C3, with IgG in about one-third of patients, and standard indirect immunofluorescence is negative in up to 75% unless complement is added (van Beek et al. 2024). Transplacental IgG1 antibodies produce transient blisters or urticarial lesions in about 5%–10% of neonates (Farladansky-Gershnabel et al. 2025). Polymorphic eruption of pregnancy is separated from pemphigoid gestationis by sparing of the umbilicus and negative DIF (Carvalho et al. 2023); it is taught in Granulomatous, Vasculitic, Neutrophilic and Eosinophilic Dermatoses: Sarcoidosis, Granuloma Annulare, Cutaneous Vasculitis and Vasculopathy, Sweet Syndrome, Pyoderma Gangrenosum and Wells Syndrome.
  • Mucous membrane pemphigoid (MMP) is a pemphigoid disease with predominant mucosal involvement. Conjunctival disease can cause blindness (Witte et al. 2018). The oral mucosa is involved in 80%–90%, the eye in 50%, the skin in 20%, the genital mucosa in 15% and the anal mucosa in 10%, and the gingiva is the most frequent oral site. Histology shows fewer inflammatory cells than bullous pemphigoid (Kamaguchi and Iwata 2019). DIF shows linear IgG, IgA and/or C3, and indirect immunofluorescence is positive in only about 50% (Witte et al. 2018). BP180 is the main antigen, with the NC16A domain targeted in about half and C-terminal epitopes more often. Laminin 332 antibodies occur in about 25% (Witte et al. 2018), and up to 30% of patients with laminin 332 antibodies develop a malignancy, so a tumor search is warranted (van Beek et al. 2024). The international consensus requires predominant mucosal lesions and tissue-bound IgG, IgA and/or C3 on DIF (Kamaguchi and Iwata 2019). Ocular MMP can be diagnosed without positive DIF or serology after other causes of cicatrizing conjunctivitis are excluded (van Beek et al. 2024).

Dermatitis herpetiformis and linear IgA disease

  • Dermatitis herpetiformis is a chronic, pruritic, gluten-induced disorder with subepidermal granular IgA deposition and a variable degree of enteropathy identical to that of celiac disease (Görög et al. 2021). Grouped vesicles and papules involve the elbows, knees and buttocks (Witte et al. 2018). Classic histology shows neutrophilic microabscesses, nuclear dust and fibrin in the papillary dermis, papillary edema and subepidermal splitting, with variable eosinophils. Histology does not separate it from other subepidermal AIBD (van Beek et al. 2024). DIF shows granular IgA at the tips of dermal papillae or along the BMZ. When DIF is repeatedly negative, minor criteria include typical histology, IgA to TG2, TG3 or endomysium, duodenal histology of celiac disease, compatible HLA, and response to a gluten-free diet or dapsone (van Beek et al. 2024). The autoantigen is epidermal transglutaminase (TG3) (Witte et al. 2018). Endomysial IgA was found in 84.3% and TG2 IgA in 78.5% of 242 patients (van Beek et al. 2024). Celiac disease histology is taught in Small Intestinal Mucosal Disease: Celiac Disease and Its Mimics, Infections, Drug Injury and Immune Enteropathies.
  • Linear IgA disease (LAD; linear IgA bullous dermatosis; chronic bullous disease of childhood in children) shows linear IgA at the BMZ (Shin et al. 2021). Vesicles often form annular lesions with vesicles at the edge. Lesional histology resembles dermatitis herpetiformis, with neutrophils along the dermal–epidermal junction and in dermal papillae. IgA usually binds the roof of salt-split skin, where the main antigen, LAD-1 (the soluble BP180 ectodomain), lies. Floor binding indicates type VII collagen, termed IgA epidermolysis bullosa acquisita (van Beek et al. 2024). Type VII collagen is the most common target in vancomycin-induced LAD (Witte et al. 2018), and vancomycin-induced cases can have a negative first DIF that becomes positive on repeat biopsy (Shin et al. 2021).

Inherited epidermolysis bullosa in the 2020 consensus reclassification

The 2020 consensus introduced the concept of genetic disorders with skin fragility, of which classical EB is the prototype. Peeling skin disorders, erosive disorders, hyperkeratotic disorders and connective tissue disorders with skin fragility form separate "EB-related" categories (Has et al. 2020). Previous rule (2014 consensus): the last international EB classification, published in 2014; new genes and clinical subtypes identified since then led to the 2020 reclassification (Has et al. 2020). EB comprises 34 subtypes in 4 major types defined mainly by the plane of cleavage, with pathogenic variants in at least 21 genes (Mumber and Perman 2026).

Major type Plane of cleavage Main genes (proteins) Previous subtype names Clinical hallmarks Source
EB simplex Within the epidermis KRT5, KRT14 (keratins 5 and 14); also PLEC, KLHL24, DST, EXPH5, CD151 Localized (Weber–Cockayne), intermediate (Köbner), severe (Dowling–Meara) Most common type; mostly autosomal dominant; heals without scarring; PLEC variants with muscular dystrophy or pyloric atresia Mumber and Perman 2026
Junctional EB Lamina lucida LAMA3, LAMB3, LAMC2 (laminin 332), COL17A1 (type XVII collagen), ITGA6, ITGB4 (integrin α6β4), ITGA3 Severe (Herlitz), intermediate (non-Herlitz) Autosomal recessive; atrophic scarring, enamel hypoplasia; severe form with granulation tissue and death often before age 2 Mumber and Perman 2026
Dystrophic EB Papillary dermis below the basement membrane, at the anchoring fibrils COL7A1 (type VII collagen) Severe recessive (Hallopeau–Siemens), intermediate recessive (non-Hallopeau–Siemens) Dominant or recessive; scarring and milia; severe recessive form with pseudosyndactyly and aggressive squamous cell carcinoma Mumber and Perman 2026
Kindler EB Variable levels FERMT1 (kindlin-1) Kindler syndrome Acral blistering in infancy, progressive poikiloderma, photosensitivity, squamous cell carcinoma risk Mumber and Perman 2026

Immunofluorescence mapping of an induced fresh blister, with transmission electron microscopy, was the traditional first diagnostic step. Next-generation sequencing of DNA from blood or a buccal swab is now the diagnostic gold standard, and skin biopsy remains recommended for characterization at the protein level (Mumber and Perman 2026). For mapping, a fresh or induced blister less than 24 hours old is sampled (Llamas-Velasco et al. 2026).

Epidermolysis bullosa acquisita

Epidermolysis bullosa acquisita (EBA) is caused by autoantibodies to type VII collagen, the major component of anchoring fibrils (van Beek et al. 2024). The classical mechanobullous form shows skin fragility, blisters or erosions on non-inflamed or scarred skin, scarring and milia at trauma-prone extensor sites such as the dorsal hands, elbows and knees. Other forms resemble bullous pemphigoid, mucous membrane pemphigoid, Brunsting–Perry pemphigoid or linear IgA disease (Koga et al. 2018). The minimal diagnostic criteria are linear immunoglobulin or C3 deposits at the dermal–epidermal junction of a perilesional biopsy with a u-serrated pattern. Routine histology does not separate EBA from other subepidermal AIBD (Koga et al. 2018). Antibodies bind the floor of salt-split skin and mostly target the NC1 domain, and circulating antibodies are detected in only about 60% of patients (Witte et al. 2018; van Beek et al. 2024). Direct immunoelectron microscopy shows deposits on anchoring fibrils in the sublamina densa, a finding shared with bullous systemic lupus erythematosus (van Beek et al. 2024).

Porphyria cutanea tarda and pseudoporphyria

  • Pathogenesis. Porphyria cutanea tarda (PCT) results from deficiency of uroporphyrinogen decarboxylase (UROD), the fifth enzyme of heme synthesis. The sporadic form is a hepatic inhibition of UROD without a germline variant, promoted by hepatic iron and susceptibility factors such as smoking, alcohol, estrogen, HIV, hepatitis C and hemochromatosis. The familial form is autosomal dominant with heterozygous UROD variants. Clinical disease requires at least two susceptibility factors (Vu et al. 2026). Biochemistry is taught in Porphyrias and Vitamin Testing.
  • Histology. PCT shows a subepidermal split with minimal inflammation, caterpillar bodies, festooning of dermal papillae and hyalinized vessels. DIF shows immunoglobulin and complement along the BMZ and around vessels, which does not separate PCT from other porphyrias or pseudoporphyria (Leasure et al. 2022). Caterpillar bodies are linear segmented structures of degenerating keratinocytes and basement membrane material in the basal layer over the blister and are PAS-positive (Cohen 2023). Biopsy cannot establish PCT because pseudoporphyria shows the same features (Vu et al. 2026). An intact blister on sun-exposed skin is sampled, because old blisters lose the diagnostic features (Llamas-Velasco et al. 2026).
  • Pseudoporphyria mimics PCT clinically and histologically, with subepidermal separation, festooning, mild perivascular infiltrate and PAS-positive thickening of vessel walls, and porphyrin levels are normal (Caroppo et al. 2023; Vu et al. 2026). Causes include naproxen and other nonsteroidal anti-inflammatory drugs, diuretics, tetracyclines, retinoids, voriconazole, hemodialysis and tanning-bed UVA (Caroppo et al. 2023; Cohen 2023). Indirect immunofluorescence may help when cell-poor bullous pemphigoid is in the differential diagnosis (Cohen 2023).

Pustular dermatoses: acute generalized exanthematous pustulosis and neonatal pustular eruptions

  • Acute generalized exanthematous pustulosis (AGEP) is a drug reaction with fever, neutrophilia and sterile pustules on erythema that usually resolves within 15 days. Eosinophilia occurs in up to 30%. β-lactam antibiotics are typical triggers, with onset 2–15 days after exposure, and hydroxychloroquine causes delayed onset. Histology shows intracorneal or subcorneal pustules, intraepidermal pustules in the upper epidermis, spongiosis, necrotic keratinocytes, vacuolization of basal keratinocytes and a mixed dermal infiltrate with eosinophils. The EuroSCAR AGEP score combines morphology, course and histology. The main differential diagnoses are pustular psoriasis, IgA pemphigus and subcorneal pustular dermatosis (Parisi et al. 2023). IL36RN variants are more frequent in some patients with AGEP and pustular psoriasis (Parisi et al. 2023).
  • Neonatal pustular eruptions. Erythema toxicum neonatorum shows subcorneal pustules and a perifollicular infiltrate rich in eosinophils, and smears show numerous eosinophils. Transient neonatal pustular melanosis occurs in about 5% of Black newborns and 0.2% of white newborns, and its smears show neutrophils. Some authors group both as sterile transient neonatal pustulosis. Infantile acropustulosis presents with recurrent very pruritic palmoplantar vesicopustules with intraepidermal pustules of neutrophils and eosinophils, and scabies is its main differential diagnosis (Reginatto et al. 2016). Infectious causes such as bullous impetigo, neonatal herpes simplex and congenital syphilis are excluded by Gram stain, Tzanck smear, culture or biopsy (Reginatto et al. 2016).

Differential diagnosis of intraepidermal blisters and pustules

Level Disorder Distinguishing finding Source
Subcorneal Pemphigus foliaceus Acantholysis; intercellular IgG; desmoglein 1 van Beek et al. 2024
Subcorneal IgA pemphigus, SPD type Neutrophilic pustules; intercellular IgA in the upper epidermis; desmocollin 1 Porro et al. 2014
Subcorneal Subcorneal pustular dermatosis Subcorneal neutrophils; flexural annular or serpiginous pustules with a hypopyon sign Xu and Tan 2023
Subcorneal AGEP Subcorneal and upper intraepidermal pustules, necrotic keratinocytes, eosinophils, drug exposure 2–15 days earlier Parisi et al. 2023
Subcorneal Erythema toxicum neonatorum Subcorneal pustule with perifollicular eosinophils in a newborn Reginatto et al. 2016
Intraepidermal Pemphigus herpetiformis Neutrophilic or eosinophilic spongiosis with little acantholysis; intercellular IgG Porro et al. 2014
Intraepidermal IgA pemphigus, IEN type Pustules in the lower or entire epidermis; intercellular IgA Porro et al. 2014
Suprabasal Pemphigus vulgaris Tombstone basal row; acantholysis of adnexal epithelium; intercellular IgG van Beek et al. 2024; Porro et al. 2024
Suprabasal Paraneoplastic pemphigus Dyskeratosis and lichenoid interface change; intercellular plus linear deposits van Beek et al. 2024
Suprabasal Hailey–Hailey disease "Dilapidated brick wall"; adnexa spared; DIF negative Porro et al. 2024
Suprabasal Darier disease and Grover disease Corps ronds and grains; DIF negative Ettinger et al. 2025

Differential diagnosis of subepidermal blisters

Infiltrate Disorder Distinguishing finding Source
Eosinophil-rich Bullous pemphigoid Linear IgG and C3, n-serrated; roof binding; elderly patient van Beek et al. 2024
Eosinophil-rich Pemphigoid gestationis Pregnancy; periumbilical onset; linear C3 with IgG in one-third Witte et al. 2018; van Beek et al. 2024
Neutrophil-rich Dermatitis herpetiformis Papillary microabscesses; granular IgA in dermal papillae van Beek et al. 2024
Neutrophil-rich Linear IgA disease Neutrophils along the BMZ; linear IgA van Beek et al. 2024
Neutrophil-rich Inflammatory EBA Linear deposits, u-serrated; floor binding van Beek et al. 2024
Cell-poor Mechanobullous EBA Trauma sites, scarring and milia; u-serrated deposits Koga et al. 2018
Cell-poor Porphyria cutanea tarda and pseudoporphyria Festooned papillae, caterpillar bodies, thickened PAS-positive vessels; porphyrin levels separate them Leasure et al. 2022; Caroppo et al. 2023; Vu et al. 2026
Cell-poor Inherited EB Fragility from birth; cleavage level by mapping or electron microscopy; gene by sequencing Mumber and Perman 2026
Few inflammatory cells, mucosal Mucous membrane pemphigoid Predominant mucosal disease; linear IgG, IgA and/or C3 Kamaguchi and Iwata 2019; Witte et al. 2018

Granulomatous, Vasculitic, Neutrophilic and Eosinophilic Dermatoses: Sarcoidosis, Granuloma Annulare, Cutaneous Vasculitis and Vasculopathy, Sweet Syndrome, Pyoderma Gangrenosum and Wells Syndrome

Definition and classification. Granulomatous dermatitis is dominated by histiocytes, vasculitis by inflammation and damage of vessel walls, vasculopathy by occlusion of vessels without primary vessel-wall inflammation, the neutrophilic dermatoses by sterile neutrophils and the eosinophilic dermatoses by eosinophils. No WHO classification or CAP protocol applies. Vasculitis nomenclature follows the 2012 revised International Chapel Hill Consensus Conference (CHCC2012) and its 2018 dermatologic addendum (D-CHCC) (Jennette et al. 2013, definitions as tabulated by Morita et al. 2020a; Sunderkötter et al. 2018). Granulomatous dermatitis is divided into infectious and non-infectious groups with overlapping histology, and infection is excluded with special stains, culture or PCR before a non-infectious diagnosis is made (Chatterjee et al. 2021).

Related page: Normal Skin, Biopsy Handling and the Reaction-Pattern Approach; Spongiotic, Psoriasiform, Keratinization and Pigmentary Disorders (biopsy site, depth and timing; the reaction-pattern approach) Related page: Vesiculobullous and Pustular Dermatoses: Pemphigus, Pemphigoid, Dermatitis Herpetiformis, Epidermolysis Bullosa, Porphyria and Direct Immunofluorescence (pemphigoid gestationis and the direct immunofluorescence patterns of blistering disease) Related page: Dermal Deposits and Degenerative, Metabolic, Nutritional and Physical-Agent Disorders of Skin: Elastic Tissue and Perforating Disorders, Mucinoses, Calcinosis and Calciphylaxis, Amyloid, Gout, Pigments, Fillers, Xanthomas and Deficiency Dermatoses (calciphylaxis, cutaneous amyloidosis and foreign-material reactions to fillers) Related page: Follicular Disorders, Alopecia, Nail Unit Pathology and Panniculitis: Rosacea, Folliculitis, Hidradenitis Suppurativa, Scarring and Non-scarring Alopecia, Hair Shaft and Nail Disorders, Septal and Lobular Panniculitis (erythema nodosum, nodular vasculitis, granulomatous rosacea and lupus miliaris disseminatus faciei) Related page: Skin Infections and Infestations: Bacterial, Mycobacterial, Spirochetal, Fungal, Viral, Protozoal and Parasitic Infections of Skin (special stains for mycobacteria, fungi and leishmania in granulomatous dermatitis) Related page: Cutaneous Lymphoid and Hematolymphoid Infiltrates: Histologic Approach, Early Mycosis Fungoides and Its Mimics, CD30-Positive Lymphoproliferative Disorders, Rare Cutaneous T-Cell Lymphomas and Reactive Lymphoid Proliferations (granulomatous mycosis fungoides and arthropod-bite pseudolymphoma) Related page: ANCA, Anti-GBM and Organ-Specific Autoantibodies: Kidney, Liver, Thyroid, Pancreas and Nervous System (ANCA testing) Related page: Complement Testing, Hereditary Angioedema, Cryoglobulins, Cytokines and Soluble IL-2 Receptor (hypocomplementemic urticarial vasculitis and cryoglobulin testing) Related page: Allergy and Hypersensitivity Testing: Total and Specific IgE, Component Diagnostics, Tryptase and Basophil Activation (urticaria workup and tryptase) Related page: Nephritic and Hematuric Glomerular Diseases: IgA Nephropathy, Lupus Nephritis, C3 Glomerulopathy, Infection-Related, Cryoglobulinemic, ANCA and Anti-GBM Glomerulonephritis, Alport Syndrome (IgA vasculitis nephritis, ANCA and cryoglobulinemic glomerulonephritis) Related page: Plasma Cell Neoplasms and Diseases with Paraproteins: MGUS, Smoldering and Plasma Cell Myeloma, Plasmacytoma, Plasma Cell Leukemia, Amyloidosis, POEMS Syndrome and Heavy Chain Diseases (paraproteins in necrobiotic xanthogranuloma and cryoglobulinemia) Related page: Classification of Myeloid Neoplasms (WHO 5th Edition and ICC 2022), Flow Cytometry of Myeloid Neoplasms, Clonal Hematopoiesis, VEXAS Syndrome and Germline Predisposition (VEXAS syndrome) Related page: AML, Myelodysplasia-Related, AML Defined by Differentiation, Myeloid Neoplasms Post Cytotoxic Therapy and of Down Syndrome, Myeloid Sarcoma, BPDCN and Acute Leukemias of Ambiguous Lineage (leukemia cutis and myeloid sarcoma) Related page: Mastocytosis, Hypereosinophilic Syndrome and Myeloid/Lymphoid Neoplasms with Tyrosine Kinase Fusions, Chronic Myelomonocytic Leukemia and Other MDS/MPN (hypereosinophilic syndrome)

Granulomatous reaction patterns in the skin

Pattern Definition Associated conditions Source
Sarcoidal Discrete, compact epithelioid granulomas without a significant lymphoid cuff ("naked") Sarcoidosis, Blau syndrome, foreign material, drugs, secondary syphilis, metastatic Crohn disease, orofacial granulomatosis, common variable immunodeficiency, chronic granulomatous disease Chatterjee et al. 2021
Tuberculoid Epithelioid histiocytes with Langhans and foreign-body giant cells, with or without caseation, surrounded by lymphoid cuffing Tuberculosis, tuberculid, leprosy, late syphilis, leishmaniasis, granulomatous rosacea, lupus miliaris disseminatus faciei, BCG granuloma Chatterjee et al. 2021
Necrobiotic (palisading) Altered collagen or elastic fibers surrounded by palisaded or diffuse histiocytes Granuloma annulare, necrobiosis lipoidica, necrobiotic xanthogranuloma, rheumatoid nodule, reaction to foreign body Chatterjee et al. 2021
Suppurative Central neutrophils and debris with a rim of lymphocytes, plasma cells and histiocytes Deep fungal infection, non-tuberculous mycobacteria, mycetoma, nocardiosis, actinomycosis, cat scratch disease, pyoderma gangrenosum, ruptured cysts and follicles Chatterjee et al. 2021
Foreign-body Multinucleated giant cells with haphazard nuclei, with or without visible material Exogenous material, ruptured cysts and follicles Chatterjee et al. 2021
Xanthogranulomatous Foamy histiocytes, Touton giant cells and variable lymphoplasmacytic infiltrate Juvenile xanthogranuloma, reticulohistiocytoma Chatterjee et al. 2021
Interstitial Loose histiocytes between collagen bundles without well-formed granulomas Interstitial granulomatous dermatitis, interstitial granulomatous drug reaction, palisaded neutrophilic and granulomatous dermatitis, giant cell elastolytic granuloma Chatterjee et al. 2021

Red and blue necrobiotic granulomas. Altered collagen is more basophilic ("blue") or more eosinophilic ("red"). Blue granulomas owe their color to mucin or to neutrophils and nuclear dust. Mucin indicates granuloma annulare, and neutrophils or nuclear dust indicate palisaded neutrophilic and granulomatous dermatitis, granulomatosis with polyangiitis or rheumatoid vasculitis. Red granulomas owe their color to hyalinized collagen (necrobiosis lipoidica and necrobiotic xanthogranuloma) or to fibrin (rheumatoid nodule) (Chatterjee et al. 2021). Alcian blue or colloidal iron highlights interstitial mucin (Chatterjee et al. 2021).

Exclusion of infection. Ziehl–Neelsen, modified Ziehl–Neelsen and Fite stains for acid-fast bacilli, PAS and Grocott for fungi and Giemsa for leishmania are applied to granulomatous dermatitis. Culture is the gold standard for isolating organisms, and PCR is a sensitive adjunct (Chatterjee et al. 2021). Organism-level findings are taught in Skin Infections and Infestations: Bacterial, Mycobacterial, Spirochetal, Fungal, Viral, Protozoal and Parasitic Infections of Skin.

Cutaneous sarcoidosis and foreign-body granulomas

  • Frequency. The skin is involved in 9%–37% of patients with systemic sarcoidosis. In one series, 27 of 37 patients (73%) with cutaneous sarcoidosis had or developed systemic involvement, and up to 25% show no systemic disease on long follow-up. Cutaneous sarcoidosis is a diagnosis of exclusion (Chatterjee et al. 2021).
  • Histology. Discrete non-caseating epithelioid granulomas without lymphoid cuffing occupy the dermis in nodular, diffuse or neurovascular ("sausage-like") distributions, often near arterioles, adnexa and nerves. Langhans and foreign-body giant cells may contain asteroid bodies (star-shaped cytoskeletal inclusions) or Schaumann bodies (calcium and protein inclusions), which are neither sensitive nor specific. Focal fibrinoid necrosis occurred in up to 43% of cases in one series and lacks the granular nuclear debris of caseation. A minority show tuberculoid or interstitial granulomas (Chatterjee et al. 2021).
  • Foreign material. Polarizable foreign bodies are found in giant cells in 22%–50% of cutaneous sarcoidosis biopsies, and their presence does not exclude sarcoidosis (Chatterjee et al. 2021).
  • Subcutaneous sarcoidosis occurs in 1.4%–6% of patients with systemic sarcoidosis, starts as a lobular granulomatous panniculitis and often fibroses (Chatterjee et al. 2021).
  • Foreign-body granulomas contain giant cells with haphazardly arranged nuclei that may hold exogenous material (tattoo pigment, splinters, suture) or endogenous keratin from ruptured follicles and cysts. Hyaluronic acid fillers can provoke a foreign-body granulomatous response (Chatterjee et al. 2021). Filler morphology is taught in Dermal Deposits and Degenerative, Metabolic, Nutritional and Physical-Agent Disorders of Skin: Elastic Tissue and Perforating Disorders, Mucinoses, Calcinosis and Calciphylaxis, Amyloid, Gout, Pigments, Fillers, Xanthomas and Deficiency Dermatoses.

Granuloma annulare, necrobiosis lipoidica and rheumatoid nodule

Feature Granuloma annulare Necrobiosis lipoidica Rheumatoid nodule Source
Patients and sites Children to young adults; arms, hands, legs, feet Middle-aged, more often female; shins, ankles, calves Adults with seropositive rheumatoid arthritis (up to 25%); olecranon, proximal ulna, finger joints Chatterjee et al. 2021
Level Upper and mid dermis Entire dermis or lower two-thirds, extending into superficial subcutis Subcutis, with or without lower dermis Chatterjee et al. 2021
Pattern of necrobiosis Large areas of necrobiotic collagen with palisaded or interstitial histiocytes Layered ("sandwich" or "wedding cake") necrobiosis alternating with normal collagen and inflammatory cells Well-demarcated central fibrinoid necrosis with palisaded histiocytes Chatterjee et al. 2021
Color and matrix Blue; mucin common (up to 93% with special stains) Red; hyalinized collagen; mucin rare Red; fibrin Chatterjee et al. 2021
Accompanying cells Lymphocytes; eosinophils in 18%–66% Lymphocytes and plasma cells at the dermal–subcutaneous junction, lymphoid aggregates Neutrophils, lymphocytes, plasma cells and histiocytes Chatterjee et al. 2021
Associations and clinical forms Localized, generalized, patch, perforating and subcutaneous forms Insulin-dependent diabetes; 11%–87% of patients with NL have diabetes, and 0.3%–1.2% of diabetic patients develop NL Rheumatoid arthritis; other autoimmune diseases Joshi and Duvic 2022; Naumowicz et al. 2024; Chatterjee et al. 2021

Interstitial granuloma annulare was the predominant pattern in 71% of 207 biopsies in one series, and the scattered histiocytes can be missed (Chatterjee et al. 2021). Subcutaneous granuloma annulare occurs almost exclusively in children, requires the bulk of the disease in the subcutis and is separated from rheumatoid nodule by mucin (Chatterjee et al. 2021). Squamous cell carcinoma is a rare complication of necrobiosis lipoidica (Chatterjee et al. 2021).

Interstitial, palisaded neutrophilic and xanthogranulomatous granulomatous dermatitis

Entity Clinical setting Histology Source
Interstitial granulomatous dermatitis Adults, mostly women, with rheumatoid arthritis or SLE; linear subcutaneous cords ("rope sign") in about 10% Interstitial epithelioid histiocytes around small foci of degenerated collagen ("floating sign") through the whole dermis; no mucin or vasculitis Chatterjee et al. 2021
Interstitial granulomatous drug reaction Calcium channel blockers, β-blockers, ACE inhibitors, statins Interstitial histiocytes plus vacuolar interface change, apoptotic keratinocytes and dermal eosinophils Chatterjee et al. 2021
Palisaded neutrophilic and granulomatous dermatitis Rheumatoid arthritis and SLE; umbilicated papules of the elbows Early leukocytoclastic vasculitis with dermal neutrophils and nuclear debris; later degenerated collagen and neutrophilic debris rimmed by palisaded histiocytes; fibrosis at the end Chatterjee et al. 2021
Necrobiotic xanthogranuloma Sixth decade; periorbital plaques; monoclonal gammopathy or multiple myeloma Necrobiosis with Touton-type giant cells; cholesterol clefts are a hallmark Steinhelfer et al. 2022
Annular elastolytic giant cell granuloma Mostly sun-exposed skin Interstitial granulomas with elastophagocytosis by giant cells, shown with elastic stains; no necrobiosis or mucin Chatterjee et al. 2021
Metastatic Crohn disease Young adults; vulva most often; precedes intestinal disease in 25%–30% Non-caseating sarcoidal granulomas, often perifollicular; granulomas absent in some biopsies Chatterjee et al. 2021
Orofacial granulomatosis and cheilitis granulomatosa Lip swelling; idiopathic form (Melkersson–Rosenthal syndrome) with facial nerve palsy Edema, dilated vessels and loose perivascular granulomas reaching salivary glands and muscle Chatterjee et al. 2021
Cutaneous granulomatosis with polyangiitis Skin involved in 10%–50%; ulcers Necrotizing small-vessel or leukocytoclastic vasculitis; transmural granulomatous vasculitis is rare; may resemble palisaded neutrophilic and granulomatous dermatitis Chatterjee et al. 2021

Many authors regard interstitial granulomatous dermatitis and palisaded neutrophilic and granulomatous dermatitis as a spectrum, and leukocytoclastic vasculitis favors the latter (Chatterjee et al. 2021). Granulomatous mycosis fungoides and granulomatous slack skin account for fewer than 2% of cutaneous T-cell lymphomas (Chatterjee et al. 2021). Paraprotein evaluation in necrobiotic xanthogranuloma is taught in Plasma Cell Neoplasms and Diseases with Paraproteins: MGUS, Smoldering and Plasma Cell Myeloma, Plasmacytoma, Plasma Cell Leukemia, Amyloidosis, POEMS Syndrome and Heavy Chain Diseases.

Vasculitis by vessel size in the 2012 Chapel Hill nomenclature and the 2018 dermatologic addendum

CHCC2012 is a nomenclature system and is neither a classification for clinical trials nor a diagnostic system (Morita et al. 2020a). The D-CHCC places skin vasculitis in three settings: a cutaneous component of a systemic vasculitis (for example cutaneous IgA vasculitis in systemic IgA vasculitis), a skin-limited variant of a systemic vasculitis (for example skin-limited IgA vasculitis or drug-induced skin-limited ANCA-associated vasculitis), and a cutaneous single-organ vasculitis without a systemic counterpart (for example nodular vasculitis). The addendum also introduced cutaneous vasculitides that CHCC2012 did not include (Sunderkötter et al. 2018).

CHCC2012 group Entities relevant to skin Definition highlights Previous name Source
Large-vessel vasculitis Takayasu arteritis; giant cell arteritis Arteritis, often granulomatous, of the aorta and major branches; giant cell arteritis after age 50 Unchanged Morita et al. 2020a
Medium-vessel vasculitis Polyarteritis nodosa; Kawasaki disease Necrotizing arteritis of medium or small arteries without glomerulonephritis, without involvement of arterioles, capillaries or venules, and without ANCA Unchanged Morita et al. 2020a; Morita et al. 2020b
Small-vessel, ANCA-associated Microscopic polyangiitis; granulomatosis with polyangiitis; eosinophilic granulomatosis with polyangiitis Necrotizing vasculitis with few or no immune deposits (pauci-immune); MPO or PR3 ANCA in most Wegener granulomatosis (GPA); Churg–Strauss syndrome (EGPA) Morita et al. 2020a
Small-vessel, immune complex Cryoglobulinemic vasculitis; IgA vasculitis; hypocomplementemic urticarial vasculitis (anti-C1q vasculitis); anti-GBM disease Moderate to marked vessel-wall deposits of immunoglobulin and/or complement in capillaries, venules or arterioles; IgA1-dominant deposits in IgA vasculitis Henoch–Schönlein purpura (IgA vasculitis); Goodpasture syndrome (anti-GBM disease) Morita et al. 2020a
Variable-vessel vasculitis Behçet disease; Cogan syndrome Arteries or veins of any size; Behçet disease with recurrent oral and/or genital aphthae Unchanged Morita et al. 2020a
Single-organ vasculitis Cutaneous small-vessel vasculitis (cutaneous leukocytoclastic angiitis); cutaneous arteritis Vasculitis confined to one organ without features of a systemic vasculitis; the organ and vessel type appear in the name Cutaneous polyarteritis nodosa (cutaneous arteritis) Morita et al. 2020a; Morita et al. 2020b
Vasculitis associated with systemic disease or probable etiology Lupus, rheumatoid and sarcoid vasculitis; hepatitis C-associated cryoglobulinemic vasculitis; hepatitis B-associated polyarteritis nodosa; drug-associated immune complex or ANCA-associated vasculitis A prefix names the association Unchanged Morita et al. 2020a

Biopsy and histologic criteria of cutaneous small-vessel vasculitis

  • Biopsy. A deep, large punch biopsy (5–6 mm) or an excision that reaches the subcutis samples vessels of all sizes. The optimal time is within 48 hours of lesion onset. Purpuric lesions biopsied in the first 24 hours show fibrin in vessel walls, mural neutrophils, hemorrhage and nuclear debris, and after 24 hours lymphocytes and macrophages replace the neutrophils. Biopsies avoid ulcers, because incidental vasculitis occurs beneath an ulcer bed. For livedo racemosa, a deep biopsy from the center of a livedo segment and level sections are needed (Morita et al. 2020a). Nodules, livedo, deep ulcers and digital infarcts indicate involvement of medium vessels at the dermal–subcutaneous junction (Morita et al. 2020a).
  • Histologic criteria. Neutrophils invading the vessel wall, fibrinoid necrosis or fibrin in the wall, nuclear dust (leukocytoclasia), extravasated erythrocytes, perivascular neutrophils and endothelial swelling define cutaneous leukocytoclastic angiitis, which mainly affects post-capillary venules (Morita et al. 2020a; Morita et al. 2020b). In late lesions neutrophils are barely visible (Cassisa and Cima 2024).
  • DIF timing. In immune complex vasculitis, immunoglobulins are found in 100% of biopsies taken within 48 hours and in 70% at 48–72 hours, and after that only complement persists in more than 50%. DIF biopsies are best taken 8–24 hours after lesion onset (Morita et al. 2020a). In a Brazilian series of 282 patients with cutaneous leukocytoclastic angiitis, DIF was positive in 70.21% and C3 was the most frequent immunoreactant (Morita et al. 2020a). For DIF, the edge of a newly evolved lesion 8–24 hours old, and no older than 48 hours, is sampled; necrotic or ulcerated lesions and the distal lower legs are avoided. In childhood IgA vasculitis, vascular IgA was found in 93% of lesional and 43% of uninvolved-skin biopsies (Mahmood 2024). Biopsy handling is taught in Normal Skin, Biopsy Handling and the Reaction-Pattern Approach; Spongiotic, Psoriasiform, Keratinization and Pigmentary Disorders.
  • IgA vasculitis. Neutrophilic vasculitis of upper dermal vessels with IgA deposits is diagnostic of IgA vasculitis, and the diagnosis can only be made when vascular IgA is found. Predominant IgM deposits in dermal and subcutaneous vessels indicate cryoglobulinemic or rheumatoid vasculitis (Morita et al. 2020a). Vascular IgA is sensitive but not specific, because it also occurs in lupus, cryoglobulinemia, paraproteinemia, erythema nodosum, venous stasis and livedoid vasculopathy (Morita et al. 2020b). In children, IgA vasculitis is much more common than non-IgA cutaneous small-vessel vasculitis (Morita et al. 2020a).
  • Causes. Cutaneous small-vessel vasculitis follows infection in about 20%, inflammatory disease in 15%–20%, drugs in 10%–15% and malignancy in 5%, and more than half of cases are idiopathic (Morita et al. 2020a). Systemic involvement was present in 12.5% of the Brazilian series (Morita et al. 2020a).
  • ANCA-associated vasculitis shows neutrophilic small-vessel vasculitis with few immune deposits on DIF (Morita et al. 2020b). Cutaneous nodules indicate vasculitis of deep dermal or subcutaneous vessels (Morita et al. 2020b). Glomerular disease is taught in Nephritic and Hematuric Glomerular Diseases: IgA Nephropathy, Lupus Nephritis, C3 Glomerulopathy, Infection-Related, Cryoglobulinemic, ANCA and Anti-GBM Glomerulonephritis, Alport Syndrome.
  • Cryoglobulinemic vasculitis. Hyaline intravascular deposits, when present, are a clue to mixed cryoglobulinemia (Cassisa and Cima 2024). In type I cryoglobulinemia, skin biopsies can show leukocytoclastic vasculitis with small-vessel fibrin thrombi that may appear only on deeper levels (Bryan et al. 2022).

Urticaria and urticarial vasculitis

Feature Urticaria Urticarial vasculitis Source
Lesion duration Chronic idiopathic urticaria lesions resolve within 2–8 hours and by definition within 24 hours Lesions last more than 24 hours, burn or hurt, and leave dusky hyperpigmentation Gu and Jorizzo 2021
Histology Dermal edema and a sparse mixed infiltrate with few eosinophils Leukocytoclastic vasculitis of post-capillary venules; marked upper dermal edema, few neutrophils, variable lymphocytes and some eosinophils in early lesions Radonjic-Hoesli et al. 2021; Cassisa and Cima 2024; Morita et al. 2020b
Complement Normal Normocomplementemic in about 80%; hypocomplementemic urticarial vasculitis syndrome with hypocomplementemia for at least 6 months, anti-C1q antibodies, glomerulonephritis in up to 50% and obstructive lung disease Morita et al. 2020b; Morita et al. 2020a

Urticarial vasculitis accounts for about 5% of chronic urticarial lesions when histologic criteria of leukocytoclastic vasculitis are met, and hypocomplementemia is a useful laboratory predictor (Gu and Jorizzo 2021). Hypocomplementemic urticarial vasculitis syndrome resembles systemic lupus erythematosus clinically and immunologically (Morita et al. 2020b). Complement and C1q testing is taught in Complement Testing, Hereditary Angioedema, Cryoglobulins, Cytokines and Soluble IL-2 Receptor.

Erythema elevatum diutinum and granuloma faciale

Both are localized chronic vasculitides of small dermal vessels with fibrosis and without a granulomatous reaction (Morita et al. 2020b).

Feature Erythema elevatum diutinum Granuloma faciale Source
Clinical presentation Symmetric red-brown papules, plaques and nodules with a 5–10-year course; women, 4th–6th decades Purple-brown plaques or nodules on the face; middle-aged men Morita et al. 2020b
Early histology Perivascular neutrophils with leukocytoclasis; the epidermis is not always spared and no grenz zone is seen Mixed infiltrate of neutrophils, lymphocytes, plasma cells and eosinophils separated from the epidermis by a narrow grenz zone Morita et al. 2020b; Cassisa and Cima 2024
Late histology Concentric perivascular fibrosis Mild concentric perivascular fibrosis Cassisa and Cima 2024
Associations and differential diagnosis IgA monoclonal gammopathy, HIV, hepatitis B and C, tuberculosis, rheumatoid arthritis, relapsing polychondritis, inflammatory bowel disease; IgA-class ANCA Differential diagnosis includes sarcoidosis, lymphoma and pseudolymphoma, discoid lupus and leprosy Morita et al. 2020b

Cutaneous arteritis (cutaneous polyarteritis nodosa) and its mimics

  • Definition and histology. Cutaneous arteritis is a recurrent chronic necrotizing vasculitis of small arteries and arterioles of the deep dermis and/or subcutis, without the systemic involvement of polyarteritis nodosa. Its lesions are ulcers, livedo racemosa and nodules of the lower legs. Four stages (acute, subacute, reparative and healing) range from mural neutrophils to luminal fibrin thrombi with neovascularization. DIF shows IgM and C3 in affected arteries. Diagnostic criteria require compatible skin lesions and fibrinoid necrotizing vasculitis of small and medium arteries without fever, weight loss, hypertension, renal, cerebral, cardiac, pleural or intestinal involvement (Morita et al. 2020b). Group A streptococcus, hepatitis B and C, HIV, parvovirus B19, tuberculosis and minocycline are reported triggers, and peripheral neuropathy occurs in 25%–32% (Morita et al. 2020b).
  • Superficial thrombophlebitis and macular arteritis as mimics of cutaneous arteritis. Polyarteritis nodosa involves muscular arteries at the dermal–subcutaneous junction. A vein is recognized by a "checkerboard" muscular wall with smooth muscle fibers interspersed with collagen. Macular (lymphocytic thrombophilic) arteritis is separated from cutaneous arteritis by an intact elastic lamina (Cassisa and Cima 2024).
  • Nodular vasculitis and erythema nodosum are taught in Follicular Disorders, Alopecia, Nail Unit Pathology and Panniculitis: Rosacea, Folliculitis, Hidradenitis Suppurativa, Scarring and Non-scarring Alopecia, Hair Shaft and Nail Disorders, Septal and Lobular Panniculitis.

Thrombotic vasculopathies and other vasculitis mimics

Vasculopathy denotes occlusion of vessels by thrombi, emboli or deposits with little primary vessel-wall inflammation. Vasculitis shows inflammatory cells damaging vessel walls, with leukocytoclasia and fibrinoid necrosis (Eswaran et al. 2022).

Disorder Setting Histology Source
Livedoid vasculopathy Women (3:1), mean onset in the 30s; painful relapsing ankle and foot ulcers that heal as atrophie blanche; associations with antiphospholipid syndrome, factor V Leiden, prothrombin G20210A, protein C, S and antithrombin deficiency, hyperhomocysteinemia and lipoprotein(a) Focal intraluminal thrombi in superficial dermal vessels under 40 µm; mural fibrin and subintimal hyalinization in chronic lesions; sparse lymphocytes; DIF C3 > IgM > IgG > IgA in vessel walls, which is nonspecific Eswaran et al. 2022; Lacerda et al. 2025
Antiphospholipid syndrome Systemic prothrombotic state One of the thrombophilias underlying livedoid vasculopathy and dermal vessel thrombosis Lacerda et al. 2025; Eswaran et al. 2022
Type I cryoglobulinemia Monoclonal gammopathy, multiple myeloma, lymphoma; thrombotic vasculopathy clinically Fibrin thrombi in small vessels, with leukocytoclastic vasculitis in some biopsies; thrombi may appear only on deeper levels Bryan et al. 2022
Cholesterol embolization Atherosclerosis; after angiography or vascular procedures; livedo reticularis, blue toes Biconvex, needle-shaped cholesterol clefts in arterioles of 100–200 µm, later with foreign-body giant cells and eosinophils; skin biopsy sensitivity about 92% Ozkok 2019
Levamisole-adulterated cocaine Cocaine users; retiform purpura or pyoderma gangrenosum-like ulcers; neutropenia Thrombotic microangiopathy and/or ANCA-associated vasculitis; high-titer perinuclear ANCA with antibodies to human neutrophil elastase Iorio et al. 2024; Urosevic-Maiwald et al. 2022
Purpura fulminans Infection, with Neisseria meningitidis and Streptococcus pneumoniae each causing 32% of infectious adult cases; inherited protein C deficiency in most affected children Disseminated intravascular coagulation with endovascular thrombosis and hemorrhagic infarcts Klifto et al. 2019
Malignant atrophic papulosis (Köhlmeier–Degos disease) Fewer than 200 cases; papules with porcelain-white atrophic centers and telangiectatic rims; systemic form with bowel perforation and stroke, fatal in about 50% within 2–3 years Wedge-shaped connective tissue necrosis of the deep dermis from thrombotic occlusion of small arteries Theodoridis et al. 2013

Antiphospholipid syndrome and polyarteritis nodosa. Livedo, digital ischemia and skin ulcers occur in both antiphospholipid syndrome and polyarteritis nodosa, and the two can coexist. Thrombosis without inflammatory infiltrates indicates the thrombotic vasculopathy of antiphospholipid syndrome, and medium-vessel vasculitis on skin biopsy indicates polyarteritis nodosa (de Carvalho and de Araujo 2026).

For livedoid vasculopathy, deep 4–6-mm punch or excisional biopsies at the ulcer margin, including surrounding healthy tissue, are recommended (Eswaran et al. 2022). Anticoagulant-induced dermal hemorrhage can mimic vasculitis and shows disproportionate erythrocyte extravasation, sparse inflammation and no fibrin (Llamas-Velasco et al. 2026). Calciphylaxis, a calcifying vasculopathy of end-stage renal disease, is taught in Dermal Deposits and Degenerative, Metabolic, Nutritional and Physical-Agent Disorders of Skin: Elastic Tissue and Perforating Disorders, Mucinoses, Calcinosis and Calciphylaxis, Amyloid, Gout, Pigments, Fillers, Xanthomas and Deficiency Dermatoses.

Pigmented purpuric dermatoses

The pigmented purpuric dermatoses (capillaritis) comprise Schamberg disease (the most common), pigmented purpuric lichenoid dermatosis of Gougerot and Blum, purpura annularis telangiectodes of Majocchi, eczematid-like purpura of Doucas and Kapetanakis, and lichen aureus. All share dilated vessels with endothelial swelling, extravasated erythrocytes, hemosiderin and a perivascular lymphocytic and macrophage infiltrate. Spongiosis and lymphocytic exocytosis are most pronounced in the Doucas and Kapetanakis type, and lichen aureus shows a band-like infiltrate separated from the epidermis by a grenz zone. Drugs such as acetaminophen and nonsteroidal anti-inflammatory drugs are triggers, and mycosis fungoides is among the associated conditions (Spigariolo et al. 2021). Early mycosis fungoides and its mimics are taught in Cutaneous Lymphoid and Hematolymphoid Infiltrates: Histologic Approach, Early Mycosis Fungoides and Its Mimics, CD30-Positive Lymphoproliferative Disorders, Rare Cutaneous T-Cell Lymphomas and Reactive Lymphoid Proliferations.

Sweet syndrome, histiocytoid Sweet syndrome and VEXAS syndrome

  • Definition and criteria. Sweet syndrome (acute febrile neutrophilic dermatosis) presents with abrupt painful erythematous plaques or nodules, fever and neutrophilia (Weiss et al. 2022). Diagnosis requires both major criteria (abrupt painful plaques or nodules; a neutrophilic infiltrate without vasculitis) and two minor criteria (fever above 38 °C; an associated inflammatory disease, pregnancy, infection or vaccination; response to corticosteroids or potassium iodide; three of four abnormal laboratory values at presentation: ESR above 20 mm/h, raised C-reactive protein, leukocytes above 8,000/µL, neutrophils above 70%) (Ferea et al. 2023). Separate criteria apply to drug-induced Sweet syndrome, most often due to G-CSF (Weiss et al. 2022; Joshi et al. 2022).
  • Histology. Mature neutrophils form a dense upper dermal infiltrate with papillary dermal edema and karyorrhexis, without leukocytoclastic vasculitis (Joshi et al. 2022; Weiss et al. 2022). Sterile tissue culture excludes infection (Weiss et al. 2022). Variants include histiocytoid, cryptococcoid, lymphocytic, subcutaneous and xanthomatized forms (Weiss et al. 2022).
  • Histiocytoid Sweet syndrome contains immature myeloid cells that resemble histiocytes and are positive for CD68 and myeloperoxidase (Joshi et al. 2022), with double staining for myeloperoxidase and MNDA (Prieto-Torres et al. 2023). A systematic review found a higher risk of underlying hematologic malignancy than in classic Sweet syndrome, although an immunohistochemical series of 33 patients did not (Weiss et al. 2022; Joshi et al. 2022). In patients with myelodysplastic neoplasms, clonally related cells have been shown in skin and bone marrow, and the term "myelodysplasia cutis" describes such clonal infiltrates (Prieto-Torres et al. 2023). Leukemia cutis is taught in AML, Myelodysplasia-Related, AML Defined by Differentiation, Myeloid Neoplasms Post Cytotoxic Therapy and of Down Syndrome, Myeloid Sarcoma, BPDCN and Acute Leukemias of Ambiguous Lineage.
  • Malignancy. Malignancy-associated Sweet syndrome is mostly hematologic. Acute myeloid leukemia is the best studied association, and Sweet syndrome occurred in 1% of 2,178 patients with AML (Joshi et al. 2022).
  • VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) results from somatic UBA1 variants and is part of the differential diagnosis of Sweet syndrome (Weiss et al. 2022; Ferea et al. 2023). It is taught in Classification of Myeloid Neoplasms (WHO 5th Edition and ICC 2022), Flow Cytometry of Myeloid Neoplasms, Clonal Hematopoiesis, VEXAS Syndrome and Germline Predisposition.

Pyoderma gangrenosum and Behçet disease

  • Pyoderma gangrenosum (PG) is associated with systemic disease in 50%–67%, most often inflammatory bowel disease, arthritis and hematologic cancers. Drug-induced cases include colony-stimulating factors and levamisole-adulterated cocaine. Histology of the ulcer border shows a dermal neutrophilic infiltrate, and bullous PG is more often associated with malignancy. Three diagnostic frameworks exist (Weiss et al. 2022).
Framework Requirement Histologic element Source
Su criteria (2004) Both major and two minor criteria Minor criterion: sterile dermal neutrophilia with or without mixed inflammation or lymphocytic vasculitis Weiss et al. 2022
Delphi consensus for ulcerative PG (2018) One major and at least four of eight minor criteria Major criterion: biopsy with a neutrophilic infiltrate; minor criterion: exclusion of infection on histology Weiss et al. 2022
PARACELSUS score (2018) More than 10 points for highly likely PG Additional criterion (1 point): suppurative inflammation Weiss et al. 2022

A skin biopsy with tissue culture from the ulcer edge is part of the work-up, and patients younger than 65 years are evaluated for inflammatory bowel disease (Weiss et al. 2022). Cocaine and levamisole can produce a skin-limited ANCA-associated vasculitis with a pyoderma gangrenosum-like presentation (Urosevic-Maiwald et al. 2022).

  • Behçet disease is a variable-vessel vasculitis in CHCC2012 (Morita et al. 2020a). Recurrent painful oral aphthae are the most common feature, genital ulcers are the most specific, and other skin lesions include papulopustules, erythema nodosum-like lesions, superficial thrombophlebitis, PG-like lesions and pathergy. Biopsy shows a nonspecific acute neutrophilic infiltrate. Prevalence is highest in Turkey (80–370 per 100,000) (Weiss et al. 2022).

Gyrate erythemas, polymorphic eruption of pregnancy and chilblains

  • Erythema annulare centrifugum. In a case series, the superficial form showed mild acanthosis, patchy spongiosis, slight parakeratosis and a superficial perivascular lymphohistiocytic infiltrate with occasional eosinophils, and the deep form showed a superficial and deep perivascular and periadnexal infiltrate without eosinophils (Maurelli et al. 2021). Its histologic overlap with pityriasis rosea is taught in Normal Skin, Biopsy Handling and the Reaction-Pattern Approach; Spongiotic, Psoriasiform, Keratinization and Pigmentary Disorders.
  • Polymorphic eruption of pregnancy (formerly pruritic urticarial papules and plaques of pregnancy) is the most frequent specific dermatosis of pregnancy, with an incidence of about 1 in 200 pregnancies, mostly in primigravidae in the third trimester. Urticarial papules begin in the abdominal striae and spare the periumbilical region. Histology is nonspecific, and DIF and indirect immunofluorescence are negative, which separates it from pemphigoid gestationis (Carvalho et al. 2023).
  • Chilblains (perniosis). In COVID-19-associated chilblains, histology showed a superficial and deep lichenoid, perivascular and perieccrine lymphocytic infiltrate with occasional plasma cells (Kolivras et al. 2020).
  • Primary chilblains and chilblain lupus. Chilblains are primary (idiopathic) or secondary to immune-mediated disease, infection (including COVID-19), malignancy or drugs, and systemic lupus erythematosus is the most common secondary association. Persistence beyond the cold months favors chilblain lupus. Mayo Clinic criteria diagnose chilblain lupus with both major criteria (acral lesions induced by cold; lupus on histopathology or direct immunofluorescence) and at least 1 minor criterion (coexisting SLE or discoid lesions; response to antilupus therapy; negative cryoglobulin and cold agglutinin studies). Familial chilblain lupus is autosomal dominant, caused by TREX1 variants and begins in childhood (Seward and LaRocque 2026).
  • Histology of chilblain lupus. Biopsies show a superficial and deep perivascular lymphocytic infiltrate, vacuolar interface change with necrotic keratinocytes, a thickened basement membrane and increased dermal mucin. Direct immunofluorescence can show immunoglobulin and complement at the dermoepidermal junction (Seward and LaRocque 2026; Perazzolli et al. 2026). Up to 20% of patients with chilblain lupus later meet criteria for SLE (Perazzolli et al. 2026).

Eosinophilic dermatoses: Wells syndrome, arthropod bite reactions and hypereosinophilic syndrome

  • Wells syndrome (eosinophilic cellulitis) is a relapsing dermatosis of pruritic, edematous, erythematous plaques with dermal eosinophils and flame figures. Peripheral eosinophilia occurs in about half of patients (Ahmed et al. 2025). Flame figures are collagen fibers coated with eosinophil granule major basic protein. They are characteristic but not specific, and later lesions show fewer eosinophils and palisading histiocytes around flame figures (Danielson et al. 2025). Triggers include insect bites, infection, vaccination, parasites and drugs, and newer reports add COVID-19, vaccines, ustekinumab and TNF-α inhibitors (Danielson et al. 2025; Ahmed et al. 2025). Bacterial cellulitis shows a dermal neutrophilic infiltrate (Danielson et al. 2025).
  • Arthropod bite reactions show a polymorphous infiltrate rich in eosinophils and can form a pseudolymphomatous lymphoid infiltrate that mimics cutaneous T-cell lymphoma. Deeper sections may show the inciting changes, such as in tick bites (Nasser Eldin et al. 2026). The wedge-shaped infiltrate pattern is tabulated in Cutaneous Lymphoid and Hematolymphoid Infiltrates: Histologic Approach, Early Mycosis Fungoides and Its Mimics, CD30-Positive Lymphoproliferative Disorders, Rare Cutaneous T-Cell Lymphomas and Reactive Lymphoid Proliferations. Eosinophilic dermatosis of hematologic malignancy, formerly termed exaggerated insect bite-like reaction, is associated mainly with chronic lymphocytic leukemia (Radonjic-Hoesli et al. 2021).
  • Eosinophils in vasculitis. Eosinophils occur in drug-related leukocytoclastic vasculitis, eosinophilic vasculitis, urticarial vasculitis, granuloma faciale, erythema elevatum diutinum, EGPA and GPA (Cassisa and Cima 2024). In hypereosinophilic syndrome and eosinophilic cellulitis, eosinophils surround dermal vessels without true necrotizing vasculitis (Morita et al. 2020b). Hypereosinophilic syndrome is taught in Mastocytosis, Hypereosinophilic Syndrome and Myeloid/Lymphoid Neoplasms with Tyrosine Kinase Fusions, Chronic Myelomonocytic Leukemia and Other MDS/MPN.

Dermal Deposits and Degenerative, Metabolic, Nutritional and Physical-Agent Disorders of Skin: Elastic Tissue and Perforating Disorders, Mucinoses, Calcinosis and Calciphylaxis, Amyloid, Gout, Pigments, Fillers, Xanthomas and Deficiency Dermatoses

Definition and classification. No WHO classification or CAP protocol governs these disorders. They are grouped by the material that accumulates or is lost in the dermis (elastic fibers, collagen, mucin, calcium, bone, amyloid, urate, exogenous pigment, filler or lipid) and by the epidermal reaction to nutritional deficiency and physical injury. Several "invisible dermatoses" in this group show nearly normal skin on hematoxylin and eosin and need special stains for diagnosis (El Jalkh et al. 2025; Maffeis et al. 2014).

Related page: Plasma Cell Neoplasms and Diseases with Paraproteins: MGUS, Smoldering and Plasma Cell Myeloma, Plasmacytoma, Plasma Cell Leukemia, Amyloidosis, POEMS Syndrome and Heavy Chain Diseases (AL amyloid typing, systemic amyloidosis and paraproteins) Related page: Non-Neoplastic and Reactive Soft Tissue and Skin Lesions on FNA (amyloid in abdominal fat pad aspirates) Related page: Synovial fluid crystal identification: compensated polarized light, gout, CPPD and other crystals (monosodium urate crystal identification by compensated polarized microscopy) Related page: Calcium, Parathyroid Hormone, Vitamin D, Magnesium and Phosphate (calcium and phosphate disorders behind metastatic calcification and calciphylaxis) Related page: Lipids, Lipoproteins and Cardiovascular Risk Markers: LDL-C Equations, ApoB and Lp(a) (hypertriglyceridemia and familial hypercholesterolemia behind xanthomas) Related page: Porphyrias and Vitamin Testing (laboratory diagnosis of pellagra and scurvy) Related page: Toxic Metals and Trace Elements: Lead, Arsenic, Mercury, Implant Metals, Copper and Wilson Disease (zinc deficiency and metal exposures) Related page: Pancreatic Neuroendocrine Neoplasms: Neuroendocrine Tumors, Functioning Syndromes, Neuroendocrine Carcinoma, Hereditary Syndromes and Staging (glucagonoma) Related page: Lymph Node Pathology: Normal Structure, Triage, Reactive and Infectious Lymphadenopathy, Castleman and IgG4-Related Disease, and Metastases to Lymph Node and Marrow (dermatopathic lymphadenopathy, including tattoo pigment in nodes) Related page: Interface and Lichenoid Dermatoses, Cutaneous Lupus and Dermatomyositis, Graft-versus-Host Disease, and Sclerosing Dermal Disorders (morphea, systemic sclerosis and nephrogenic systemic fibrosis) Related page: Vesiculobullous and Pustular Dermatoses: Pemphigus, Pemphigoid, Dermatitis Herpetiformis, Epidermolysis Bullosa, Porphyria and Direct Immunofluorescence (porphyria cutanea tarda and pseudoporphyria in renal failure) Related page: Granulomatous, Vasculitic, Neutrophilic and Eosinophilic Dermatoses: Sarcoidosis, Granuloma Annulare, Cutaneous Vasculitis and Vasculopathy, Sweet Syndrome, Pyoderma Gangrenosum and Wells Syndrome (sarcoidal and foreign-body granulomas and the thrombotic vasculopathies) Related page: Follicular Disorders, Alopecia, Nail Unit Pathology and Panniculitis: Rosacea, Folliculitis, Hidradenitis Suppurativa, Scarring and Non-scarring Alopecia, Hair Shaft and Nail Disorders, Septal and Lobular Panniculitis (nail unit pathology and panniculitis)

Special stains for dermal deposits and degenerative changes

Stain Material shown Diagnostic use in skin Source
Verhoeff–van Gieson, orcein or Weigert Elastic fibers Band-like loss of papillary dermal fibers in PXE-like papillary dermal elastolysis; reduced fibers in anetoderma and cutis laxa; increased fibers in late-onset focal dermal elastosis El Jalkh et al. 2025; Maffeis et al. 2014; Alanazi et al. 2026; Fantini et al. 2022
von Kossa or Alizarin red Calcium and phosphate Calcified elastic fibers in pseudoxanthoma elasticum; subtle vascular calcification in calciphylaxis El Jalkh et al. 2025; Chewcharat and Nigwekar 2025
Congo red Amyloid Congophilic deposits with apple-green birefringence under polarized light; PAS-negative glassy material on hematoxylin and eosin Parvathy et al. 2026
High-molecular-weight cytokeratin Keratin-derived amyloid Positive in about two thirds of lichen and macular amyloidosis; detected deposits missed by Congo red in 3 cases Parvathy et al. 2026
Kappa and lambda light chains Light chain-derived amyloid Light chain restriction in all nodular amyloidosis in one series Parvathy et al. 2026
Colloidal iron and Alcian blue Acid mucin (hyaluronic acid) Mucinoses; colloidal iron detects mucin in reticular erythematous mucinosis more reliably than Alcian blue, which can be falsely negative Bălăceanu-Gurău et al. 2025; Wickramasinghe et al. 2025
Perls iron Hemosiderin and iron-chelated drug Type I and II minocycline pigmentation Okinaka et al. 2023
Fontana–Masson Melanin Type III minocycline pigmentation Loh et al. 2019
PAS after diastase Non-glycogen material Diastase-resistant PAS-positive foam cells of verruciform xanthoma Mondal et al. 2025

Elastic tissue disorders: pseudoxanthoma elasticum, its mimics, anetoderma, cutis laxa and solar elastosis

Pseudoxanthoma elasticum (PXE). PXE is an autosomal recessive disease with a prevalence of about 1 in 25,000 to 56,000. Pathogenic variants of ABCC6 (chromosome 16p13.1) reduce serum pyrophosphate, a main inhibitor of ectopic calcification, and soft connective tissue calcifies (Stumpf et al. 2021). Elastic fibers mineralize in the skin, Bruch membrane and the cardiovascular system. Biallelic ABCC6 deficiency also causes the infantile phenotype, generalized arterial calcification of infancy type 2 (GACI2). A definitive diagnosis of PXE requires 2 or more major criteria from different categories: skin, eye or a genetic test showing biallelic pathogenic ABCC6 variants (Bertamino et al. 2025). Calcification and breaks in Bruch membrane appear as angioid streaks on fundoscopy, and choroidal neovascularization is the main ocular cause of visual loss (Stumpf et al. 2021). PXE is distinguished clinically from its mimics by systemic comorbidities. Histologically it shows fragmented, calcified elastic fibers in the reticular dermis with sparing of the papillary dermis and no melanophages (El Jalkh et al. 2025).

Disorder Clinical setting Elastic fiber change on elastic stains Source
Pseudoxanthoma elasticum Yellow papules in flexures; eye and vascular disease; ABCC6 Fragmented, calcified (von Kossa-positive) fibers in the reticular dermis; papillary dermis spared; no melanophages El Jalkh et al. 2025; Stumpf et al. 2021
PXE-like papillary dermal elastolysis Postmenopausal women; 2–3-mm yellowish papules on the lateral and posterior neck; no systemic disease Band-like loss of elaunin and oxytalan fibers in the papillary dermis; sparse melanophages; near-normal skin on hematoxylin and eosin; von Kossa negative El Jalkh et al. 2025
Papillary dermal elastosis Clinically similar to PXE-like papillary dermal elastolysis Focal clumps of elastic fibers alternating with loss of oxytalan and elaunin fibers; increased reticular dermal fibers; no melanophages El Jalkh et al. 2025
White fibrous papulosis Non-confluent whitish firm papules on the posterior neck Loss of elastic fibers with dermal fibrosis; melanophages possible El Jalkh et al. 2025
Mid-dermal elastolysis Patches of fine wrinkles or perifollicular papules on the trunk and proximal limbs Loss of elastic fibers confined to the reticular dermis; no melanophages El Jalkh et al. 2025
Late-onset focal dermal elastosis PXE-like papules on the neck and flexures; no systemic lesions Increase of thick, interlacing fibers in the mid and deep reticular dermis without fragmentation, calcification or phagocytosis Fantini et al. 2022
Anetoderma Macular depressions or pouch-like herniations Focal loss of mid-dermal elastic tissue; hematoxylin and eosin nearly normal Maffeis et al. 2014
Acquired cutis laxa Loose, inelastic skin in adults, often after inflammation Diminished and fragmented fibers throughout the dermis Alanazi et al. 2026
Solar elastosis Chronically sun-damaged skin Basophilic degeneration of elastotic fibers below a narrow grenz zone of horizontal collagen Heng et al. 2014
  • Anetoderma. Loss of elastic tissue results from decreased production or increased destruction of elastic fibers. Anetoderma is primary (idiopathic) or secondary to autoimmune, infectious, inflammatory, neoplastic or drug-induced disease. The Jadassohn–Pellizzari (preceding inflammation) and Schweninger–Buzzi (no inflammation) types are of historical interest because their histology and prognosis are the same. Anetoderma of prematurity develops in extremely premature infants at the sites of monitoring devices such as electrocardiographic electrodes (Maffeis et al. 2014).
  • Cutis laxa. Inherited cutis laxa follows autosomal dominant, autosomal recessive and X-linked patterns. Acquired cutis laxa develops in adulthood after inflammatory, infectious or immune-mediated skin disease. Ehlers–Danlos syndrome, anetoderma and PXE are the main clinical mimics (Alanazi et al. 2026).
  • Solar elastotic syndromes. These include solar elastosis, Favre–Racouchot syndrome, elastotic nodules of the ears, collagenous and elastotic plaques of the hands and colloid milium. Solar elastosis is the most common (Heng et al. 2014). Actinic granuloma is a granulomatous response to photodamage in which histiocytes and multinucleated giant cells engulf elastotic fibers against a background of solar elastosis (Saravanan et al. 2026).

Acquired perforating dermatoses: reactive perforating collagenosis, Kyrle disease, elastosis perforans serpiginosa and perforating folliculitis

The acquired perforating dermatoses expel dermal material through the epidermis (transepidermal elimination) with minimal harm to adjacent structures. They are associated with diabetes mellitus and chronic kidney disease, including patients on hemodialysis, and are diagnosed by skin biopsy (Arriaga Escamilla et al. 2024; Junghetu et al. 2026). The four classical forms are separated by the eliminated material (Papadopoulou et al. 2025).

Disorder Eliminated material Histology and clinical features Source
Acquired reactive perforating collagenosis Altered collagen Necrotic basophilic collagen fibers expelled into a cup-shaped epidermal depression; umbilicated papules or nodules with an adherent keratotic plug; adults with diabetes, chronic kidney disease, cardiovascular disease, malignancy, drugs or trauma; pruritus in almost all Junghetu et al. 2026
Kyrle disease (hyperkeratosis follicularis et parafollicularis in cutem penetrans) Abnormal keratin Pruritic hyperkeratotic papules with central plugs, typically on extensor surfaces of the lower limbs; usually linked to systemic illness Kruczek et al. 2026; Papadopoulou et al. 2025
Elastosis perforans serpiginosa Elastic fibers Thickened, vertically arranged papillary dermal elastic fibers entering narrow transepidermal channels that open into a cup-shaped cavity with a horny plug; basophilic debris of keratinocytes, inflammatory cells and elastic fibers in the channel; papules in serpiginous or annular groups Polańska et al. 2016
Perforating folliculitis Follicular contents Transepidermal elimination through the follicle Papadopoulou et al. 2025
  • Faver criteria for acquired reactive perforating collagenosis. The criteria are umbilicated papules or nodules with a central adherent keratotic plug, onset after 18 years of age, and histologic expulsion of necrotic basophilic collagen fibers into a cup-shaped epidermal depression. Histologic transepidermal elimination of altered collagen is mandatory. In a systematic review, 73% of acquired perforating dermatoses eliminated only collagen and were classified as reactive perforating collagenosis (Junghetu et al. 2026).
  • Pathogenesis of reactive perforating collagenosis. Scratching in diabetic or uremic pruritus damages the basement membrane and exposes basal keratinocytes to collagen modified by advanced glycation end products. The extruded collagen bundles are altered on light microscopy but ultrastructurally intact (Junghetu et al. 2026).
  • Elastosis perforans serpiginosa associations. About 75% of patients are men. The reactive form accompanies Ehlers–Danlos syndrome, cutis laxa, Marfan syndrome, acrogeria, Rothmund–Thomson syndrome, osteogenesis imperfecta, PXE and Down syndrome. The drug-induced form follows D-penicillamine. Lesions are usually symmetrical except in Down syndrome and penicillamine-induced disease (Polańska et al. 2016). In penicillamine-treated Wilson disease, the dermis contains broad, rough elastic fibers with serrations and buds sprouting perpendicular to the fibers (Besekar et al. 2023).

Cutaneous mucinoses: scleromyxedema, localized lichen myxedematosus, pretibial myxedema, reticular erythematous mucinosis, focal mucinosis and digital mucous cyst

Dermal mucin is composed of acid glycosaminoglycans, chiefly hyaluronic acid and dermatan sulfate, produced by fibroblasts. It absorbs up to 1,000 times its own weight in water, so mucin-rich dermis is edematous and the skin looks waxy (Cárdenas-Gonzalez et al. 2019). Primary mucinoses have mucin deposition as the main histologic feature. In secondary mucinoses, mucin accompanies another cutaneous or systemic disorder (Kobkurkul et al. 2026).

Mucinosis Distribution of mucin and other histologic features Clinical and laboratory association Source
Scleromyxedema (generalized lichen myxedematosus, Arndt–Gottron syndrome) Triad of diffuse mucin in the upper and mid-reticular dermis, increased collagen and irregularly arranged fibroblasts Generalized waxy papules and sclerosis; monoclonal gammopathy, most often IgG lambda; no thyroid disease; potentially life-threatening course Kalantari et al. 2025; Cárdenas-Gonzalez et al. 2019
Localized lichen myxedematosus (discrete papular, acral persistent papular mucinosis, self-healing papular mucinosis, papular mucinosis of infancy, nodular) Mucin deposition and fibroblast changes of lichen myxedematosus No paraproteinemia, systemic involvement or thyroid disease Cárdenas-Gonzalez et al. 2019
Pretibial myxedema Mucin extending into the deep reticular dermis and subcutis; angioplasia and vascular thickening uncommon Graves disease or other thyroid disorders; euthyroid cases occur Kobkurkul et al. 2026
Obesity-associated lymphedematous mucinosis Mucin in the upper dermis and around vessels; dermal edema and fibrosis, angioplasia, vertically oriented vessels and lymphangiectasia Obese, euthyroid patients with chronic leg lymphedema Kobkurkul et al. 2026
Reticular erythematous mucinosis Mucin separating collagen bundles around infiltrates, appendages and the upper dermis; mild superficial and mid-dermal perivascular lymphocytes with mast cells, histiocytes and factor XIIIa-positive dendrocytes; occasional stellate cells Middle-aged women; reticular erythematous macules, papules or plaques on the midline chest or back; associated with viral infection, ultraviolet light, radiotherapy, malignancy and immune dysfunction Bălăceanu-Gurău et al. 2025
Solitary cutaneous focal mucinosis Well-circumscribed myxoid connective tissue with delicate collagen and scattered spindle fibroblasts; SMA, CD34 and CD68 negative Solitary polypoid skin lesion Wickramasinghe et al. 2025
Digital mucous (myxoid) cyst Pseudocyst without a lining; may communicate with the distal interphalangeal joint by a pedicle Fingers more than toes; trauma, repetitive stress and osteoarthritis; type B lesions over the nail matrix cause a longitudinal nail groove Li et al. 2026
  • Rongioletti classification of lichen myxedematosus. Scleromyxedema requires the microscopic triad of mucin deposition, fibroblast proliferation and fibrosis, a monoclonal gammopathy (predominantly IgG lambda, less often IgG kappa) and the absence of thyroid disease. Atypical forms share features of scleromyxedema and the localized forms and meet the criteria of neither (Cárdenas-Gonzalez et al. 2019).
  • Differential diagnosis of scleromyxedema. The main mimics are systemic sclerosis, scleredema, generalized myxedema of severe hypothyroidism and nephrogenic systemic fibrosis. Serum protein electrophoresis and immunofixation detect the gammopathy (Kalantari et al. 2025).
  • Differential diagnosis of focal mucinosis. Superficial angiomyxoma has prominent vessels, neutrophils, a lobular pattern and CD34-positive spindle cells, and multiple lesions raise Carney complex. Myxoid dermatofibroma is CD68-positive, and dermatofibrosarcoma protuberans with myxoid change contains CD34-positive spindle cells (Wickramasinghe et al. 2025).

Calcinosis cutis: dystrophic, metastatic, idiopathic and iatrogenic types

Calcinosis cutis is classified into 5 main types: dystrophic, metastatic, idiopathic, iatrogenic and calciphylaxis. Dystrophic calcinosis is the most common type. The extremities and buttocks are the sites most often affected (Kim et al. 2024). Another scheme replaces iatrogenic calcinosis with tumoral calcinosis (Mormile et al. 2023).

Type Mechanism and serum calcium and phosphate Typical settings Source
Dystrophic Calcification of damaged or devitalized tissue with normal serum calcium and phosphate Dermatomyositis, juvenile dermatomyositis, systemic sclerosis, lupus, Sjögren syndrome, overlap syndromes, rheumatoid arthritis Mormile et al. 2023; Kim et al. 2024
Metastatic Elevated serum calcium or phosphate Systemic disease; raised calcium or phosphate is also reported in idiopathic calcinosis and calciphylaxis Kim et al. 2024
Idiopathic Calcification without prior tissue damage No identified cause Kim et al. 2024
Iatrogenic Calcification after treatment Intravenous calcium or para-aminosalicylic acid Kim et al. 2024
Calciphylaxis Calcification of small and medium-sized vessels Chronic renal failure and dialysis; nonuremic cases in connective tissue disease Kim et al. 2024; Mormile et al. 2023
  • Calcinosis in connective tissue disease. Calcinosis cutis occurs in 18%–49% of patients with systemic sclerosis and is more prominent in CREST syndrome and with anticentromere antibodies. Tumoral (pseudotumoral) calcinosis occurs in about 3% of patients with systemic sclerosis. Calcinosis develops in up to 70% of juvenile dermatomyositis, 2–3 years after onset, and in up to 30% of adult dermatomyositis (Mormile et al. 2023).

Calciphylaxis (calcific uremic arteriolopathy): histologic criteria and biopsy

Calciphylaxis is calcification of microvessels in the subcutaneous adipose tissue that causes painful, ischemic skin lesions. Reported survival is about 50% at 6–12 months after diagnosis (Søndergaard et al. 2026).

Feature Finding Source
Major histologic criteria Medial calcification and intimal fibroplasia of pannicular arterioles with cutaneous necrosis Dutta et al. 2019
Minor histologic criteria Extravascular calcium deposition; thrombosis of pannicular or dermal arterioles Dutta et al. 2019
Frequency of findings (70 patients) Microvascular calcification 86%; necrosis 73%; fibrin thrombi associated with pain severity Dutta et al. 2019
Other reported findings Perieccrine calcification, adipose tissue necrosis, panniculitis, fibrointimal hyperplasia; extravascular calcium in the subcutis, deep dermis or superficial dermis Dutta et al. 2019
Special stains von Kossa or Alizarin red to highlight subtle calcium and phosphate deposits Chewcharat and Nigwekar 2025
Biopsy technique Punch or telescoping biopsy from the peripheral, non-necrotic region by an experienced operator; contraindicated in acral, penile or suspected infected sites; may be omitted in end-stage kidney disease with classic lesions Chewcharat and Nigwekar 2025
  • Patient profile. In a clinicopathologic series of 70 patients, 60% were women, 83% had end-stage renal disease, 56% were obese, 61% had diabetes and 47% were taking warfarin. Pain was severe in 74%, and 87% had open necrotic wounds at diagnosis (Dutta et al. 2019). Lesions favor areas of high adiposity such as the abdomen, buttocks and thighs (Chewcharat and Nigwekar 2025).
  • Risk factors in chronic kidney disease. A systematic review found consistent associations with low albumin, higher alkaline phosphatase, diabetes, higher body mass index, female sex, vitamin K antagonist use, a raised calcium-phosphate product, and calcification and thrombosis of subcutaneous small arteries (Søndergaard et al. 2026).
  • Specificity of vascular findings. Calcification of small arteries and arterioles is more frequent and more extensive in calciphylaxis than in matched kidney disease controls. Perieccrine calcification varies between studies, and intimal hyperplasia was not more frequent than in amputation specimens from patients with end-stage kidney disease. No standardized system for evaluating calciphylaxis biopsies exists (Søndergaard et al. 2026).
  • Nonuremic calciphylaxis. Calciphylaxis without renal failure is rare and has been reported with lupus and antiphospholipid syndrome, rheumatoid arthritis and overlapping autoimmune disease. Deficiency of matrix Gla protein, a vitamin K-dependent inhibitor of vascular calcification, induced by glucocorticoids and warfarin, is a proposed mechanism (Mormile et al. 2023).

Progressive osseous heteroplasia, Albright hereditary osteodystrophy, pseudohypoparathyroidism and primary osteoma cutis share superficial heterotopic ossification and heterozygous inactivating GNAS variants. GNAS encodes the α subunit of the stimulatory G protein (Gsα) of adenylyl cyclase (Pignolo et al. 2015).

  • Parent of origin. Pseudohypoparathyroidism type 1a is caused mainly by maternally inherited GNAS variants, and progressive osseous heteroplasia by variants on the paternal allele. Gsα is expressed only from the maternal allele in renal proximal tubules, thyroid, pituitary and gonads, which explains hormone resistance with maternal inheritance (Pignolo et al. 2015).
  • Morphology of ossification. In progressive osseous heteroplasia, intramembranous ossification begins in subcutaneous fat and then extends into muscle and fascia (Pignolo et al. 2015).
  • Albright hereditary osteodystrophy. Superficial heterotopic ossification occurs with short adult stature, obesity, round face, brachydactyly and neurobehavioral problems (Pignolo et al. 2015).

Cutaneous amyloidosis: keratin-derived and light chain-derived deposits

Amyloid is pale, eosinophilic, amorphous, glassy and PAS-negative on routine sections and is congophilic with apple-green birefringence under polarized light. Cutaneous deposits may come from systemic AL amyloidosis of plasma cell dyscrasia, systemic AA amyloidosis, or primary localized cutaneous amyloidosis (PLCA), which is confined to the skin without systemic deposition or a clonal disorder (Parvathy et al. 2026).

Form Histology Amyloid source and immunohistochemistry Source
Lichen amyloidosis (50% of 42 PLCA cases) Amyloid limited to the papillary dermis; acanthosis 90.5%, melanophages 66.7%, perivascular lymphocytes 57.1%, hyperkeratosis and parakeratosis 57.1% Keratinocyte-derived; HMWCK positive in 66.7% Parvathy et al. 2026
Macular amyloidosis Scanty papillary dermal amyloid with pigment incontinence; mild acanthosis in a subset Keratinocyte-derived; HMWCK positive in 63.6% Parvathy et al. 2026
Amyloidosis cutis dyschromica Papillary dermal amyloid Keratinocyte-derived; HMWCK positive in 2 of 3 Parvathy et al. 2026
Nodular amyloidosis (7 cases) Nodular dermal deposits; perivascular lymphoplasmacytic infiltrate (57.1%) and acanthosis (42.9%) Light chain restriction in all cases; systemic amyloidosis must be excluded Parvathy et al. 2026
  • HMWCK and Congo red. HMWCK staining was more extensive than Congo red, often extended into the reticular dermis, and detected tiny papillary dermal deposits in 3 cases that were missed on light microscopy and Congo red (Parvathy et al. 2026).
  • Mechanism of keratin-derived amyloid. Ultrastructural tonofilament deposits resemble amyloid filaments and share keratin immunoreactivity with epidermal keratinocytes. The secretory theory attributes the deposits to basal keratinocytes dropping into the papillary dermis (Parvathy et al. 2026).
  • Nodular amyloidosis. Clonality and plasma cells suggest a low-grade B-cell lymphoproliferative process and warrant follow-up, although none of the series cases developed systemic disease on long follow-up (Parvathy et al. 2026).

Gouty tophus in skin

A tophus is pathognomonic for gout. It is a granuloma of histiocytes and foreign-body giant cells surrounding deposits of urate crystals. In formalin-fixed tissue the dermis contains well-defined, rounded, basophilic deposits with slight striations, bordered by histiocytes and multinucleated cells. Fixation in alcohol is preferred because aqueous formalin dissolves urate deposits (Anavi and Stoyanova 2026).

Exogenous pigments and drug deposits: tattoo, argyria, chrysiasis, minocycline, amiodarone and ochronosis

Pigment or drug Clinical pattern Histology and stains Source
Tattoo ink Black (carbon, zinc oxide), red (mercury sulfide [cinnabar], cadmium selenide, ferric hydrate, organic dyes), white, yellow, green and brown inks; adverse reactions in up to 67% of tattooed people, most often with red ink Particles in the papillary and reticular dermis at 1–3 mm, held by macrophages and fibroblasts; reaction patterns: lichenoid, spongiotic, granulomatous, pseudolymphomatous, pseudoepitheliomatous hyperplasia and sclerodermoid Chalarca-Cañas et al. 2024
Silver (argyria) Slate-gray or bluish discoloration accentuated in sun-exposed skin; localized dark-blue macules after local implantation; azure lunulae Extracellular rows of brown-black granules (<1 µm) on basement membranes of eccrine glands and vessels, along elastic fibers and the dermoepidermal junction; epidermis spared Mota and Dinis-Oliveira 2021; Jung et al. 2017
Gold (chrysiasis) Generalized chrysiasis; fine gold particles also in the cornea Gold deposits in the extracellular matrix of the upper dermis and within macrophages Martin et al. 2022
Minocycline type I Blue-black pigment in scars or inflamed facial skin Pigment in macrophages from hemosiderin phagocytosis and minocycline chelation; reversible Okinaka et al. 2023
Minocycline type II Blue-gray pigment on the lower legs and forearms Blue iron-positive granules in macrophages at all dermal levels; reversible Okinaka et al. 2023
Minocycline type III Slate blue-gray pigment of the face, gums, teeth and nail beds, sparing sun-protected skin (reported case) Intracellular and extracellular dermal melanin, Fontana–Masson positive; does not resolve after the drug is stopped Loh et al. 2019; Okinaka et al. 2023
Amiodarone Blue-gray discoloration of the nose, forehead and cheeks that increases with sunlight Dense bodies resembling lipofuscin attached to lysosomal membranes on ultrastructure Samadi Takaldani et al. 2023; Doshi et al. 2026
Hydroquinone (exogenous ochronosis) Bluish-gray patches with coarse texture and caviar-like papules on the face, mainly in dark skin after long-term skin-lightening creams Yellow-brown, sharply defined, elongated "banana-like" deposits in the upper dermis with solar elastosis Qorbani et al. 2020
  • Tattoo reactions. In a systematic review, granulomatous reactions made up 48.48% of tattoo complications, infections 21.21% and allergic reactions 12.12%. Foreign body reactions appear months to years after tattooing, and about 29.3% are associated with cutaneous or systemic sarcoidosis. Pigment is eliminated transepidermally in the first month until the basement membrane regenerates. Pigment carried to lymph nodes appears with histiocytes and Langerhans cells in the paracortex as dermatopathic lymphadenopathy. Henna stains only the stratum corneum. Metallic salts such as mercury sulfide caused many of the historical adverse reactions, and hypersensitivity reactions are still attributed mainly to mercury in red inks (Chalarca-Cañas et al. 2024).
  • Mechanism of argyria. Silver deposits are photoreduced in sun-exposed skin, the same process that darkens photographic film, and silver stimulates melanin production (Mota and Dinis-Oliveira 2021).
  • Minocycline dose and reversibility. Type II and III pigmentation can occur after a cumulative minocycline dose above 70–100 g. Types I and II resolve after the drug is stopped, and types III and IV do not (Okinaka et al. 2023). Dermal pigment positive for both iron and Fontana–Masson in a patient taking minocycline indicates drug-induced pigmentation and can mimic hemosiderin of venous stasis (Doshi et al. 2026).
  • Endogenous ochronosis. Alkaptonuria is an autosomal recessive deficiency of homogentisic acid oxidase. Homogentisic acid accumulates and turns cartilage of the ear and joints dark blue (Qorbani et al. 2020). It is caused by HGD variants, and skin or scleral pigmentation was present in 58.24% of 91 Chinese patients, more often in adults (Qiu et al. 2025). Exogenous ochronosis follows topical phenols such as hydroquinone, or intramuscular antimalarials, and resembles the endogenous form histologically (Qorbani et al. 2020).

Cosmetic fillers and foreign-body reactions

In a systematic review of 303 histologically diagnosed adverse reactions to face and neck fillers, the materials were silicone (19.7%), hyaluronic acid (15.5%), hydroxyethyl methacrylate/ethyl methacrylate in hyaluronic acid (5.6%), calcium hydroxylapatite (5.6%), polyalkamide (5.3%), poly-L-lactic acid (5.0%), autologous fat (5.0%), polyacrylamide gel (2.6%), polymethylmethacrylate (2.0%) and collagen (1.6%) (Machado et al. 2023).

Reaction pattern Frequency (303 patients) Histology Source
Foreign body granuloma 87.1% Dense lymphohistiocytic infiltrate with eosinophils and foreign-body giant cells; vacuolated cyst-like spaces with a "Swiss cheese" pattern Machado et al. 2023
Inflammatory granuloma 3% Macrophage and epithelioid core with a lymphocytic cuff and variable fibrosis Machado et al. 2023
Lipogranuloma and sclerosing lipogranuloma 3% and 0.3% Granulomatous response to extracellular lipid Machado et al. 2023
Xanthelasma-like reaction 2.3% After calcium hydroxylapatite and polycaprolactone; xanthelasma after hyaluronic acid, which can bind extravasated low-density lipoprotein Machado et al. 2023
Fibrotic reaction, amorphous material, siliconoma 1%, 0.7%, 0.3% Reported as fibrotic reaction, amorphous tissue and siliconoma Machado et al. 2023

Mild lymphohistiocytic infiltrates without granulomas and lymphoplasmacytic infiltrates without visible filler also occur. Granulomas to inorganic matter such as silica and silicone lack the lymphocytic cuff of immunologic granulomas (Machado et al. 2023).

Morphology of specific fillers. Fillers are biodegradable (hyaluronic acid, poly-L-lactic acid and calcium hydroxylapatite) or permanent (paraffin, silicone, hydroxyethyl methacrylate, polymethylmethacrylate and polyacrylamide hydrogel) (Abdelhammed et al. 2026). Silicone appears as abundant translucent microvacuoles of silicone-like material within CD68-positive histiocytes of a foreign body granuloma (Gamez-Siller et al. 2025). A delayed reaction to polyacrylamide gel (Argiform) filled the dermis with vacuolated adipocyte-like cells, some resembling multivacuolated or signet-ring lipoblasts, without giant cells or visible extracellular filler. The cells were CD68-positive and S100- and pancytokeratin-negative, which excluded atypical lipomatous tumor and signet-ring carcinoma (Abdelhammed et al. 2026).

Xanthomas: eruptive, tuberous and verruciform

Xanthomas form when macrophages take up cholesterol, triglycerides and phospholipids and become foam cells in the dermis (Kashif et al. 2016). Qualitatively altered plasma lipoproteins and free fatty acids accumulate in dermal foam cells (Narasimhan et al. 2022).

Xanthoma Lipid disorder Histology Source
Eruptive Raised serum triglycerides, often with uncontrolled diabetes; triglycerides that leak through capillaries are phagocytosed by dermal macrophages; dermal and retinal lipid deposits (lipemia retinalis) at triglycerides >2,000 mg/dL Dermal lipid deposition with foam cells Kashif et al. 2016; Shrestha et al. 2024
Tuberous Raised total and LDL cholesterol in homozygous familial hypercholesterolemia; lesions over large and small joints Scattered foamy macrophages in the upper dermis with cholesterol clefts Narasimhan et al. 2022
Tendinous Familial hypercholesterolemia with raised LDL cholesterol and apolipoprotein B; firm fusiform swellings of the Achilles tendons Foam cells and cholesterol clefts Kumar et al. 2026
Diffuse normolipemic plane Normal lipids; often a hematologic disorder, about half lymphoproliferative, including monoclonal gammopathy; symmetrical flat yellow patches or plaques of the eyelids, neck, upper trunk and flexures Foam cells with variable Touton giant cells, lymphocytes and foamy histiocytes Cerqueira et al. 2025
Verruciform Not linked to disordered lipid metabolism in oral lesions Foam cells (xanthoma cells) that are PAS-positive and diastase-resistant Mondal et al. 2025

Eruptive xanthomas indicate severe hypertriglyceridemia, which can be complicated by acute pancreatitis, and they regress as triglycerides fall with treatment (Shrestha et al. 2024; Kashif et al. 2016). Juvenile xanthogranuloma is taught in Vascular Anomalies and Vascular Tumors of Skin, Kaposi Sarcoma and Angiosarcoma, Cutaneous Histiocytic and Mast Cell Infiltrates, and Metastases to Skin.

Nutritional and metabolic dermatoses and the pattern of upper epidermal pallor

Pellagra, acrodermatitis enteropathica, necrolytic acral erythema and necrolytic migratory erythema share pallor and ballooning of the upper epidermis that can progress to necrosis and separation, usually with parakeratosis or psoriasiform hyperplasia. Early lesions can be subtle and nonspecific (Ladas et al. 2026; Smith et al. 2024; Sushantika and Sethi 2025).

Disorder Deficiency and setting Histology Source
Pellagra Niacin (vitamin B3) or tryptophan deficiency: alcohol use disorder, malnutrition, eating disorders, malabsorption, untreated maize diets, Hartnup disease Dilated dermal vessels with minimal inflammation, epidermal pallor, keratinocyte ballooning, compact or parakeratotic hyperkeratosis, subepidermal bullae; full-thickness epidermal necrosis in bullous pellagra Ladas et al. 2026; Yamada et al. 2026
Acrodermatitis enteropathica and zinc deficiency Autosomal recessive SLC39A4 (ZIP4 intestinal zinc transporter), about 1 in 500,000; transient neonatal zinc deficiency from maternal SLC30A2 (ZnT2) variants with low breast-milk zinc; acquired deficiency Psoriasiform pattern, epidermal pallor and confluent parakeratosis Botelho et al. 2024; Sushantika and Sethi 2025
Necrolytic acral erythema Usually hepatitis C; also nutritional deficiency, diabetes, cirrhosis, hypoalbuminemia or zinc deficiency; treated with zinc Mid and upper epidermal pallor progressing to necrosis and separation; basal vacuolopathy and squamatization Smith et al. 2024
Necrolytic migratory erythema Glucagonoma; hyperglucagonemia depletes zinc, amino acids and essential fatty acids, so the eruption is classed as a deficiency dermatosis Variable; one reported glucagonoma showed confluent parakeratosis with neutrophils and mild psoriasiform hyperplasia without overt pallor Anelli et al. 2025; Rozo-Paz et al. 2026
Scurvy Vitamin C deficiency impairing collagen synthesis; signs after 4–12 weeks of inadequate intake Follicular hyperkeratosis and perifollicular extravasated red cells without vasculitis; hemosiderin; epidermal atrophy Kassa et al. 2024; Chieng et al. 2026
  • Pellagra. Casal necklace is a symmetrical hyperpigmented band around the neck caused by the photosensitivity of pellagra (Yamada et al. 2026). Deficiency of urocanic acid, an ultraviolet filter, explains the photosensitive lesions (Ahmed et al. 2023). In a forensic autopsy of anorexia nervosa, postmortem serum tryptophan of 16.1 nmol/mL (reference range 40.9–68 nmol/mL) supported the diagnosis (Yamada et al. 2026).
  • Zinc deficiency. The genetic and acquired forms look alike, with erythematous desquamative plaques, vesicles, bullae and pustules in periorificial and acral sites, alopecia and diarrhea. Classic acrodermatitis enteropathica usually begins when breastfeeding stops (Botelho et al. 2024).
  • Glucagonoma syndrome. The syndrome comprises necrolytic migratory erythema, diabetes mellitus, weight loss, normochromic normocytic anemia, diarrhea, venous thrombosis and neuropsychiatric disturbance (Anelli et al. 2025). The tumor has spread to the liver at detection in 50%–80% of patients, and necrolytic migratory erythema improved in 80% of patients treated with somatostatin analogues (Rozo-Paz et al. 2026).
  • Scurvy. Clinical findings and laboratory diagnosis of scurvy and pellagra are in Porphyrias and Vitamin Testing. Perifollicular extravasated red cells without vasculitis are pathognomonic in skin biopsies (Kassa et al. 2024). Scurvy can mimic IgA vasculitis or small-vessel vasculitis, and a biopsy can resemble a pigmented purpuric dermatosis (Kassa et al. 2024; Chieng et al. 2026).
  • Kwashiorkor. Protein-energy malnutrition with edema and hypoalbuminemia produces flaky (peeling) paint dermatosis; incidence was 3 per 1,000 person-months at 2–3 years of age (Karnan 2024). The skin progresses from dryness and atrophy to hyperkeratosis and hyperpigmentation that peels off, attributed to low methionine impairing keratin sulphation (Vijayasankar and Karthikeyan 2021).
  • Histology of nutritional deficiency dermatoses, including kwashiorkor. In 29 biopsies from 24 hospitalized patients with laboratory-confirmed nutritional deficiency, parakeratosis and loss of the granular layer were present in 93.1%, dermal edema in 72.4%, confluent parakeratosis in 72%, and epidermal pallor and ballooning in only 17.2% each. Pallor was associated with lower total protein. Most biopsies showed asteatotic dermatitis-like change (compact hyperkeratosis without spongiosis) and lacked the classic psoriasiform hyperplasia and pallor. Kwashiorkor biopsies showed slight epidermal atrophy, confluent parakeratosis, a retained granular layer and dermal edema (Milanovic et al. 2026).

Reactions to physical agents and light: erythema ab igne, photodermatoses, coma blister, electrical injury and frostbite

Disorder Cause Histology Source
Erythema ab igne Repeated heat or infrared exposure below the burn threshold (heating pads, blankets, car seats, space heaters, laptops) Epidermal atrophy, basal keratinocyte atypia, melanin and hemosiderin deposition and superficial vascular dilation; lichenoid interface change resembling keratosis lichenoides chronica in rare cases Hesseltine and Sulewski 2026; Prohic et al. 2021
Polymorphous light eruption Sunlight; lesions appear soon after exposure and heal in a few days without further exposure; women, onset in the 2nd–4th decades Subepidermal edema, spongiosis, rare dyskeratotic keratinocytes and superficial and deep perivascular lymphocytes with histiocytes and neutrophils, without vasculitis; a neutrophil-predominant variant shows eosinophilic and neutrophilic spongiosis with little papillary edema Daruish et al. 2024; Lew and Jacob 2014; Ogunremi and Hopkins 2026
Actinic prurigo Abnormal photosensitivity to UVB and UVA Hyperkeratosis, spongiosis and acanthosis with dermal perivascular lymphocytes Saravanan et al. 2026
Chronic actinic dermatitis (actinic reticuloid) Ultraviolet light; spectrum includes persistent light reactivity and photosensitive eczema Spongiosis and acanthosis with superficial and deep perivascular lymphohistiocytic infiltrates Saravanan et al. 2026
Coma blister Sustained pressure and hypoxia in decubitus areas during coma-like episodes Subepidermal bulla with transepidermal necrosis and eccrine sweat gland or duct necrosis; direct immunofluorescence negative for IgG, IgA, IgM, C3 and fibrin Riley et al. 2025
Electrical mark Heat generated at the contact site by skin resistance Epidermal coagulative injury, intraepidermal clefting, dermoepidermal separation, nuclear hyperchromasia, pyknosis and elongation or streaming of epidermal nuclei Caruso et al. 2026
  • Erythema ab igne and carcinoma. Squamous cell carcinoma is the main long-term risk, with rare lymphoma and basal cell carcinoma (Prohic et al. 2021). Squamous atypia within erythema ab igne is termed thermal keratosis because it resembles actinic keratosis (Hesseltine and Sulewski 2026).
  • Coma blister versus retiform purpura. Eccrine sweat gland necrosis strongly favors a coma blister because the glands are susceptible to ischemia from their high metabolic demand (Riley et al. 2025).
  • Electrical injury in forensic practice. Metallization studies, scanning electron microscopy, energy-dispersive X-ray analysis and microbeam X-ray fluorescence support the histologic assessment in selected cases (Caruso et al. 2026).
  • Frostbite. Prolonged subfreezing exposure forms intracellular or extracellular ice crystals in skin and deeper tissue and causes ischemic damage. Severe frostbite progresses to vesiculation, necrosis and gangrene (Scheinkman et al. 2025). Superficial frostbite shows extracellular ice crystals and clear blisters, and deep frostbite shows microvascular thrombosis, hemorrhagic blisters and necrosis (Obaidi et al. 2026).

Follicular Disorders, Alopecia, Nail Unit Pathology and Panniculitis: Rosacea, Folliculitis, Hidradenitis Suppurativa, Scarring and Non-scarring Alopecia, Hair Shaft and Nail Disorders, Septal and Lobular Panniculitis

Definition and classification. No WHO classification or CAP protocol governs inflammatory disease of the hair follicle, nail unit or subcutis. Primary cicatricial alopecias are grouped by the North American Hair Research Society (NAHRS) classification as lymphocytic, neutrophilic, mixed or nonspecific according to the predominant inflammatory infiltrate (Brunetti et al. 2026). Panniculitides are classified as septal or lobular according to where the infiltrate is mainly located. Erythema nodosum is the most common panniculitis and the prototype of septal panniculitis (Pérez-Garza et al. 2021). Rothmann–Makai syndrome, Weber–Christian disease and cytophagic histiocytic panniculitis are no longer regarded as specific entities (Moulonguet and Fraitag 2021).

Related page: Normal Skin, Biopsy Handling and the Reaction-Pattern Approach; Spongiotic, Psoriasiform, Keratinization and Pigmentary Disorders (normal scalp and adnexal histology, biopsy types and handling, the reaction-pattern approach) Related page: Interface and Lichenoid Dermatoses, Cutaneous Lupus and Dermatomyositis, Graft-versus-Host Disease, and Sclerosing Dermal Disorders (lichen planus, discoid lupus erythematosus, morphea and other interface and sclerosing dermatoses outside the follicle and subcutis) Related page: Granulomatous, Vasculitic, Neutrophilic and Eosinophilic Dermatoses: Sarcoidosis, Granuloma Annulare, Cutaneous Vasculitis and Vasculopathy, Sweet Syndrome, Pyoderma Gangrenosum and Wells Syndrome (cutaneous polyarteritis nodosa, sarcoidosis and other granulomatous and vasculitic patterns that involve the subcutis) Related page: Skin Infections and Infestations: Bacterial, Mycobacterial, Spirochetal, Fungal, Viral, Protozoal and Parasitic Infections of Skin (herpetic folliculitis, dermatophytes and Majocchi granuloma, mycobacterial infection and the special-stain table for organisms in skin) Related page: Cutaneous Lymphoid and Hematolymphoid Infiltrates: Histologic Approach, Early Mycosis Fungoides and Its Mimics, CD30-Positive Lymphoproliferative Disorders, Rare Cutaneous T-Cell Lymphomas and Reactive Lymphoid Proliferations (subcutaneous panniculitis-like T-cell lymphoma, primary cutaneous γδ T-cell lymphoma and the approach to cutaneous lymphoid infiltrates) Related page: Solid Cellular Neoplasms of the Pancreas: Solid Pseudopapillary Neoplasm, Acinar Cell Carcinoma, Pancreatoblastoma and Metastases to the Pancreas (acinar cell carcinoma and the lipase hypersecretion syndrome)

Rosacea, lupus miliaris disseminatus faciei and acneiform eruptions

Granulomatous rosacea was formerly listed as a variant beside the erythematotelangiectatic, papulopustular, ocular and phymatous subtypes. Granulomas also occur in erythematotelangiectatic and papulopustular rosacea, so granulomatous rosacea is now regarded as a histologic variant. The updated rosacea classification replaces subtypes with combinations of phenotypes (Park et al. 2024). Lupus miliaris disseminatus faciei (LMDF) presents as discrete yellow-brown dome-shaped centrofacial papules, and a tuberculous etiology has been refuted (Park et al. 2024).

Feature (62 patients) Granulomatous rosacea Lupus miliaris disseminatus faciei Source
Male-to-female ratio 1:3.5 1:0.8 Park et al. 2024
Mean age 51.7 years 44.4 years Park et al. 2024
Vascular symptoms 77.7% 23.0% Park et al. 2024
Epithelioid granulomas 55.6% 84.6% Park et al. 2024
Caseation necrosis About 10% in earlier studies 38.5% (20%–43% in earlier studies); may be absent in early or late lesions Park et al. 2024
Other dermal findings Capillary dilatation, solar elastosis and Demodex folliculorum more frequent (not statistically significant) Deep-seated papules correspond to granulomas with caseation Park et al. 2024
Immunohistochemistry CD3- and CD8-positive T cells; weaker CD68 CD3, CD8 and strong CD68 Park et al. 2024

Acne and acneiform mimics. Subclinical inflammation, mediated by keratinocyte-derived interleukin-1α, CCL20 and lipoteichoic acid, precedes comedo formation in acne-prone skin (Frew 2020). Malassezia folliculitis produces monomorphic follicular papulopustules of the neck, trunk and upper limbs without comedones, often coexists with acne in adolescents and is often misdiagnosed as bacterial folliculitis or acne (Martínez-Ortega et al. 2024).

Comedones on in vivo microscopy. On line-field confocal optical coherence tomography of 52 facial acne lesions, microcomedones showed bright perifollicular rings of early follicular hyperkeratinization in 83.3%. Closed comedones were cystic keratin-filled follicular structures beneath an intact epidermis, open comedones had a surface opening with a mixed keratin plug, and papules and pustules showed perifollicular inflammatory cells (Traini et al. 2026).

Infectious and noninfectious folliculitis

Folliculitis Clinical setting Histologic and laboratory findings Source
Malassezia (Pityrosporum) folliculitis Young and middle-aged adults; sweating, hot climate, recent antibiotics or corticosteroids, immunosuppression and high sebum production Pustule smears show clusters of yeasts with unipolar budding; H&E and PAS sections show follicular plugging and inflammation and detect cases missed by direct examination Martínez-Ortega et al. 2024
Eosinophilic pustular folliculitis (Ofuji disease, described 1970) Classic form (Japan, mainly males), infantile form and immunosuppression-associated form (HIV infection, malignancy); seborrheic areas Eosinophil-predominant infiltrate within and around folliculosebaceous units; PAS, Giemsa and Ziehl–Neelsen stains negative; follicular mucin occasionally present, mainly in HIV-infected patients Kanaki et al. 2021; Zhu et al. 2026
Folliculitis decalvans Primary neutrophilic cicatricial alopecia of the scalp; follicular tufting Neutrophilic folliculitis with follicular rupture; mixed inflammation and perifollicular fibrosis in later lesions; culture of pustules may grow Staphylococcus aureus, a supportive finding Brunetti et al. 2026; Singh et al. 2025
Dissecting cellulitis of the scalp Young adult men, darker skin phototypes; nodules, abscesses and sinus tracts Deep follicular rupture, dense neutrophilic infiltrate with lymphocytes, plasma cells and histiocytes, abscesses and interconnected sinus tracts in dermis and subcutis; healing by granulation tissue and fibrosis Mokos et al. 2026; Brunetti et al. 2026
Demodex folliculitis (demodicosis) Immunocompromised or predisposed patients; rosacea, blepharitis and acne are associated with increased mite density Dense perivascular and perifollicular lymphohistiocytic and neutrophilic infiltrate with numerous mites in follicular infundibula; mites alone are not diagnostic because they occur in normal-appearing skin; diagnosis needs compatible morphology, increased or aberrantly located mites and response to acaricidal therapy Palladino et al. 2026
Pseudofolliculitis barbae Beard area and other shaved terminal-hair sites after shaving or plucking; more frequent in men of African and, to a lesser extent, Asian descent with tightly curled hair Sharp tips of curved growing hairs penetrate the adjacent skin and provoke a foreign-body reaction with papules, pustules and postinflammatory hyperpigmentation Ogunbiyi 2019
  • Perifollicular lymphocytic inflammation and fibrosis beyond the lesion. Perifollicular infundibulo-isthmic lymphocytic inflammation and fibrosis (PIILIF) was present in all 12 biopsies of clinically normal-appearing scalp from men with dissecting cellulitis. Active lesions also showed neutrophils (9 of 9), granulation tissue and sebaceous gland loss. PIILIF had been reported in normal-appearing scalp in acne keloidalis nuchae, central centrifugal cicatricial alopecia, lichen planopilaris, frontal fibrosing alopecia and folliculitis decalvans (Umar et al. 2026).
  • HIV-associated eosinophilic folliculitis. The HIV-associated form, rare since combined antiretroviral therapy, shows unremitting pruritus, sparing of palms and soles and leukopenia. In classic disease fewer than 50% have pruritus, 20% have palm and sole involvement and most have leukocytosis (Kanaki et al. 2021).

Hidradenitis suppurativa and the follicular occlusion tetrad

  • Follicular occlusion tetrad. Hidradenitis suppurativa, acne conglobata, dissecting cellulitis of the scalp and pilonidal disease share a sequence of follicular hyperkeratosis, occlusion, rupture and secondary neutrophilic inflammation that ends in deep tissue destruction and scarring. Lesional TNF-α, IL-1β, IL-17 and IL-23 are raised in both dissecting cellulitis and hidradenitis suppurativa (Mokos et al. 2026).
  • Pathogenesis. Hidradenitis suppurativa is being reclassified from a primary disorder of follicular occlusion to an autoinflammatory keratinization disease. Comedones occur in flexural and nonflexural, inflamed, scarred and noninflamed skin. Axillary, inguinal and submammary folds are the sites of predilection. A minority of familial and spontaneous cases carry γ-secretase complex mutations (Frew 2020).
  • Histology. Dense perifollicular and intrafollicular inflammation coexists with discontinuities of the follicular epithelium. Lesional nodules contain T cells, dendritic cells, plasma cells, neutrophils and monocytes. Long-standing disease shows B-cell infiltrates, neutrophil extracellular traps, epithelialized tunnels and loss of follicular and adnexal structures (Frew 2020).

Scalp biopsy technique and horizontal sectioning for alopecia

Biopsy is indicated when alopecia remains uncertain after clinical examination and trichoscopy, when a scarring process must be confirmed or excluded, or when documentation is needed before systemic therapy (Brunetti et al. 2026).

Step Recommendation Source
Instrument 4-mm punch (about 13 mm², nearly twice the 7 mm² of a 3-mm punch) Brunetti et al. 2026
Orientation and depth Parallel to the direction of hair growth and into subcutaneous fat; anagen bulbs lie in the subcutis and are amputated by a superficial biopsy Brunetti et al. 2026
Site in scarring alopecia Active margin with residual inflamed follicles; completely bald scalp shows only nonspecific end-stage fibrosis Brunetti et al. 2026
Site in diffuse non-scarring alopecia Vertex or mid-scalp for androgenetic alopecia, female pattern hair loss and telogen effluvium Brunetti et al. 2026
Headington transverse sectioning Cut about 1 mm above the dermis–subcutis junction, the level at which sebaceous ducts enter the follicle Palo 2026
HoVert technique Transection about 1 mm below the surface; the epidermal disc is bisected for vertical sections and the deep portion is sectioned horizontally, keeping the full punch width for follicle counts Brunetti et al. 2026
Tyler technique Vertical bisection of the punch, then transverse sectioning of one half; half the punch remains for counts Brunetti et al. 2026
St John's protocol Two 4-mm punches; non-scarring alopecia: affected scalp plus a control site, both horizontal; scarring alopecia: one horizontal and one bisected vertically for H&E and direct immunofluorescence Brunetti et al. 2026
  • Normal values on horizontal sections. About 85%–90% of normal scalp follicles are in anagen and telogen follicles account for less than 10%–15%. A terminal-to-vellus ratio below 4:1 at the isthmus supports androgenetic alopecia. An increased telogen fraction with a preserved terminal-to-vellus ratio supports telogen effluvium (Brunetti et al. 2026).
  • Plane of section. A meta-analysis found no significant overall difference in diagnostic yield between horizontal and vertical sections, and a series of 228 biopsies found the combination gave the highest yield. In that series, 22 biopsies (9.6%) were inconclusive because of faulty grossing (Brunetti et al. 2026).
  • Ancillary stains. Direct immunofluorescence showing granular immunoglobulin and complement along the basement membrane zone supports discoid lupus over lichen planopilaris. PAS identifies fungi in tinea capitis. Elastic stains such as Verhoeff–Van Gieson separate follicular streamers from true follicular scars on horizontal sections (Brunetti et al. 2026).
  • Multifactorial alopecia. More than 1 diagnosis was present in 12.5% of 1,360 consecutive scalp biopsies. Androgenetic alopecia with central centrifugal cicatricial alopecia was the most frequent combination, followed by central centrifugal cicatricial alopecia with end-stage traction alopecia (Brunetti et al. 2026).

Non-scarring alopecias: alopecia areata, androgenetic alopecia, telogen effluvium and traumatic alopecia

Disorder Diagnostic histology Key distinction Source
Androgenetic alopecia and female pattern hair loss Progressive follicular miniaturization with a shift to vellus-like hairs; terminal-to-vellus ratio below 4:1 Horizontal sections outperform vertical sections for diagnosis and for predicting treatment response Brunetti et al. 2026
Acute telogen effluvium Preserved follicle count with a disproportionate increase in telogen follicles Terminal-to-vellus ratio preserved Brunetti et al. 2026
Alopecia areata, acute Peribulbar lymphocytic infiltrate ("swarm of bees") Inflammation may be sparse or absent in later stages Brunetti et al. 2026
Alopecia areata, subacute and chronic Increased catagen and telogen follicles; chronic lesions show miniaturization and nanogen follicles; fibrous stelae of loose capillary-rich tissue below follicles that entered telogen prematurely Diffuse alopecia areata may show more intense peribulbar inflammation with eosinophils and CD8-positive T cells Brunetti et al. 2026; Marwah et al. 2014
Alopecia areata incognita Preserved follicular units, fewer terminal follicles, telogen structures averaging 37%, terminal-to-vellus ratio averaging 3.3:1, small telogen follicles and dilated infundibular openings (46 cases) Mimics telogen effluvium; trichoscopy shows diffuse yellow dots and short regrowing hairs Brunetti et al. 2026
Trichotillomania Distorted follicles, traumatized bulbs, trichomalacia, pigment casts and empty follicular sheaths with minimal inflammation Increased catagen follicles occur in both trichotillomania and alopecia areata; hair-shaft damage, trichomalacia and pigment casts indicate trauma Brunetti et al. 2026
Traction alopecia Loss of terminal follicles, fibrous tracts and relative preservation of sebaceous glands Three or more pauci-follicular units (non-inflamed units with an intact sebaceous gland and fewer than 2 follicles) in one 4-mm punch on horizontal sections Brunetti et al. 2026
  • Telogen follicles on horizontal sections. A telogen bulb lacks pigment, has a serrated inner root sheath and lies higher in the dermis than anagen bulbs. A catagen follicle shows apoptosis and a thick, hyalinized, convoluted membrane (Marwah et al. 2014).

Primary cicatricial alopecias in the NAHRS classification

All primary cicatricial alopecias share follicular destruction, replacement by fibrous tracts, loss of sebaceous glands and eccrine duct dilation. Destruction of follicular stem cells in the bulge region makes the hair loss irreversible (Brunetti et al. 2026).

NAHRS group Disorder Diagnostic histology Clinical and laboratory correlates Source
Lymphocytic Lichen planopilaris Lichenoid interface dermatitis at the infundibulum and isthmus with hypergranulosis, Civatte bodies and concentric lamellar fibroplasia; interfollicular interstitial lymphocytes and epidermal lichenoid change more frequent than in frontal fibrosing alopecia Patchy alopecia of the central scalp; 27 women and 15 men in one series Brunetti et al. 2026; Özcan et al. 2026
Lymphocytic Frontal fibrosing alopecia Same follicular lichenoid pattern, involving vellus follicles; more apoptosis and less but deeper inflammation; sebaceous gland atrophy can precede pilosebaceous destruction Frontotemporal hairline recession with eyebrow loss; all 19 patients in one series were women (mean age 55.6 years) Brunetti et al. 2026; Özcan et al. 2026
Lymphocytic Fibrosing alopecia in a pattern distribution Lichen planopilaris features with the miniaturization of androgenetic alopecia 18% of scarring alopecia in a 10-year single-center series Brunetti et al. 2026
Lymphocytic Discoid lupus erythematosus Patchy vacuolar interface dermatitis, superficial and deep folliculocentric infiltrate reaching eccrine glands, basement membrane thickening and dermal mucin Granular immunoglobulin and complement at the basement membrane zone on direct immunofluorescence Brunetti et al. 2026
Lymphocytic Central centrifugal cicatricial alopecia Premature desquamation of the inner root sheath, concentric lamellar perifollicular fibrosis and variable isthmus lymphocytes; no interface change Most common scarring alopecia in women of African descent; PADI3 variants in about 25% of patients; can be indistinguishable from lichen planopilaris Brunetti et al. 2026; Persson et al. 2026
Neutrophilic Folliculitis decalvans Neutrophilic folliculitis, follicular rupture, tufted follicles in fibrosis Pustules and tufted hairs Brunetti et al. 2026
Neutrophilic Dissecting cellulitis of the scalp Deeper follicular rupture, suppurative inflammation and abscesses Follicular occlusion tetrad Brunetti et al. 2026; Mokos et al. 2026
Mixed Acne keloidalis nuchae Neutrophilic and lymphocytic inflammation Nape; biopsy of the active papular or pustular margin Brunetti et al. 2026
  • Separation of fibrosing alopecia in a pattern distribution from central centrifugal cicatricial alopecia. Vacuolar or lichenoid interface change is present in fibrosing alopecia in a pattern distribution and absent in central centrifugal cicatricial alopecia, although both present as centroparietal hair loss with miniaturization (Brunetti et al. 2026).

Hair shaft abnormalities

Abnormality Light microscopic appearance Associations and genes Source
Monilethrix Irregular narrowing of the shaft in a "beaded necklace" pattern; perifollicular hyperkeratosis Autosomal dominant; hair keratin genes KRT81, KRT83, KRT86; normal hair at birth becomes brittle after a few months So et al. 2025
Pili torti Flattened shaft of variable diameter with 180° twists and fractures at regular intervals Isolated or with Menkes disease (X-linked recessive, ATP7A, copper deficiency), Björnstad and Bazex syndromes So et al. 2025
Trichorrhexis nodosa Spurs at irregular intervals where open cuticle exposes fragmented cortical fibers Congenital (Menkes disease, Netherton syndrome, argininosuccinic aciduria) or acquired hair damage from heat, chemicals, traction or chlorinated water So et al. 2025
Trichorrhexis invaginata ("bamboo hair") Distal shaft telescoped into a dilated proximal shaft ("ball and socket") Netherton syndrome: autosomal recessive SPINK5 loss of function (LEKTI deficiency) with congenital ichthyosiform erythroderma or ichthyosis linearis circumflexa and atopic diathesis So et al. 2025; Mocarska et al. 2025
Trichothiodystrophy Trichoschisis (transverse fractures); alternating light and dark "tiger-tail" banding in polarized light Autosomal recessive ERCC2/XPD; sulfur-deficient hair with ichthyosis, photosensitivity and developmental abnormalities So et al. 2025

Nail unit pathology

  • Nail clippings in onychomycosis. Onychomycosis accounts for 50% of nail diseases. Direct mycologic examination with culture has at least 30% false negatives and a sensitivity of 25%–80%, and culture takes 3–6 weeks. PAS-stained sections of a distal nail clipping give results in 24–48 hours. A fragment at least 5 mm long and 2 mm wide is submitted in formalin or dry. Hyphae lie mainly in the ventral nail plate and subungual hyperkeratosis, and subungual hyperkeratosis alone allowed diagnosis in 97% of cases in one study. Starch particles, serum and parakeratotic cells can produce false-positive PAS staining. Uniform septate hyphae invading the plate suggest a dermatophyte, thicker hyphae with irregular walls a nondermatophyte mold, and conidia on the ventral plate with budding and pseudohyphae Candida. Degenerated hyphae and isolated arthroconidia after prior antifungal treatment may need methenamine silver (Grocott) staining in addition to PAS (Bertanha and Chiacchio 2016).
  • Onychomycosis versus nail psoriasis. In 62 clippings with onychomycosis compared with 50 with psoriasis, onychomycosis showed thicker subungual keratin, more serous lakes, more neutrophils and more layers of parakeratosis. Bacteria were more frequent in psoriasis. A blurred, irregular nail transition zone favored onychomycosis, and clipping histology helped separate the two diseases even when fungi were absent (Trevisan et al. 2019).
  • Longitudinal melanonychia. Melanin in the nail plate results from melanocytic activation (more melanin from a normal number of melanocytes) or melanocytic proliferation (lentigo with isolated melanocytes, or nevus when at least one nest is present). Activation is the most common cause in adults and a matrix nevus the most common cause in children. The normal adult matrix contains about 4–9 melanocytes per millimeter (mean 7.7/mm) of the epithelial–dermal junction. SOX10 or MITF nuclear stains are preferred for counts because Melan-A and HMB-45 stain dendrites and S100 may fail to label matrix melanocytes. Subungual melanoma in situ averaged 58.9 melanocytes/mm (range 39–136) in one study. Pediatric matrix lesions can exceed 36 melanocytes/mm, and pediatric reference data are scarce. Fontana–Masson staining shows sparse pigment in activation (Moulonguet et al. 2026).
  • Matrix biopsy technique. Bands wider than 3 mm or arising from the proximal matrix carry a risk of permanent nail dystrophy and are removed by elliptical excision or tangential (shave) matrix excision, which removes the matrix epithelium with a thin layer of dermis (Moulonguet et al. 2026).
  • Subungual hemorrhage. Trauma ruptures nail bed vessels, and blood between the nail plate and nail bed appears as purplish-red to black pigment that can mimic nail unit melanoma. The pigment migrates distally and resolves as the nail grows. Lesions that fail to migrate distally, persist or develop irregular longitudinal pigmentation or a true Hutchinson sign need further evaluation and biopsy (Wu et al. 2026).
  • Nail clipping in pigmented nails. A toenail with brown-black discoloration, first diagnosed as subungual hematoma and onychomycosis, showed melanin, scattered melanocytes and melanocyte remnants in the nail plate of a clipping. Matrix biopsy showed melanoma in situ, and the Mohs excision showed invasion of 0.5 mm (pT1a) (Harouni et al. 2026).
  • Onychomatricoma. Onychomatricoma is a benign fibroepithelial tumor of the nail matrix with finger-like fibroepithelial digitations, CD34-positive stromal spindle cells and honeycomb-like cavities at the free edge of a thickened nail plate. Molecular studies published in 2023 support a predominantly mesenchymal neoplasm (Zou et al. 2026).

Approach to panniculitis: biopsy and septal versus lobular patterns

Most panniculitides present as tender erythematous subcutaneous nodules where fat is abundant, whatever the cause. Late lesions show nonspecific findings, so early lesions are sampled, and the specimen must include subcutaneous fat (Moulonguet and Fraitag 2021). A deep incisional or excisional biopsy with a generous portion of fat confirms erythema nodosum (Pérez-Garza et al. 2021). Most pediatric panniculitides have a lobular pattern (Moulonguet and Fraitag 2021).

Pattern Disorder Diagnostic clue Source
Septal, no vasculitis Erythema nodosum Thickened septa; Miescher radial granulomas Pérez-Garza et al. 2021
Septal Otulipenia (OTULIN-related autoinflammatory syndrome) Predominantly septal, occasional small- and medium-vessel vasculitis Moulonguet and Fraitag 2021
Lobular, with vasculitis in a subset Nodular vasculitis and erythema induratum of Bazin Lobular granulomatous panniculitis with necrosis; vasculitis not required Guillet et al. 2025
Lobular, neutrophilic Pancreatic panniculitis Enzymatic fat necrosis with ghost adipocytes and calcification Pomerantz et al. 2025; Seguí et al. 2023
Lobular, neutrophilic Alpha-1 antitrypsin deficiency panniculitis Liquefactive necrosis with destruction of septa and "floating" fat lobules Murinello et al. 2022; Moulonguet and Fraitag 2021
Lobular, neutrophilic Infectious panniculitis Necrosis and suppurative granulomas; organisms rare in immunocompetent hosts Moulonguet and Fraitag 2021
Lobular, neutrophilic Factitial panniculitis; vemurafenib panniculitis; familial Mediterranean fever Fat necrosis with neutrophils; cultures negative in vemurafenib panniculitis; no necrosis or vasculitis in familial Mediterranean fever Moulonguet and Fraitag 2021
Lobular, lymphocytic Lupus erythematosus panniculitis; panniculitis of dermatomyositis Lymphoid follicles, plasma cells and hyaline sclerosis of septa Moulonguet and Fraitag 2021
Lobular, lymphocytic, atypical Subcutaneous panniculitis-like T-cell lymphoma Atypical cytotoxic T cells rimming adipocytes; taught in Cutaneous Lymphoid and Hematolymphoid Infiltrates: Histologic Approach, Early Mycosis Fungoides and Its Mimics, CD30-Positive Lymphoproliferative Disorders, Rare Cutaneous T-Cell Lymphomas and Reactive Lymphoid Proliferations Alberti-Violetti and Berti 2018
Lobular, lymphohistiocytic Cold panniculitis Infiltrate most intense at the dermal–subcutaneous junction Moulonguet and Fraitag 2021
Lobular, crystal-containing Subcutaneous fat necrosis of the newborn; post-steroid panniculitis; sclerema neonatorum Radially arranged needle-shaped clefts in adipocytes and histiocytes Moulonguet and Fraitag 2021
Granulomatous Blau syndrome (NOD2) Non-necrotizing sarcoidal granulomas Moulonguet and Fraitag 2021
Sclerosing Lipodermatosclerosis Sclerosis and hemosiderin in venous insufficiency; lipomembranous fat necrosis Garimella et al. 2026; Matsukuma et al. 2022

Erythema nodosum: histology and causes

  • Histology. Erythema nodosum is a predominantly septal panniculitis without vasculitis. Early lesions show hemorrhage and edematous septa with lymphocytes, histiocytes, eosinophils and numerous neutrophils extending into the periphery of adjacent lobules. Late lesions show thickened fibrotic septa with lymphocytes, histiocytes, multinucleated giant cells and few neutrophils. Miescher radial granulomas are small collections of histiocytes around a central star-shaped cleft and are relatively specific but not pathognomonic. Small- and medium-vessel vasculitis has occasionally been reported (Pérez-Garza et al. 2021). In children, neutrophils predominate in acute lesions and mononuclear cells and histiocytes in chronic lesions (Moulonguet and Fraitag 2021).
  • Epidemiology. In north-western Spain, biopsy-proven erythema nodosum had an annual incidence of 52 cases per million people aged 14 years or older, higher in the first half of the year (Pérez-Garza et al. 2021). The incidence peaks in adolescence, and idiopathic cases account for 40% in children (Moulonguet and Fraitag 2021).
Cause of erythema nodosum Frequency or clue Source
Idiopathic (primary) 32%–72% of cases remain without a cause Pérez-Garza et al. 2021
Streptococcal pharyngitis Lesions appear 2–3 weeks after infection; throat culture, rapid antigen test or antistreptolysin O Pérez-Garza et al. 2021
Tuberculosis Leading cause in Egypt (1994–2002); PCR positive in 30.4% and interferon-γ release assay in 59.4% of patients with erythema nodosum in a Chinese study Pérez-Garza et al. 2021
Sarcoidosis Most common cutaneous lesion of sarcoidosis; Löfgren syndrome (erythema nodosum, bilateral hilar lymphadenopathy, fever); leading cause in Spain Pérez-Garza et al. 2021
Inflammatory bowel disease 4%–15% of patients with Crohn disease and 3%–10% with ulcerative colitis Pérez-Garza et al. 2021
Behçet disease Erythema nodosum lesions in about 44%; septal pattern in 27% of biopsied lesions Pérez-Garza et al. 2021
Drugs 2.9%–5% of cases; sulfonamides, bromides and oral contraceptives Pérez-Garza et al. 2021
Pregnancy 2%–6% of cases Pérez-Garza et al. 2021

Lobular panniculitides: nodular vasculitis, pancreatic, alpha-1 antitrypsin deficiency, cold, factitial and infectious

Disorder Histology Clinical and laboratory correlates Source
Nodular vasculitis and erythema induratum of Bazin Lobular panniculitis in all biopsies; granulomas (40 of 62 patients), necrosis (41), small-vessel vasculitis (21), medium-vessel vasculitis (11), plasma cells (10); early lesions show granulomatous and lymphocytic infiltrates with small necrotic foci, late lesions septal fibrosis; Ziehl–Neelsen, PAS and Brown–Brenn stains negative in all 32 tested 76% women, mean age 52 years; dorsal lower legs and calves; QuantiFERON positive in 59% and mycobacterial PCR positive in 7.4%; erythema induratum is regarded by some authors as a tuberculin hypersensitivity form of nodular vasculitis Guillet et al. 2025
Pancreatic panniculitis Neutrophilic lobular panniculitis with enzymatic fat necrosis, anucleate "ghost" adipocytes and calcification; a peripheral eosinophilic striated rim (Splendore–Hoeppli phenomenon) around ghost adipocyte aggregates in 9 of 34 cases 0.3%–3% of patients with pancreatic disease; about 16% of patients with acinar cell carcinoma; acute pancreatitis was the most common association (23 of 34, gallstones in 17); lower extremities; may precede pancreatic symptoms; pancreatitis, panniculitis and polyarthritis syndrome Pomerantz et al. 2025; Seguí et al. 2023; Moulonguet and Fraitag 2021
Alpha-1 antitrypsin deficiency panniculitis Extensive liquefactive necrosis of dermis and fat, neutrophils and destruction of fibrous septa with separation of lobules ("floating fat") from collagenolysis and elastolysis; hemorrhage at the periphery without vasculitis Most often Pi*ZZ (SERPINA1); about one-third follow trauma, exertion or surgery; ulceration with oily discharge and atrophic scars; may precede emphysema by years Murinello et al. 2022; Moulonguet and Fraitag 2021
Cold panniculitis Lobular lymphohistiocytic infiltrate, also septal, most intense at the dermal–subcutaneous junction; superficial and deep perivascular dermal lymphocytes without vasculitis Infants and children; cheeks and chin 48–72 hours after cold (ice packs for supraventricular tachycardia, "popsicle panniculitis") Moulonguet and Fraitag 2021
Factitial and iatrogenic panniculitis Acute lobular panniculitis with fat necrosis and neutrophils; post-vaccination aluminum granuloma shows a dense deep dermal and subcutaneous infiltrate of lymphocytes, eosinophils and histiocytes with bluish granular cytoplasm that stains with Morin reagent, sometimes with germinal centers Aluminum-adsorbed vaccines (median onset 3 months); factitial lesions in young children raise the possibility of Munchausen syndrome Moulonguet and Fraitag 2021
Infectious panniculitis Lobular neutrophilic panniculitis with necrosis and suppurative granulomas; vasculitis rare Mostly immunosuppressed patients; cultures needed when organisms are not seen Moulonguet and Fraitag 2021
Post-steroid panniculitis Lobular foamy histiocytes and lymphocytes with needle-shaped clefts; fewer crystals than in fat necrosis of the newborn Children 1–10 days after abrupt withdrawal of high-dose corticosteroids Moulonguet and Fraitag 2021
Panniculitis of dermatomyositis Lobular lymphocytes and plasma cells, hyaline sclerosis of septal collagen, lipophagic granulomas with calcification Juvenile dermatomyositis; may be the only cutaneous sign Moulonguet and Fraitag 2021

Differential of neutrophilic lobular panniculitis. Alpha-1 antitrypsin deficiency is considered in any biopsy with lobular neutrophilic or necrotizing panniculitis. Its differential includes factitial panniculitis, foreign-body reactions, bacterial, fungal and protozoal infection, and pancreatic panniculitis (Murinello et al. 2022).

Lupus erythematosus panniculitis and subcutaneous panniculitis-like T-cell lymphoma

  • Lupus erythematosus panniculitis (lupus profundus). Lupus panniculitis is a lymphocytic lobular panniculitis with septal sclerosis, hyaline and myxoid change of septa and lower dermis, fat necrosis, lymphoid follicles with germinal centers beside fibrous septa, plasma cells and sometimes lymphocytic vasculitis with nuclear dust. Overlying basal vacuolar change may be present (Moulonguet and Fraitag 2021). Epidermal atrophy, basement membrane thickening, dermal mucin and superficial and deep perivascular lymphocytes indicate overlying lupus. Direct immunofluorescence shows linear IgM and C3 at the dermoepidermal junction (Alberti-Violetti and Berti 2018).
  • Clinical features of lupus panniculitis. In 43 patients, 88.4% were women and the median age at onset was 23.5 years. Lesions involved the proximal upper extremities (48.8%), face (34.9%), lower extremities (23.3%) and trunk (18.6%), and lipoatrophy or contour change occurred in 58.1%. Three patients first suspected of lupus panniculitis had subcutaneous panniculitis-like T-cell lymphoma (Obiakor et al. 2026).

Parameters separating lupus erythematosus panniculitis from SPTCL (LeBlanc et al. 2016, 13 SPTCL and 7 lupus panniculitis patients, with histologic and phenotypic data from Alberti-Violetti and Berti 2018 and Drabent et al. 2026). A limited panel of Ki-67, CD3, CD4 and CD8 identifies the hotspots, and high-throughput sequencing helps confirm neoplastic clones (LeBlanc et al. 2016).

Parameter Lupus erythematosus panniculitis SPTCL Source
Distribution Lobular with septal sclerosis; overlying interface change, mucin and superficial and deep infiltrate common Lobular; dermis and epidermis usually spared Alberti-Violetti and Berti 2018; Moulonguet and Fraitag 2021
Lymphocyte atypia with CD8-positive rimming Partial rimming by CD8-positive cells may occur Atypia combined with CD8-positive rimming within Ki-67 hotspots is highly specific Alberti-Violetti and Berti 2018 (lupus panniculitis); LeBlanc et al. 2016 (SPTCL)
Ki-67 hotspots Not identified Foci enriched in atypical cytotoxic CD8-positive T cells LeBlanc et al. 2016; Drabent et al. 2026
Hyaline lipomembranous change, B-cell aggregates, plasmacytoid dendritic cell clusters and plasma cell aggregates Favor lupus panniculitis Present in some cases, including patients with hemophagocytic lymphohistiocytosis LeBlanc et al. 2016
Phenotype Mixed infiltrate with CD8-positive αβ T cells that do not predominate βF1, CD3, CD8, CD45RO, TIA-1, granzyme B and perforin positive; CD4, CD56 and EBV negative; TCRγδ negative Alberti-Violetti and Berti 2018; Drabent et al. 2026; Moulonguet and Fraitag 2021
T-cell receptor gene rearrangement Usually polyclonal, occasionally monoclonal Clonal αβ rearrangement Alberti-Violetti and Berti 2018
Outcome No hemophagocytic lymphohistiocytosis or death in 7 patients Hemophagocytic lymphohistiocytosis in 6 of 13 and 2 deaths; 5-year overall survival 91% without and 46% with hemophagocytic syndrome LeBlanc et al. 2016; Alberti-Violetti and Berti 2018

Neonatal panniculitis: subcutaneous fat necrosis of the newborn and sclerema neonatorum

Feature Subcutaneous fat necrosis of the newborn Sclerema neonatorum Source
Patients Term or post-term newborns in the first days of life (median diagnosis 7 days); associated with perinatal asphyxia, meconium aspiration, maternal gestational diabetes or hypertension, macrosomia and therapeutic hypothermia Gravely ill preterm newborns in the first week, often with sepsis or congenital heart disease Frank et al. 2022; Moulonguet and Fraitag 2021; Alhalabi et al. 2023
Clinical lesions Indurated plaques and nodules on the buttocks, shoulders, back, cheeks and thighs; may ulcerate Generalized woody hardening sparing palms, soles and genitalia Moulonguet and Fraitag 2021; Alhalabi et al. 2023
Histology Lobular panniculitis with fat necrosis and no dermal involvement; adipocytes and histiocytes with radially arranged needle-shaped clefts (dissolved fatty acid crystals); lymphocytes, lipophages, giant cells, sometimes eosinophils or neutrophils; late septal fibrosis and calcification Needle-shaped clefts within fat cells, thick fibrosis around fat lobules and sparse inflammation without granulomas Moulonguet and Fraitag 2021; Alhalabi et al. 2023
Course Resolves within weeks to 6 months; hypercalcemia in 70.5% of cases with reported calcium, with suppressed parathyroid hormone in 89.3% of these; prolonged calcium monitoring High fatality; regarded by some as a severe form of subcutaneous fat necrosis in premature newborns Frank et al. 2022; Moulonguet and Fraitag 2021

Lipodermatosclerosis and lipomembranous (membranous) fat necrosis

  • Lipodermatosclerosis. Lipodermatosclerosis is a sclerosing panniculitis of the lower extremities with erythema, hemosiderin pigmentation and sclerosis. Venous ultrasonography was abnormal in 327 of 430 patients (76.0%) with biopsy-confirmed disease (Garimella et al. 2026). Its histologic hallmark is lipomembranous fat necrosis. Earlier editions of a standard dermatopathology text described lipomembranous fat necrosis as relatively specific to lipodermatosclerosis, and the 11th edition classes it as a distinct type of adipocyte necrosis in panniculitis (Matsukuma et al. 2022).
  • Lipomembranous fat necrosis. Lipomembranous fat necrosis consists of eosinophilic or hyaline, crenulated, serpiginous membranes with an "arabesque" or "frost on a windowpane" appearance lining microcysts and macrocysts, or crushed within fibrous tissue. The membranes are PAS-positive with or without diastase, red with Masson trichrome and positive with Sudan black B and Luxol fast blue. They occur in venous insufficiency (stasis dermatitis, lipodermatosclerosis, deep venous thrombosis, varicose veins), ischemia, erythema nodosum, erythema induratum, pancreatic and traumatic panniculitis, morphea and lupus panniculitis. Lipomembranous change was found in 21% of 33 consecutive cases of subcutaneous fat necrosis. It was first described in Nasu–Hakola disease (Matsukuma et al. 2022).

Skin Infections and Infestations: Bacterial, Mycobacterial, Spirochetal, Fungal, Viral, Protozoal and Parasitic Infections of Skin

Scope and classification. No WHO classification or CAP protocol governs infections of the skin. Skin infections are grouped by organism and by the tissue reaction they produce in a biopsy: subcorneal cleavage, suppuration, granulomas (tuberculoid, suppurative, palisaded or macrophage-rich), angioinvasion with infarction, viral cytopathic change and plasma cell-rich infiltrates. Culture remains the reference method for most bacteria and fungi, and histopathology confirms tissue invasion, shows the host reaction and identifies organisms with special stains when culture is unavailable or negative (Dhar et al. 2024).

Related page: Mycobacteria, Nocardia, Spirochetes, Mycoplasma, Chlamydia and Other Intracellular Bacteria (mycobacterial culture and NAAT, Mycobacterium leprae, Nocardia, Treponema serologic algorithms, Borrelia and Rickettsia) Related page: Gram-Positive Bacteria and Anaerobes: Staphylococci, Streptococci, Enterococci, Gram-Positive Rods and Clostridioides difficile (Staphylococcus aureus, Streptococcus pyogenes, necrotizing fasciitis organisms and Actinomyces) Related page: Gram-Negative Bacteria: Enterobacterales, Nonfermenters, Neisseria, Haemophilus and Fastidious Gram-Negative Rods (Bartonella and other gram-negative skin pathogens) Related page: Microbiology Specimens, Stains, Culture Media and Blood Cultures (chemistry of the Gram, acid-fast, Fite, GMS and PAS stains) Related page: Bacterial Identification: Biochemical Tests, MALDI-TOF Mass Spectrometry, Sequencing and Rapid Molecular Panels Related page: Melanoma, Merkel Cell Carcinoma and Skin FNA (Tzanck smear for herpesvirus and pemphigus) Related page: Oral Brush Cytology (oral HSV on brush cytology) Related page: Organisms in Cervical Cytology (HSV cytopathic effect in Pap tests) Related page: Cytomorphology of Anal Cytology Samples (koilocytes and condyloma in anal cytology) Related page: Granulomatous Lymphadenitis (Cytology) Related page: Large B-Cell Lymphomas, Burkitt Lymphoma, Immunodeficiency-Associated Lymphoproliferations, Hodgkin Lymphomas and Lymphoma Staging (EBV-positive mucocutaneous ulcer) Related page: Cervical Squamous Intraepithelial Lesions, Squamous Cell Carcinoma and Cervical Cancer Staging and Anal Canal Neoplasia, Colorectal Neuroendocrine Tumors and Other Lower GI Tumors (HPV biology and anogenital squamous intraepithelial lesions) Related page: Vesiculobullous and Pustular Dermatoses: Pemphigus, Pemphigoid, Dermatitis Herpetiformis, Epidermolysis Bullosa, Porphyria and Direct Immunofluorescence (pemphigus foliaceus, which shares the cleavage level of SSSS) Related page: Interface and Lichenoid Dermatoses, Cutaneous Lupus and Dermatomyositis, Graft-versus-Host Disease, and Sclerosing Dermal Disorders (erythema multiforme, SJS and TEN, and the frozen-section distinction of TEN from SSSS) Related page: Granulomatous, Vasculitic, Neutrophilic and Eosinophilic Dermatoses: Sarcoidosis, Granuloma Annulare, Cutaneous Vasculitis and Vasculopathy, Sweet Syndrome, Pyoderma Gangrenosum and Wells Syndrome (noninfectious granulomas, vasculitis and the arthropod bite reaction) Related page: Follicular Disorders, Alopecia, Nail Unit Pathology and Panniculitis: Rosacea, Folliculitis, Hidradenitis Suppurativa, Scarring and Non-scarring Alopecia, Hair Shaft and Nail Disorders, Septal and Lobular Panniculitis (infectious folliculitis, onychomycosis on nail clippings and infectious panniculitis)

Special stains and ancillary tests for organisms in skin biopsies

Organism group Stain or test Finding in skin Source
Fungi (hyphae and yeasts) PAS; Grocott methenamine silver (GMS) PAS identified the spores of chromoblastomycosis in 25% of cases with low fungal load. Normal collagen fibers can be mistaken for hyphae on GMS Dhar et al. 2024
Dermatophytes PAS Hyphae were visible on H&E in only 6 of 18 PAS-positive tinea biopsies (33%) Park et al. 2014
Cryptococcus Mayer mucicarmine Stains the polysaccharide capsule red Hayashida et al. 2017; Dhar et al. 2024
Mycobacterium leprae Fite-Faraco Confirms weakly acid-fast bacilli that may be missed with conventional Ziehl–Neelsen van Wyk et al. 2026
M. tuberculosis Ziehl–Neelsen; culture; PCR on fresh or paraffin tissue Acid-fast bacilli were found in 0%–5% of cutaneous tuberculosis biopsies in most series. Pooled PCR sensitivity was 73% Santos et al. 2014
Nocardia Gram; modified Ziehl–Neelsen (1% sulfuric acid decolorizer) Gram-positive branching filaments with partial acid fastness Saoji et al. 2012
Actinomycetoma versus eumycetoma grains Gram and Ziehl–Neelsen (actinomycetes); H&E, PAS, GMS and Gridley (fungal grains) Actinomycete filaments about 1 µm thick are gram-positive. Fungal grains contain septate hyphae 4–5 µm thick Ahmed et al. 2017
Bartonella Warthin–Starry (modified silver) Clumps of tangled bacilli in bacillary angiomatosis Mejía and Seas 2014
Klebsiella granulomatis Giemsa, Leishman or Wright Donovan bodies inside large vacuolated histiocytes; difficult to see on H&E Belda Junior 2020
Treponema pallidum Immunohistochemistry; Warthin–Starry and Steiner silver stains; PCR Immunohistochemistry preferred for formalin-fixed paraffin-embedded tissue Papp et al. 2024
Rickettsia Immunohistochemistry; PCR on tissue Eschar tissue is the preferred specimen Stewart and Stewart 2021
Leishmania H&E; Giemsa Giemsa shows the nucleus and kinetoplast of amastigotes Wijesinghe et al. 2020
HSV and VZV Immunohistochemistry HSV antigen in epidermal keratinocytes confirms verrucous herpes Vattigunta and Jaller 2026
CMV PCR on skin PCR on a separate skin sample confirmed endothelial inclusions as CMV Neumann et al. 2016
Orthopoxvirus (mpox) Anti-vaccinia immunohistochemistry; electron microscopy Cytoplasmic staining of ballooned keratinocytes Rodríguez-Cuadrado et al. 2023

Splitting the specimen. A deep surgical biopsy for mycetoma is divided in the operating room: one part in normal saline for grain culture and one part in 10% formal saline for histology. Grains from open sinuses are usually nonviable and contaminated (Ahmed et al. 2017). For sporotrichosis, two punch biopsies (or one biopsy divided in two) go to culture and histology, and a minimum of 20 serial sections is recommended because organisms are rarely seen (Arenas et al. 2018). Mycobacterial culture has to be requested specifically (Santos et al. 2014).

Impetigo and staphylococcal scalded skin syndrome

Pathogenesis. Exfoliative toxins A and B of Staphylococcus aureus are serine proteases that cleave desmoglein 1 in the stratum granulosum. Only about 5% of S. aureus strains release them. Bullous impetigo results from local toxin release. Staphylococcal scalded skin syndrome (SSSS) results from hematogenous spread of toxin from a distant site. Desmoglein 3 is not cleaved and maintains adhesion in the lower epidermis and in mucosa, so mucosae are spared. Neonates in the first weeks of life express desmoglein 3 throughout the epidermis, which protects them (Brazel et al. 2021).

Epidemiology. SSSS occurs mostly in children younger than 5 years, with most cases between 2 and 3 years. Mortality is less than 5% in children and greater than 60% in adults, who are almost always immunocompromised (severe renal disease, HIV infection or malignancy). Nonbullous impetigo accounts for 70% of impetigo and bullous impetigo for 30%; 90% of bullous impetigo occurs before 2 years of age (Brazel et al. 2021).

Feature Bullous impetigo SSSS Source
Toxin delivery Local exfoliative toxin at the infection site Hematogenous exfoliative toxin from a distant site Brazel et al. 2021
Cleavage level Granular layer (subcorneal blister) Granular layer (superficial intraepidermal cleavage beneath the stratum corneum) Brazel et al. 2021
Lesional findings Mixed dermal infiltrate, crusting, epidermal hyperplasia and cocci in clusters Subcorneal acantholysis without inflammation, crust or cocci Brazel et al. 2021
Culture Bullae and erosions are culture-positive Nasopharyngeal and periorificial sites are most often positive; blood cultures are usually negative in children and positive in most adults Brazel et al. 2021
Nikolsky sign Negative Positive Brazel et al. 2021

Cellulitis and necrotizing fasciitis

Pathology. Necrotizing fasciitis invades the deep fascia. Bacterial enzymes destroy fascia and fat, and invasive bacteria thrombose the nutrient vessels of the hypodermis, which causes ischemia and later skin necrosis. Necrosis of the fascia and hypodermis is wider than the overlying skin change. Lymphangitis and lymphadenopathy are rare because of vessel thrombosis (Misiakos et al. 2014; Roje et al. 2011).

Microbiologic type Organisms Frequency Source
Type I Polymicrobial, synergistic aerobes and anaerobes 70%–80% Roje et al. 2011
Type II Usually monomicrobial 20% Roje et al. 2011
Type III Gram-negative monomicrobial, including marine organisms (Vibrio) Uncommon Roje et al. 2011
Type IV Fungal Uncommon Roje et al. 2011

Frozen section and the finger test. In patients with equivocal findings and a Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score above 5, a 2-cm incision to the deep fascia (the finger test) is positive with "dishwater" pus, absent bleeding and no resistance to blunt dissection. An incisional biopsy to the fascia with an immediate frozen section, culture and Gram stain is a complementary bedside test. Surgical exploration with microbiologic and histopathologic analysis of 1 cm³ of soft tissue is the reference standard when the diagnosis is uncertain (Misiakos et al. 2014). Gas in soft tissue, present in almost half of patients, strongly suggests Clostridium (Misiakos et al. 2014).

Cutaneous tuberculosis and Mycobacterium marinum infection

All forms of cutaneous tuberculosis share lymphocytes, epithelioid histiocytes and giant cells. The forms differ in how well the host organizes granulomas, which divides them into three histologic groups (Santos et al. 2014).

Histologic group Clinical form Histologic findings and acid-fast bacilli Source
Well-formed granulomas without caseous necrosis Lupus vulgaris Atrophic or hyperplastic epidermis (up to pseudoepitheliomatous hyperplasia); tuberculoid granulomas with Langhans giant cells, sometimes sarcoidal; dense lymphocytes; caseation rare and focal. Acid-fast bacilli: infrequent Santos et al. 2014
Well-formed granulomas without caseous necrosis Lichen scrofulosorum Superficial epithelioid granulomas beside adnexa; giant cells usually absent. Acid-fast bacilli: not found Santos et al. 2014
Granulomas with caseous necrosis Tuberculosis verrucosa cutis Hyperkeratosis, acanthosis and papillomatosis over caseating granulomas of moderate intensity. Acid-fast bacilli: can be found Santos et al. 2014
Granulomas with caseous necrosis Primary inoculation tuberculosis (tuberculous chancre) Early necrotizing neutrophilic infiltrate; granulomas organize later. Acid-fast bacilli: numerous early, fewer later Santos et al. 2014
Granulomas with caseous necrosis Acute miliary tuberculosis Nonspecific lymphocyte- and plasma cell-rich infiltrate; focal caseation; occasional microabscesses. Acid-fast bacilli: vary with severity Santos et al. 2014
Granulomas with caseous necrosis Tuberculosis orificialis Tuberculoid granulomas around a superficial ulcer with deep dermal caseation. Acid-fast bacilli: higher yield in exudative lesions Santos et al. 2014
Granulomas with caseous necrosis Papulonecrotic tuberculid Dermal necrosis with granulomatous infiltrate, leukocytoclastic vasculitis or follicular necrosis with suppuration Santos et al. 2014
Poorly formed granulomas with massive caseous necrosis Scrofuloderma Central necrosis with abscess and suppuration; residual granulomas at the periphery. Acid-fast bacilli: present at the periphery when found Santos et al. 2014
Poorly formed granulomas with massive caseous necrosis Metastatic tuberculous abscess (tuberculous gumma) Central ulceration with abundant caseous necrosis rimmed by giant cells and macrophages. Acid-fast bacilli: frequently detected Santos et al. 2014
  • Diagnostic yield. Tuberculoid dermal granulomas are found in 57%–96% of cutaneous tuberculosis biopsies, and annular, sarcoidal and suppurative granulomas also occur. PCR positivity was 55% in tuberculosis verrucosa cutis, 60% in lupus vulgaris and 54% in erythema induratum, and 100% in multibacillary disease in immunocompromised patients (Santos et al. 2014). Erythema induratum is taught with the lobular panniculitides in Follicular Disorders, Alopecia, Nail Unit Pathology and Panniculitis: Rosacea, Folliculitis, Hidradenitis Suppurativa, Scarring and Non-scarring Alopecia, Hair Shaft and Nail Disorders, Septal and Lobular Panniculitis.
  • Mycobacterium marinum. M. marinum is found in aquatic environments ("swimming pool" or "fish tank" granuloma) and infects traumatized skin, usually of the hand. The diagnosis is confirmed by culture of lesional tissue. A verrucous hand plaque showed pseudoepitheliomatous hyperplasia, multinucleated giant cells and a plasma cell- and neutrophil-rich infiltrate, and M. marinum grew on Löwenstein–Jensen medium after earlier cultures were negative (Seidel et al. 2022).

Leprosy: Ridley–Jopling spectrum, WHO operational classification and leprosy reactions

Mycobacterium leprae infects macrophages and Schwann cells and prefers cooler body sites (27 °C–30 °C). The bacilli form parallel chains bound together as globi (Lastória and Abreu 2014a). Biopsy is taken from the active margin of the most recent lesion and includes the full dermis and part of the subcutaneous fat (Chen et al. 2022).

Ridley–Jopling group Histologic findings Bacilli (bacterial index) WHO operational class Source
Indeterminate Nonspecific lymphohistiocytic infiltrate in periadnexal and perineural locations Absent or scarce Usually paucibacillary Lastória and Abreu 2014b; Chen et al. 2022
Tuberculoid (TT) Epithelioid granulomas with Langhans giant cells and a dense lymphocytic halo extending to the basal layer with no grenz zone; dermal nerve twigs often destroyed Absent or scarce Usually paucibacillary Lastória and Abreu 2014b; Chen et al. 2022
Borderline tuberculoid (BT) As TT, with a free subepidermal grenz zone; nerves heavily infiltrated but still discernible Absent or scarce (+ to ++) Usually paucibacillary Lastória and Abreu 2014b; Chen et al. 2022
Borderline borderline (BB, mid-borderline) Epithelioid cells dispersed through the granulomas without lymphocyte foci; scarce giant cells; nerves easily identified with moderate Schwann cell proliferation +++ to ++++ Multibacillary Lastória and Abreu 2014b; Chen et al. 2022
Borderline lepromatous (BL) Undifferentiated or vacuolated macrophages, few lymphocytes, dense perineural lymphocytic foci; grenz zone maintained +++++, few globi Multibacillary Lastória and Abreu 2014b; Chen et al. 2022
Lepromatous (LL) Histiocytic infiltrate reaching the hypodermis with vacuolated foamy (lepra) cells; scarce lymphocytes; flat epidermis separated from the infiltrate by a band of collagen (band of Unna) Abundant, singly and in globi Multibacillary Lastória and Abreu 2014b; Chen et al. 2022

Bacterial index is graded on Ridley's logarithmic scale (Chen et al. 2022).

  • WHO operational classification. The WHO classification is paucibacillary (≤5 skin lesions with negative skin smears) or multibacillary (>5 lesions, or any smear-positive case) (van Wyk et al. 2026). Misclassifying multibacillary disease as paucibacillary shortens treatment and raises the relapse risk (Lastória and Abreu 2014a; Chen et al. 2022; van Wyk et al. 2026). The clinical diagnosis requires one of three cardinal signs: a hypopigmented or reddish patch with definite sensory loss, a thickened peripheral nerve with sensory or motor deficit, or acid-fast bacilli in a slit-skin smear or biopsy (van Wyk et al. 2026).
  • Sensitivity. Skin biopsy has a sensitivity of 49%–70% and a specificity of 70%–72% for leprosy (Chen et al. 2022). S100 immunohistochemistry shows remnants of dermal nerves and neurotropism of the infiltrate, and intact nerve endings in a granulomatous dermatitis argue against leprosy (Lastória and Abreu 2014b).
  • Type 1 (reversal) reaction. A type IV cell-mediated reaction of BT, BB and BL disease; about 95% occur in the first 2 years after multidrug therapy starts (Chen et al. 2022). Histology shows interstitial and intracellular edema. In upgrading (reversal), granulomas become more organized with more lymphocytes, epithelioid cells and giant cells, and nerve damage can produce caseous necrosis. In downgrading, granulomas loosen and intact bacilli increase (Lastória and Abreu 2014b).
  • Type 2 reaction (erythema nodosum leprosum). A type III immune complex reaction of LL and occasionally BL disease (Chen et al. 2022). Histology shows vasodilation, neutrophilic exudation into pre-existing granulomas with microabscesses and granular bacilli; necrotizing ENL contains intravascular thrombi (Lastória and Abreu 2014b).
  • Lucio phenomenon. In Lucio and classic lepromatous leprosy, abundant bacilli infect capillary endothelium and cause endothelial proliferation, thrombosis and vascular occlusion, a mechanism distinct from the immune complex vasculitis of necrotic ENL (Lastória and Abreu 2014a).

Actinomycosis, nocardiosis, botryomycosis, bacillary angiomatosis, granuloma inguinale and rhinoscleroma

Infection Organism Clinical and tissue findings Stain or confirmation Source
Actinomycosis Actinomyces species (gram-positive anaerobic filamentous commensals of mouth, gut and genitals) Cervicofacial, shoulder girdle or pelvic lesions that mimic mycetoma; granules with filamentous bacteria at their periphery Gram stain Dhar et al. 2024
Primary cutaneous nocardiosis Nocardia brasiliensis most often in skin (N. asteroides in lung and disseminated disease) Fluctuant swelling with draining sinuses after traumatic soil inoculation Gram-positive, partially acid-fast branching filaments; culture needs 1–2 weeks and must be flagged to the laboratory Saoji et al. 2012
Botryomycosis (bacterial pseudomycosis) S. aureus most often; also Pseudomonas, Escherichia coli, Proteus and Streptococcus species Chronic granulomatous skin infection with fluctuant nodules that mimics mycetoma Bacterial culture; fungal stains and culture negative Devi et al. 2013
Bacillary angiomatosis Bartonella species Reactive vasoproliferative lesion in immunocompromised patients; clinically indistinguishable from Kaposi sarcoma and pyogenic granuloma Warthin–Starry stain shows clumps of tangled bacilli; Bartonella PCR Mejía and Seas 2014
Granuloma inguinale (donovanosis) Klebsiella granulomatis (formerly Calymmatobacterium granulomatis) Pseudoepitheliomatous acanthosis with neutrophilic microabscesses; dermal lymphocytes, plasma cells and bulky vacuolated histiocytes containing Donovan bodies Giemsa on tissue or crush smears; Donovan bodies are pathognomonic Belda Junior 2020
Rhinoscleroma Klebsiella rhinoscleromatis (gram-negative rod) Plasma cells with Russell bodies and large foamy Mikulicz cells Gram-negative and PAS-positive intracytoplasmic bacilli Malkud and Mahajan 2018

Kaposi sarcoma and pyogenic granuloma, the vascular mimics of bacillary angiomatosis, are taught in Vascular Anomalies and Vascular Tumors of Skin, Kaposi Sarcoma and Angiosarcoma, Cutaneous Histiocytic and Mast Cell Infiltrates, and Metastases to Skin.

Syphilis, Lyme disease and rickettsial infections of skin

Clinical stages. The primary chancre appears 3–90 days (mean 21 days) after inoculation as a painless, indurated ulcer 0.5–3 cm across, usually solitary; multiple chancres suggest HIV coinfection (Talhari et al. 2025). Secondary syphilis appears 6 weeks to 6 months after infection. Tertiary cutaneous syphilis is nodular (dermoepidermal) or gummatous (hypodermal) (Talhari et al. 2025). Atypical secondary syphilis was found in 25.8% of patients in one series, most often annular or psoriasiform plaques (Ciccarese et al. 2024).

Histology of secondary syphilis. In a multicenter review of 106 biopsy-proven cases, most specimens had 5 to 7 of the features studied. Endothelial swelling was present in 87.7%, plasma cells in 69.8% and elongated rete ridges in 75.5%. Specimens with 5 or fewer features more often lacked plasma cells (present in only 48.3%) and more often showed an interstitial inflammatory pattern (75.9%). Combinations of endothelial swelling, interstitial inflammation, irregular acanthosis, elongated rete ridges, vacuolar interface dermatitis with a lymphocyte in nearly every vacuole and lymphocytes with visible cytoplasm raise the possibility of syphilis (Flamm et al. 2015). Psoriasiform secondary syphilis shows a dense infiltrate of lymphocytes, macrophages, plasma cells, neutrophils and eosinophils extending into the deep dermis (Ciccarese et al. 2024).

Detection of T. pallidum in tissue. Immunohistochemistry is preferred over Warthin–Starry or Steiner silver staining for formalin-fixed, paraffin-embedded skin, brain, placenta and umbilical cord, and biopsy helps identify the cause of atypical ulcers or lesions that do not respond to therapy (Papp et al. 2024). In secondary syphilis, immunohistochemistry detected treponemes in the epidermis and upper dermis in 90% of biopsies, PCR for the 47-kDa gene in 75%, and the two combined in 92% (Buffet et al. 2007). Reactive eruptions in syphilis (Sweet syndrome-like or erythema multiforme-like) show no treponemes by immunohistochemistry (Talhari et al. 2025).

Lyme borreliosis. Erythema migrans typically shows a superficial and deep perivascular and interstitial lymphocytic infiltrate with eosinophils centrally and histiocytes and plasma cells at the periphery. Early lesions can contain interstitial histiocytes with few or no plasma cells, and the biopsy can precede seroconversion (Brem and Goldberg 2022). Acrodermatitis chronica atrophicans shows dermal atrophy and lymphocytic and plasma cell infiltrates. In 693 Slovenian patients, histology was compatible in 87.8% of biopsied cases, Borrelia was isolated from 30.1% of skin samples, and 92.8% of isolates were B. afzelii. Acrodermatitis chronica atrophicans usually affects older women (Ogrinc et al. 2021).

Rickettsial infections. Most Rickettsia species infect endothelial cells and spread from cell to cell along contiguous endothelium. R. akari infects macrophages. An eschar at the inoculation site occurs in less than 1% of Rocky Mountain spotted fever, 72% of boutonneuse fever and 32%–95% of African tick bite fever. Eschar tissue is the preferred specimen: PCR sensitivity on eschars reaches 92%, far above blood, and immunohistochemistry on skin has 70% sensitivity and 100% specificity (Stewart and Stewart 2021).

Dermatophytosis, Majocchi granuloma, tinea versicolor and cryptococcosis

  • Dermatophytosis. Proposed histologic clues are neutrophils in the stratum corneum, compact orthokeratosis, papillary dermal edema and hyphae between two zones of cornified cells (the "sandwich" sign). In 18 PAS-positive cases of tinea corporis and faciei, parakeratosis was present in 72%, basket-weave keratin in 56%, neutrophils in the stratum malpighii in 50%, spongiosis in 44%, papillary dermal edema in 33%, neutrophils in the stratum corneum in 28%, compact orthokeratosis in 22% and the sandwich sign in 22%. Hyphae were visible on H&E in only 33% and were identified only with PAS in the other 67%. Allergic contact dermatitis, psoriasis and cellulitis were the initial clinical diagnoses in 3 of the 18 cases (Park et al. 2014).
  • Majocchi granuloma. Majocchi granuloma is a deep fungal folliculitis caused mostly by dermatophytes, with Trichophyton rubrum the most common agent in 147 patients. Prior immunosuppressant and topical corticosteroid use were common. Histopathologic confirmation is usually needed to direct prolonged systemic antifungal therapy (Khodadadi et al. 2023).
  • Tinea versicolor. Malassezia species (M. globosa, M. furfur, M. sympodialis) cause scaly hypopigmented or hyperpigmented macules of the upper trunk. Histology shows hyperkeratosis, parakeratosis, slight acanthosis and a mild superficial perivascular infiltrate, with short hyphae and spores in a "spaghetti and meatballs" pattern in the stratum corneum on H&E, PAS or GMS. Hyperpigmented lesions contain more organisms than hypopigmented lesions (Leung et al. 2022).
  • Cryptococcosis. Skin lesions (papules, nodules, ulcers, cellulitis-like and molluscum-like lesions) usually mark disseminated disease, and patients need evaluation of the lungs and CNS (Dhar et al. 2024). Biopsies show granulomatous or suppurative granulomatous dermatitis with yeasts separated by thick capsules. PAS stains the yeasts and mucicarmine stains the capsule red (Hayashida et al. 2017; Dhar et al. 2024). All 4 patients in one series with skin lesions had CNS involvement (Hayashida et al. 2017).
  • Candidiasis in tissue. In primary subcutaneous candidiasis of a leg ulcer, GMS showed pseudohyphae 2.5–3.5 µm in diameter and yeasts 2.0–4.0 µm within fibrin and hemorrhage over granulation tissue (Kavanoor Sridhar et al. 2026). Potassium hydroxide preparations of superficial cutaneous candidiasis show pseudohyphae and spores, and culture identifies the species (Liu et al. 2026).

Subcutaneous and deep fungal infections of skin

Implantation (subcutaneous) mycoses follow penetrating trauma, and systemic mycoses reach the skin from a pulmonary primary. In a 10-year Indian multicenter series of 124 deep mycoses, chromoblastomycosis (42), mycetoma (28) and rhinosporidiosis (17) were the most common, the lower limb was involved in 67%, and only two patients had HIV infection (Dhar et al. 2024).

Infection Tissue reaction Organism form in tissue Source
Chromoblastomycosis (Fonsecaea pedrosoi in about 90%; also Cladophialophora carrionii, Phialophora verrucosa) Pseudoepitheliomatous hyperplasia; suppurative and epithelioid granulomas with Langhans and foreign body giant cells; transepidermal elimination of organisms into the stratum corneum Round, brown, thick-walled muriform (sclerotic, Medlar or "copper penny") cells 4–12 µm that divide by septation in two planes; seen on H&E in 75% and needing PAS in 25% Brito and Bittencourt 2018; Dhar et al. 2024
Eumycetoma Dermal abscesses with grains at their center, surrounded by lymphocytes, plasma cells and histiocytes; foreign body granulomas Grains of broad septate, often brown, hyphae 4–5 µm with swollen cells at the edge and variable cement. Madurella mycetomatis forms large hard black grains 0.5–3 mm Ahmed et al. 2017; Dhar et al. 2024
Actinomycetoma Same suppurative pattern Homogeneously eosinophilic grains of gram-positive filaments about 1 µm thick; white, yellow or red grains. Nocardia is Ziehl–Neelsen-positive; Actinomadura madurae and Streptomyces somaliensis are negative Ahmed et al. 2017
Phaeohyphomycosis Deep dermal or subcutaneous cyst without epithelial lining; fibrous wall with tuberculoid granulomas and cholesterol clefts; a wood splinter in one lumen Pigmented septate branched hyphae in the lumen and wall Dhar et al. 2024
Hyalohyphomycosis (Fusarium, Scedosporium, Acremonium, Aspergillus) Cysts, abscesses and granulomas in deep dermis and fat Hyaline septate hyphae Dhar et al. 2024
Sporotrichosis (lymphocutaneous, fixed and disseminated) Pseudoepitheliomatous hyperplasia; tuberculoid granulomas with microabscesses and fibrosis Organisms rarely seen. Clusters of round to oval narrow-budding yeasts on PAS or GMS in a minority of cases; asteroid bodies (yeasts surrounded by host immunoglobulin, the Splendore–Hoeppli phenomenon) infrequent Arenas et al. 2018; Dhar et al. 2024
Entomophthoromycosis (basidiobolomycosis, conidiobolomycosis) Eosinophil- and plasma cell-rich granulomatous inflammation of dermis and fat with microabscesses Broad, ribbon-like, pauciseptate hyphae with Splendore–Hoeppli material Dhar et al. 2024
Rhinosporidiosis Polypoid nasal or ocular masses; focal granulomas Thick-walled sporangia packed with thousands of spores; coccidioidal spherules are smaller Dhar et al. 2024
Blastomycosis Pyogranulomatous inflammation; pseudoepitheliomatous hyperplasia is characteristic when skin is involved Thick-walled yeasts 8–15 µm, visible on H&E, with a single bud attached by a broad base Linder and Kauffman 2020
Histoplasmosis Suppurative granulomas to sheets of histiocytes Yeasts 2–4 µm with narrow-based budding on GMS or PAS, packed in histiocyte cytoplasm Linder and Kauffman 2020; Dhar et al. 2024
Talaromycosis (penicilliosis; Talaromyces marneffei) Suppurative granulomatous inflammation in HIV-infected patients Intracellular yeast-like cells with a transverse septum (division by fission), giving sausage-shaped forms Dhar et al. 2024
Coccidioidomycosis Suppurative granulomas Double-walled refractile spherules 10–80 µm containing endospores Garcia Garcia et al. 2015

Grain color in mycetoma. Black grains come from Madurella, Leptosphaeria, Curvularia, Exophiala and Phialophora (eumycetoma). Pale grains come from Scedosporium apiospermum, Acremonium and Aspergillus (eumycetoma) and from Actinomadura madurae and Nocardia (actinomycetoma). Red grains indicate Actinomadura pelletieri, and yellow to brown grains Streptomyces (Ahmed et al. 2017). Grain morphology gives a provisional identification and is confirmed by culture or PCR (Ahmed et al. 2017).

Reactive cutaneous coccidioidomycosis. Erythema nodosum is the most frequent reactive skin manifestation of coccidioidomycosis, and its biopsies contain no organisms (Garcia Garcia et al. 2015).

Angioinvasive fungi in skin: Aspergillus, Mucorales and Fusarium

Feature Mucorales (mucormycosis) Aspergillus Fusarium Source
Hyphae Thick, hyaline, nonseptate, bifurcating; irregular right-angle branching on KOH Hyaline septate hyphae with regular dichotomous branching at about 45° (acute angle) Septate hyphae with both 45° and 90° branching and a smaller, irregular diameter than Aspergillus; macroconidia can be present Castrejón-Pérez et al. 2017; Mimouni et al. 2026; Fan et al. 2010
Tissue reaction Edema, thrombosis, infarction and necrosis with neutrophils, plasma cells and eosinophils Dense dermal polymorphic infiltrate; epidermis altered only in primary cutaneous disease Microvessel thrombosis with hyphae in papillary dermis and hypodermis Castrejón-Pérez et al. 2017; Bernardeschi et al. 2015; Fan et al. 2010
Biopsy and culture Biopsy from the lesion center including fat; cultures positive in 72%–89% of cutaneous cases; antibiotic-free media A. flavus in all primary cutaneous cases; A. fumigatus most frequent in secondary cases Blood cultures can be negative despite dissemination; tissue culture identifies the species Castrejón-Pérez et al. 2017; Bernardeschi et al. 2015; Fan et al. 2010
Outcome Cutaneous mucormycosis mortality 25%–31% in three series 3-month survival 100% in primary and 30% in secondary cutaneous aspergillosis Mortality 70%–87% in fusariosis Castrejón-Pérez et al. 2017; Bernardeschi et al. 2015; Fan et al. 2010

Hyphae within a thrombosed dermal microvessel in an immunocompromised patient are highly suggestive of disseminated fungal infection and allow antifungal therapy to start before culture results (Fan et al. 2010). Histology does not reliably separate Fusarium from other non-Aspergillus hyalohyphomycetes, and culture remains the standard for species identification (Fan et al. 2010). Frozen sections have been used to define margins during debridement of cutaneous mucormycosis (Castrejón-Pérez et al. 2017).

Herpesvirus and cytomegalovirus infections of skin

  • HSV and VZV. Both produce an intraepidermal vesicle with variable epithelial necrosis, ballooned keratinocyte nuclei with a ground-glass appearance and multinucleated giant keratinocytes (Requena and Requena 2010). The cytopathic change (karyomegaly, peripheral chromatin margination and multinucleation) involves the epidermis and the epithelium of hair follicles (Neumann et al. 2016). Multinucleated cells show nuclear molding (Pritt and Aubry 2017).
  • Mimics of herpetic multinucleation. Epithelial multinucleated giant cells also occur in acantholytic dermatoses (pemphigus vulgaris and transient acantholytic dermatosis) and in tumors (trichoepithelioma and pleomorphic basal cell carcinoma). Histiocytic multinucleated cells occur in giant cell lichenoid dermatitis and lichen nitidus. A herpes diagnosis based on epithelial multinucleated cells alone is reconsidered when clinical findings, response to antiviral therapy or confirmatory laboratory studies do not support it (Cohen et al. 2014).
  • Verrucous herpes. In immunocompromised patients, especially with HIV infection, HSV can produce a wart-like or vegetative anogenital mass that mimics condyloma acuminatum or squamous cell carcinoma. Biopsy shows acanthosis with intraepidermal acantholytic cells bearing nuclear inclusions, and HSV immunohistochemistry confirms the diagnosis (Vattigunta and Jaller 2026).
  • CMV. CMV involves endothelial cells of small dermal vessels. The cells enlarge, take an epithelioid appearance and contain a coarse eosinophilic inclusion with a clear halo, nuclear or cytoplasmic. Ulcers with vascular thrombi occur, often anogenital, and skin involvement in a transplant recipient can indicate severe systemic infection (Neumann et al. 2016; Requena and Requena 2010).

Molluscum contagiosum, orf, milker nodule and mpox

Infection Virus Histologic findings Source
Molluscum contagiosum Molluscipoxvirus Lobules of epithelium opening onto the surface; large eosinophilic intracytoplasmic inclusions (Henderson–Patterson bodies) Requena and Requena 2010; Meza-Romero et al. 2019
Orf (ecthyma contagiosum) and milker nodule Parapoxviruses (orf virus from sheep and goats; pseudocowpox virus) Acanthotic epidermis with ballooned keratinocytes containing eosinophilic cytoplasmic inclusions. Six clinical stages of about 1 week each: maculopapular (vacuolated upper epidermal cells), target, acute (epidermis lost), regenerative, papilloma (finger-like downward epidermal projections) and regressive Requena and Requena 2010; Kassa 2021
Mpox Orthopoxvirus Full-thickness epidermal necrosis with hyperplasia and ballooned keratinocytes at the edges; follicular outer root sheath and sebaceous epithelium can be involved; occasional cytoplasmic inclusions and multinucleated keratinocytes; anti-vaccinia immunohistochemistry stains ballooned keratinocytes, and electron microscopy shows viral particles Rodríguez-Cuadrado et al. 2023

Cutaneous HPV lesions and epidermodysplasia verruciformis

Lesion Clinical setting Histologic findings Source
Verruca vulgaris (common wart) Hands and other sites; spread by skin contact Acanthosis, papillomatosis and hyperkeratosis, with rete ridges converging toward the center of the lesion and koilocytes Requena and Requena 2010; Zhu et al. 2022
Myrmecia (deep palmoplantar wart) HPV 1; soles and palms Hyperkeratosis, acanthosis and papillomatosis with large eosinophilic intracytoplasmic inclusion bodies Patel et al. 2026
Condyloma acuminatum Genitalia, anus and perianal skin; sexual transmission Papillomatosis and acanthosis with koilocytosis (Wang et al. 2026). In 51 men, histopathology was more accurate than colposcopy for diagnosis (95.6% versus 88.2%). In another study, 95% of histologic diagnoses were HPV-positive, but histology predicted HPV 6/11 with a sensitivity of only 43.6%–46.6% (Zhu et al. 2022) Wang et al. 2026; Zhu et al. 2022
Epidermodysplasia verruciformis Germline TMC6 (EVER1) or TMC8 (EVER2) loss of function (chromosome 17q25) with susceptibility to β-HPV; acquired form in HIV infection and iatrogenic immunosuppression Thickened epidermis with parakeratosis, acanthosis and hypergranulosis; large keratinocytes with pale, finely granular cytoplasm and vacuolated nuclei in a band within the epidermis Patel et al. 2010; Cuestas et al. 2024

Verruca plana (flat wart) occurs on the hands and face and verruca plantaris on the soles (Zhu et al. 2022). Biopsy of verruca plana-like lesions shows koilocytes, which separate verruca plana from seborrheic keratosis (Kim et al. 2024). In inherited epidermodysplasia verruciformis, half of patients develop carcinoma in situ (Bowen type) or invasive squamous cell carcinoma in the fourth and fifth decades, mainly on sun-exposed skin (Patel et al. 2010).

Cutaneous leishmaniasis and other organisms in dermal macrophages

Cutaneous leishmaniasis. Old World cutaneous leishmaniasis (Asia, Africa, the Mediterranean, the Middle East and southern Europe) is generally self-limiting, and New World disease (the Americas) carries more adverse sequelae (Chiang et al. 2026). After a sandfly bite, Leishmania (Viannia) braziliensis first produces a papule (early cutaneous leishmaniasis), and a typical ulcer with raised borders develops 2–4 weeks later. Early lesions contain more amastigotes than ulcers. Ulcers show a larger infiltrate of T cells, B cells, plasma cells and macrophages with granuloma formation, and macrophage number correlates with the area of necrosis (Saldanha et al. 2017). In L. donovani cutaneous leishmaniasis in Sri Lanka, 44% of biopsies had well-defined granulomas and 38% an ill-defined histiocytic infiltrate. Amastigotes are oval with a "dot and dash" appearance (nucleus and kinetoplast) on Giemsa. They were seen on H&E in 66% of biopsies and only on Giemsa in a further 22%, and parasites become scarce as granulomas predominate in late lesions (Wijesinghe et al. 2020).

Leishman–Donovan bodies and their mimics. The dermal infiltrate of macrophages, lymphocytes and plasma cells often destroys adnexal structures, sometimes forms granulomas and rarely leaves a grenz zone. Amastigotes with nucleus and kinetoplast (Leishman–Donovan bodies) lie within macrophages and can be mistaken for Toxoplasma, Mycobacterium leprae or Histoplasma (Nandakumar and Ashique 2026).

Organism Size and form in macrophages Stain profile Source
Leishmania amastigotes Round to oval bodies with nucleus and kinetoplast; no budding Negative with PAS and GMS; Giemsa shows the kinetoplast Dhar et al. 2024; Wijesinghe et al. 2020
Histoplasma capsulatum Yeasts 2–4 µm with narrow-based budding, packed in histiocytes GMS- and PAS-positive; poorly seen on Gram stain Linder and Kauffman 2020; Dhar et al. 2024
Talaromyces marneffei Yeast-like cells with a central transverse septum (fission) PAS-positive Dhar et al. 2024
Klebsiella granulomatis (Donovan bodies) Small oval bodies inside large vacuolated histiocytes Giemsa, Leishman or Wright Belda Junior 2020
Klebsiella rhinoscleromatis Bacilli in large foamy Mikulicz cells with plasma cells and Russell bodies Gram-negative; PAS-positive Malkud and Mahajan 2018
Cryptococcus Yeasts widely separated by thick mucoid capsules PAS-positive yeast; mucicarmine-positive capsule Dhar et al. 2024

Scabies, myiasis and cutaneous larva migrans

  • Scabies. The adult female Sarcoptes scabiei (0.3–0.5 mm) digs a burrow 1–10 mm long in the superficial epidermis and lays 2–3 eggs daily. Burrows favor the finger webs, flexor wrists, axillae, umbilicus, belt line, nipples, buttocks and penile shaft (Micali et al. 2016). Confirmed scabies (level A of the 2020 International Alliance for the Control of Scabies criteria) requires direct visualization of mites, eggs or fecal pellets (scybala) by light microscopy of skin samples (A1), high-powered imaging (A2) or dermoscopy (A3). Clinical scabies (level B) and suspected scabies (level C) rest on clinical signs (Engelman et al. 2020). Typical scabies shows spongiosis, parakeratosis, eosinophils and sometimes mites in the stratum corneum (Nasser Eldin et al. 2026). On biopsy, burrows are spaces between the stratum corneum and the underlying keratinocytes containing mites (Hassevoort et al. 2026), and crusted scabies shows a subcorneal burrow with mites beneath a neutrophilic crust (Roberts et al. 2026). Nodular scabies often represents a hypersensitivity reaction with a mixed infiltrate of eosinophils and plasma cells, and mites may not be found even on deeper sections (Nasser Eldin et al. 2026).
  • Myiasis. Myiasis is infestation of living tissue by dipteran fly larvae. Cordylobia anthropophaga is the commonest cause in sub-Saharan Africa (66.2% of 157 cases) (Jallow et al. 2024).
  • Cutaneous larva migrans. Animal hookworm larvae (Ancylostoma braziliense, A. caninum, Uncinaria stenocephala) enter the skin from soil contaminated by animal feces and produce pruritic serpiginous tracks. The diagnosis rests on the clinical presentation and exposure history (Osman et al. 2024).

Protothecosis and amebic infections of skin

  • Protothecosis. Prototheca species are achlorophyllic algae that infect debilitated hosts. Non-budding cells and large spherical sporangia containing endospores arranged in a morula pattern prove the diagnosis on histology. The skin is the main portal of entry and the organ most often involved in disseminated disease; P. wickerhamii and P. zopfii differ in pathogenicity (Wang et al. 2022).
  • Acanthamoeba. Disseminated infection can present with necrotic skin lesions. In one patient, repeated biopsies showed granulomatous medium-vessel vasculitis with neutrophils and necrosis, and only a later PAS stain showed large histiocytoid perivascular cells, confirmed as Acanthamoeba by 18S rDNA PCR. The lesions had first been treated as immune-mediated vasculitis (Koshy et al. 2026).
  • Balamuthia mandrillaris. Trophozoites measure 30–60 µm and usually have one nucleus. Cutaneous disease presents as plaques or nodules of rubbery to hard consistency on the face, trunk or limbs and precedes CNS infection by 30 days to 2 years (average 5–8 months) (Siddiqui and Khan 2015).

Cutaneous Lymphoid and Hematolymphoid Infiltrates: Histologic Approach, Early Mycosis Fungoides and Its Mimics, CD30-Positive Lymphoproliferative Disorders, Rare Cutaneous T-Cell Lymphomas and Reactive Lymphoid Proliferations

Definition and classification. Primary cutaneous lymphomas are non-Hodgkin lymphomas that present in the skin with no evidence of extracutaneous disease at the time of diagnosis. In the Western world, cutaneous T-cell lymphomas (CTCL) make up about 75%–80% of primary cutaneous lymphomas and cutaneous B-cell lymphomas 20%–25% (Willemze 2019). The WHO-EORTC classification of 2005 was updated in 2018 and published in the 4th edition of the WHO Classification of Skin Tumours (Willemze 2019). The WHO Classification of Skin Tumours, 5th edition (Skin5), the WHO Classification of Haematolymphoid Tumours, 5th edition (WHO-HAEM5), and the International Consensus Classification (ICC 2022) are the current systems. Skin5 adds reactive lymphoid proliferations, inborn error of immunity (IEI)-associated T-cell lymphoproliferative disorders and mature plasmacytoid dendritic cell proliferation associated with a myeloid neoplasm (Goldman-Lévy 2026; Kempf 2024).

Related page: Mature T-Cell and NK-Cell Neoplasms: Nodal, Leukemic, Extranodal and Cutaneous T-Cell Lymphomas (mycosis fungoides and Sézary syndrome definitions, MF subtypes, TNMB staging and blood classes, primary cutaneous ALCL with DUSP22, extranodal NK/T-cell lymphoma and EBV-positive T- and NK-cell lymphoproliferations of childhood, including hydroa vacciniforme lymphoproliferative disorder) Related page: Small B-Cell Lymphomas and Leukemias: CLL/SLL, Mantle Cell, Follicular, Marginal Zone, Splenic B-Cell and Lymphoplasmacytic Lymphomas and Hairy Cell Leukemia (primary cutaneous marginal zone lymphoma and primary cutaneous follicle center lymphoma by classification) Related page: Large B-Cell Lymphomas, Burkitt Lymphoma, Immunodeficiency-Associated Lymphoproliferations, Hodgkin Lymphomas and Lymphoma Staging (primary cutaneous diffuse large B-cell lymphoma, leg type, EBV-positive mucocutaneous ulcer and intravascular large B-cell lymphoma) Related page: AML, Myelodysplasia-Related, AML Defined by Differentiation, Myeloid Neoplasms Post Cytotoxic Therapy and of Down Syndrome, Myeloid Sarcoma, BPDCN and Acute Leukemias of Ambiguous Lineage (myeloid sarcoma and BPDCN criteria, including the immunophenotypic table for BPDCN) Related page: Classification of Lymphoid Neoplasms (WHO 5th Edition and ICC 2022), Flow Cytometry and Immunohistochemistry in Hematopathology (CD markers, TRBC1 and flow cytometric clonality) Related page: Plasma Cell Neoplasms and Diseases with Paraproteins: MGUS, Smoldering and Plasma Cell Myeloma, Plasmacytoma, Plasma Cell Leukemia, Amyloidosis, POEMS Syndrome and Heavy Chain Diseases (extramedullary plasmacytoma, AESOP and Schnitzler syndromes) Related page: Follicular Disorders, Alopecia, Nail Unit Pathology and Panniculitis: Rosacea, Folliculitis, Hidradenitis Suppurativa, Scarring and Non-scarring Alopecia, Hair Shaft and Nail Disorders, Septal and Lobular Panniculitis (lupus erythematosus panniculitis and the table separating it from subcutaneous panniculitis-like T-cell lymphoma) Related page: Normal Skin, Biopsy Handling and the Reaction-Pattern Approach; Spongiotic, Psoriasiform, Keratinization and Pigmentary Disorders (Zoon balanitis and vulvitis) Related page: Interface and Lichenoid Dermatoses, Cutaneous Lupus and Dermatomyositis, Graft-versus-Host Disease, and Sclerosing Dermal Disorders (pityriasis lichenoides, lichen sclerosus and lichenoid drug eruption) Related page: Skin Infections and Infestations: Bacterial, Mycobacterial, Spirochetal, Fungal, Viral, Protozoal and Parasitic Infections of Skin (secondary syphilis, Borrelia infection and nodular scabies)

Histologic patterns of cutaneous lymphoid infiltrates and their differential diagnosis

The distribution of the infiltrate within the epidermis, dermis or subcutis gives the first differential (Willemze 2019; Hatipoğlu 2026).

Pattern Entities Distinguishing findings Source
Epidermotropic, band-like Patch and plaque MF (Mature T-Cell and NK-Cell Neoplasms: Nodal, Leukemic, Extranodal and Cutaneous T-Cell Lymphomas); pagetoid reticulosis; LyP types B and D; CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma (AECTCL); epidermal pattern of primary cutaneous γδ T-cell lymphoma MF: CD4-positive small cerebriform cells along the basal layer and Pautrier microabscesses. LyP B and D: self-healing papules. AECTCL: CD8-positive cells with epidermal necrosis and ulcerated plaques or tumors Lee 2023; Swallow 2024; Marques-Piubelli 2026; Muhsen 2022
Wedge-shaped dermal LyP type A; pityriasis lichenoides; arthropod bite reaction LyP: broad superficial base tapering into the deep dermis, with scattered CD30-positive large cells Marques-Piubelli 2026; Nasser Eldin 2026
Nodular or diffuse dermal, T-cell Primary cutaneous ALCL; LyP type C; CD4-positive small or medium T-cell lymphoproliferative disorder (SMLPD); acral CD8-positive T-cell lymphoproliferative disorder; primary cutaneous peripheral T-cell lymphoma, NOS Acral CD8-positive disorder: medium-sized CD8-positive cells separated from the epidermis by a grenz zone. SMLPD: PD-1-positive small and medium CD4-positive cells with <30% large cells Willemze 2019; Hatipoğlu 2026
Nodular or diffuse dermal, B-cell Primary cutaneous marginal zone lymphoma (PCMZL); primary cutaneous follicle center lymphoma (PCFCL); primary cutaneous DLBCL, leg type; reactive B-cell-rich lymphoid proliferation PCMZL: periadnexal infiltrate, grenz zone, monotypic plasma cells. Reactive proliferation: reactive germinal centers, tingible body macrophages, polytypic light chains Drabent 2026; Hatipoğlu 2026
Interstitial dermal blasts with grenz zone Myeloid leukemia cutis; lymphoblastic lymphoma; BPDCN Monotonous blasts between collagen bundles sparing the papillary dermis. Myeloid: lysozyme, CD68 and MPO. Lymphoblastic: TdT. BPDCN: CD4, CD56, CD123, TCL1 and TCF4 with MPO and lysozyme negative Drabent 2026
Subcutaneous (lobular) Subcutaneous panniculitis-like T-cell lymphoma (SPTCL); subcutaneous pattern of primary cutaneous γδ T-cell lymphoma; lupus erythematosus panniculitis SPTCL: CD8-positive αβ T cells rimming adipocytes. γδ: TCRγδ-positive, βF1-negative, often CD56-positive Willemze 2019; Drabent 2026
Angiocentric and angiodestructive LyP type E; extranodal NK/T-cell lymphoma; hydroa vacciniforme lymphoproliferative disorder LyP E: CD30-positive cells and eschar-like necrotic lesions. NK/T-cell lymphoma and hydroa vacciniforme disorder: EBV-positive by in situ hybridization Willemze 2019; Drabent 2026

Biopsy for suspected early MF. Multiple biopsies, each a punch of at least 4 mm from the most indurated area, are recommended. Topical treatment is stopped for more than 2 weeks before biopsy (Lee 2023).

Wedge-shaped infiltrates on punch biopsy. The wedge-shaped architecture of LyP may not be evident in a punch biopsy and is better seen in an excision (Marques-Piubelli 2026).

Immunohistochemistry and clonality testing of cutaneous lymphoid infiltrates

Marker or test Diagnostic use in skin Limitation Source
CD3, CD4, CD8 Lineage and subset. MF, LyP types A to C, SMLPD and pcALCL are CD4-positive. SPTCL, AECTCL, LyP type D and the acral CD8-positive disorder are CD8-positive. γδ T-cell lymphoma is usually CD4-negative and CD8-negative or positive CD4 predominance also occurs in inflammatory dermatoses Willemze 2019; Nasser Eldin 2026
CD2, CD5, CD7 Pan-T-cell antigen loss supports MF. In the ISCL algorithm, <50% CD2-, CD3- or CD5-positive T cells, <10% CD7-positive T cells or epidermal-dermal discordance each count Partial CD7 loss also occurs in lichen sclerosus, pigmented purpuric dermatosis and infection Lee 2023; Nasser Eldin 2026
CD30 Defines the primary cutaneous CD30-positive lymphoproliferative disorders. Uniform positivity in LyP type C and pcALCL. Scattered large cells in LyP type A Activated CD30-positive cells also occur in nodular scabies and other reactive infiltrates Marques-Piubelli 2026; Nasser Eldin 2026
TIA-1, granzyme B, perforin Cytotoxic phenotype of SPTCL, γδ T-cell lymphoma, AECTCL and LyP type D. The acral CD8-positive disorder is TIA-1-positive and negative for granzyme B and perforin Cytotoxic markers alone do not predict behavior Willemze 2019; Swallow 2024
βF1 and TCRγδ αβ lineage in SPTCL and AECTCL. TCRγδ-positive, βF1-negative cells define γδ T-cell lymphoma Rare otherwise classic MF and LyP express TCRγδ and keep their indolent course Willemze 2019
CD56 Positive in γδ T-cell lymphoma (40%–80% of cases) and extranodal NK/T-cell lymphoma. Negative in SPTCL Also expressed by BPDCN Muhsen 2022; Willemze 2019; Drabent 2026
PD-1, BCL6, CXCL13 T-follicular helper phenotype of SMLPD PD-1 is also strongly expressed in Sézary syndrome Willemze 2019
CD68 Golgi dot-like staining in the acral CD8-positive disorder Helpful but nonspecific Willemze 2019; Hatipoğlu 2026
Ki-67 Low (<10%) in the acral CD8-positive disorder and <5%–20% in SMLPD. Ki-67 hotspots of atypical CD8-positive cells favor SPTCL over lupus panniculitis Rises in many reactive infiltrates Willemze 2019; LeBlanc 2016
EBER in situ hybridization Positive in extranodal NK/T-cell lymphoma and hydroa vacciniforme disorder. Negative in SPTCL, γδ T-cell lymphoma, AECTCL, LyP and IEI-associated disorders In hydroa vacciniforme disorder the EBV-positive cells are a minority of the infiltrate Willemze 2019; Goldman-Lévy 2026
CD123 Clusters of plasmacytoid dendritic cells (often ≥10 cells) favor lupus erythematosus over MF and are more frequent in lupus panniculitis than SPTCL CD123 is also expressed in myelomonocytic leukemia Nasser Eldin 2026; Drabent 2026
κ and λ light chains, IGH rearrangement Monotypic plasma cells in PCMZL. Reactive B-cell proliferations lack IGH monoclonality and light-chain restriction Monotypic plasma cells also occur in some cases of SMLPD Drabent 2026; Hatipoğlu 2026
TRG or TRB gene rearrangement Clonal TCR rearrangement scores 1 point in the ISCL algorithm. PCR for TRG or TRB rearrangement and next-generation sequencing are recommended methods Clonal rearrangements occur in lichen sclerosus (including TRG), fixed drug eruption, pityriasis lichenoides and pigmented purpuric dermatosis. A clone alone does not establish lymphoma. The same clone persisting on repeat biopsies raises suspicion of lymphoma Lee 2023; Nasser Eldin 2026; Almeida-Silva 2026

Classification of cutaneous lymphoid proliferations: WHO Skin 5th edition changes with the WHO-EORTC 2018 rule beside each

Entity in the 5th edition 5th-edition change Previous rule (WHO-EORTC 2018, WHO Skin 4th edition) Source
Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder Downgraded from lymphoma to a lymphoproliferative disorder because of consistently indolent behavior; shared by WHO-HAEM5 and ICC 2022 Primary cutaneous acral CD8-positive T-cell lymphoma, a new provisional entity; most participants at the Clinical Advisory Committee favored the term lymphoma Goldman-Lévy 2026; Kempf 2024; Willemze 2019
Reactive T-cell-rich and B-cell-rich lymphoid proliferations Covered as a chapter with essential and desirable criteria Termed "pseudolymphoma" in the 3rd edition; not included in the 4th edition Goldman-Lévy 2026; Kempf 2024
Primary cutaneous γδ T-cell lymphoma, CD8-positive AECTCL and CD4-positive SMLPD Each listed as a separate definite entity Grouped under "primary cutaneous peripheral T-cell lymphoma, rare subtypes"; AECTCL and SMLPD were provisional Ho 2023; Kempf 2024; Willemze 2019
Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder Definite lymphoproliferative disorder Provisional lymphoproliferative disorder in 2018; provisional lymphoma (primary cutaneous CD4-positive small/medium T-cell lymphoma) in WHO-EORTC 2005 Kempf 2024; Willemze 2019
Primary cutaneous peripheral T-cell lymphoma, NOS Used for primary cutaneous T-cell lymphomas that fit no defined type Listed with the same name in the 2018 table Ho 2023; Willemze 2019
IEI-associated T-cell lymphoproliferative disorders New: CD8-positive T-cell-rich, EBV-negative cutaneous infiltrates in inherited immunodeficiency No corresponding entity in the 2018 table Goldman-Lévy 2026; Willemze 2019
Mature plasmacytoid dendritic cell proliferation associated with a myeloid neoplasm Described for the first time in the skin classification No corresponding entity Goldman-Lévy 2026

Terms used in both editions. Mycosis fungoides with folliculotropic MF, pagetoid reticulosis and granulomatous slack skin, Sézary syndrome, primary cutaneous ALCL, LyP, SPTCL, extranodal NK/T-cell lymphoma, PCMZL, PCFCL, primary cutaneous DLBCL leg type, EBV-positive mucocutaneous ulcer and intravascular large B-cell lymphoma appear in the 2018 WHO-EORTC table (Willemze 2019). Their classification in WHO-HAEM5 and ICC 2022 is taught in Mature T-Cell and NK-Cell Neoplasms: Nodal, Leukemic, Extranodal and Cutaneous T-Cell Lymphomas, Small B-Cell Lymphomas and Leukemias: CLL/SLL, Mantle Cell, Follicular, Marginal Zone, Splenic B-Cell and Lymphoplasmacytic Lymphomas and Hairy Cell Leukemia and Large B-Cell Lymphomas, Burkitt Lymphoma, Immunodeficiency-Associated Lymphoproliferations, Hodgkin Lymphomas and Lymphoma Staging. WHO-HAEM5 calls the marginal zone neoplasm primary cutaneous marginal zone lymphoma, and ICC 2022 calls it primary cutaneous marginal zone lymphoproliferative disorder (Kempf 2024).

Primary versus secondary cutaneous lymphoma. A lymphoma is primary cutaneous only when staging shows no extracutaneous disease at diagnosis (Willemze 2019). Staging is not recommended in typical cases of SMLPD and the acral CD8-positive disorder (Willemze 2019). ALK protein expression in a cutaneous CD30-positive lymphoma strongly suggests secondary skin involvement by systemic ALK-positive ALCL, although rare ALK-positive primary cutaneous cases occur (Willemze 2019).

Table. Relative frequency and 5-year disease-specific survival of primary cutaneous lymphomas in the Dutch and Austrian registries, 2002–2017 (Willemze 2019). Adult T-cell leukemia/lymphoma and chronic active EBV infection (each <1%, no survival data) are omitted.

Entity (WHO-EORTC 2018 term) Frequency (%) 5-year disease-specific survival (%)
Mycosis fungoides 39 88
Folliculotropic MF 5 75
Pagetoid reticulosis <1 100
Granulomatous slack skin <1 100
Sézary syndrome 2 36
Primary cutaneous ALCL 8 95
Lymphomatoid papulosis 12 99
SPTCL 1 87
Extranodal NK/T-cell lymphoma, nasal type <1 16
Primary cutaneous γδ T-cell lymphoma <1 11
CD8-positive AECTCL <1 31
CD4-positive small/medium T-cell lymphoproliferative disorder 6 100
Acral CD8-positive T-cell lymphoma <1 100
Primary cutaneous peripheral T-cell lymphoma, NOS 2 15
PCMZL 9 99
PCFCL 12 95
Primary cutaneous DLBCL, leg type 4 56
EBV-positive mucocutaneous ulcer <1 100
Intravascular large B-cell lymphoma <1 72

Early mycosis fungoides: ISCL diagnostic algorithm and inflammatory mimics

Table. ISCL algorithm for early mycosis fungoides (Pimpinelli 2005, as tabulated in Lee 2023). A total of 4 points from any combination of criteria establishes the diagnosis.

Criteria Findings Scoring
Clinical Basic: persistent and/or progressive patches or thin plaques. Additional: non-sun-exposed location; size or shape variation; poikiloderma 2 points for the basic criterion and 2 additional criteria; 1 point for the basic criterion and 1 additional criterion
Histopathologic Basic: superficial lymphoid infiltrate. Additional: epidermotropism without spongiosis; lymphoid atypia (enlarged hyperchromatic nuclei with irregular or cerebriform contours) 2 points for the basic criterion and 2 additional criteria; 1 point for the basic criterion and 1 additional criterion
Molecular biologic Clonal T-cell receptor gene rearrangement 1 point
Immunopathologic <50% CD2-, CD3- and/or CD5-positive T cells; <10% CD7-positive T cells; epidermal-dermal discordance of CD2, CD3, CD5 or CD7 (antigen deficiency confined to the epidermis) 1 point for 1 or more criteria

Histologic clues to patch and plaque MF. Classic epidermotropism shows Pautrier microabscesses, alignment of tumor cells along the basement membrane and pericellular halos. Epidermal change is slight compared with the intensity of epidermotropism, with no hyperplasia and no or subtle spongiosis. A band-like infiltrate of tumor cells and reactive lymphocytes fills the upper dermis (Drabent 2026). Papillary dermal fibrosis with wiry ("fettuccine-like") collagen bundles and disproportionate epidermotropism involving the full epidermal thickness favor MF over lichen sclerosus (Nasser Eldin 2026). In sparse early infiltrates, clonality testing may be polyclonal because of the small number of neoplastic cells (Drabent 2026).

Table. Inflammatory dermatoses that mimic mycosis fungoides and the findings that separate them (Nasser Eldin 2026).

Mimic Findings shared with MF Findings favoring the mimic
Discoid lupus erythematosus Dense band-like or nodular infiltrate Vacuolar interface change, increased dermal mucin, thickened basement membrane, clusters of CD123-positive plasmacytoid dendritic cells, preserved pan-T-cell antigens, polyclonal TCR
Lichen sclerosus Band-like infiltrate, epidermotropism, occasional monoclonal TRG rearrangement Anogenital site, epidermotropism confined to the lower epidermis, papillary dermal hyalinization, vacuolar basal change, mild or absent atypia
Vitiligo (inflammatory stage) Lymphocytic exocytosis with occasional Pautrier-like clusters, often CD8-predominant Sharply demarcated depigmentation with reduced or absent melanocytes on Melan-A or HMB-45
Pigmented purpuric dermatosis and lichen aureus Dense band-like infiltrate, partial antigen loss and occasional monoclonal TCR Erythrocyte extravasation, hemosiderin, clinical stability, no significant atypia; rare patients later develop MF
Psoriasis Psoriasiform hyperplasia Neutrophilic parakeratosis, no disproportionate epidermotropism, no lymphocyte atypia
Lichen planus and lichen striatus Dense band, adnexotropism Classic interface dermatitis, hypergranulosis, no reproducible antigen loss or clonality
Pityriasis lichenoides CD8-positive infiltrate, clonality in some cases Crops of lesions, wedge-shaped infiltrate with epidermal necrosis, non-progressive course
Annular lichenoid dermatitis of youth Annular or hypopigmented lesions in young patients Keratinocyte apoptosis confined to rete tips, no papillary dermal fibrosis, polyclonal TCR
Lymphomatoid contact dermatitis Dense infiltrate, Pautrier-like collections Exposure history, spongiosis, eosinophils, preserved phenotype, improvement after allergen avoidance; Langerhans cell microgranulomas favor eczema
Actinic reticuloid (chronic actinic dermatitis) Dense atypical infiltrate Marked photosensitivity, eczematous epidermal change, CD8-predominant phenotype, polyclonal TCR
Drug-induced pseudolymphoma and fixed drug eruption Pautrier-like collections, cerebriform cells, clonal TCR in some cases Temporal drug exposure, interface change with necrotic keratinocytes and eosinophils, regression after withdrawal
Secondary syphilis Epidermotropism, CD8-predominant infiltrate, atypia Plasma cell-rich lichenoid or perivascular infiltrate, polytypic plasma cells, Treponema pallidum immunohistochemistry, resolution after penicillin

Folliculotropic mycosis fungoides in skin biopsies. Atypical T cells infiltrate the follicular epithelium, with or without follicular mucinosis and with or without epidermal involvement. The head and face are the sites most often involved, and the male-to-female ratio ranges from 2:1 to 5:1. Follicular mucinosis is primary (idiopathic) or secondary, most often to mycosis fungoides (Pampaloni 2026). Epidermal sparing with folliculotropic CD4-positive T cells and perifollicular fibrosis separated folliculotropic MF from pityriasis rubra pilaris and lichen spinulosus in one report (Giorgio 2026). Its classification is taught in Mature T-Cell and NK-Cell Neoplasms: Nodal, Leukemic, Extranodal and Cutaneous T-Cell Lymphomas, and its distinction from lichen striatus in Interface and Lichenoid Dermatoses, Cutaneous Lupus and Dermatomyositis, Graft-versus-Host Disease, and Sclerosing Dermal Disorders.

Sézary syndrome in skin biopsies. Skin histology in Sézary syndrome resembles MF, but infiltrates may be sparse, epidermotropism minimal or absent, and up to one-third of biopsies are nonspecific. Blood findings therefore establish the diagnosis, as taught in Mature T-Cell and NK-Cell Neoplasms: Nodal, Leukemic, Extranodal and Cutaneous T-Cell Lymphomas. Strong PD-1 (CD279) expression by the neoplastic T cells helps separate Sézary syndrome from erythrodermic inflammatory dermatoses (Willemze 2019).

Lymphomatoid papulosis: clinical definition, histologic types and differential diagnosis

Clinical definition. Lymphomatoid papulosis (LyP) is a primary cutaneous CD30-positive lymphoproliferative disorder of recurrent, self-healing clustered papules or small nodules, each <2.0 cm, on the trunk and extremities. Lesions at different stages coexist and regress with crusts within a few weeks, and the disease persists from weeks to years (Marques-Piubelli 2026). LyP and primary cutaneous ALCL form a spectrum that accounts for about 25% of CTCL. Clinical presentation and course separate them because histology and phenotype overlap (Willemze 2019). LyP has an incidence of 1.2–1.9 per million, peaks in the fifth decade, is more common in men and occurs in children (Marques-Piubelli 2026). It is the most common cutaneous hematologic neoplasm of childhood (Drabent 2026). A second lymphoma precedes, accompanies or follows LyP in 10%–20% of patients, and the LyP clone may match a coexisting MF or primary cutaneous ALCL (Marques-Piubelli 2026). Lesion number grades severity: mild <12, moderate 12–50 and severe >50 (Marques-Piubelli 2026).

Table. Histologic types of lymphomatoid papulosis (Willemze 2019 for frequency, phenotype and main differential; Marques-Piubelli 2026 for morphology).

Type Frequency Morphology Phenotype Main differential diagnosis
A >80% Wedge-shaped infiltrate of scattered large Hodgkin/Reed–Sternberg-like CD30-positive cells among neutrophils, eosinophils and histiocytes CD4-positive, CD8-negative, CD30-positive Primary cutaneous ALCL; tumor-stage MF; classic Hodgkin lymphoma
B <5% Epidermotropic band of small to medium cerebriform cells CD4-positive, CD8-negative, usually CD30-negative Plaque-stage MF
C 10% Sheets of large CD30-positive cells with few inflammatory cells CD4-positive, CD8-negative Primary cutaneous ALCL; transformed MF
D <5% Marked epidermotropism of small to medium atypical cells, resembling pagetoid reticulosis CD8-positive, CD4-negative, CD30-positive, βF1-positive, TIA-1-positive, EBER-negative CD8-positive AECTCL
E <5% Angiocentric and angiodestructive infiltrate of small to medium cells with scattered large CD30-positive cells; clinically, papules that ulcerate into eschar-like necrotic lesions CD8-positive, CD4-negative Extranodal NK/T-cell lymphoma
With DUSP22/IRF4 rearrangement (6p25.3) <5% Biphasic: small cerebriform epidermotropic cells with weak or absent CD30 and large dermal cells with strong CD30 and LEF1; TIA-1-negative; older patients with localized lesions CD4-negative and CD8-positive, or CD4-negative and CD8-negative Transformed MF

Rare forms. Folliculotropic LyP shows perifollicular atypical cells with follicular cystic dilatation or rupture, intrafollicular neutrophilic pustules and follicular mucinosis. Syringotropic, granulomatous and γδ forms also occur. Large atypical CD30-positive cells are present in all forms (Marques-Piubelli 2026). TCRγδ-positive LyP keeps the indolent course of αβ LyP and is diagnosed as LyP (Willemze 2019).

Phenotype and genetics. The large cells usually express CD3, CD4, CD25, CD30, CD45RO, HLA-DR, TIA-1 and granzyme B, with variable loss of CD2, CD5 and CD7. TRG or TRB rearrangement is usually monoclonal. NPM1::TYK2 fusions activate STAT signaling. No virus, including EBV, is associated with LyP (Marques-Piubelli 2026). DUSP22 or IRF4 rearrangement cannot be resolved between the two genes by FISH because they lie too close together (Marques-Piubelli 2026).

Prognostic meaning of LyP types. Recognition of the types avoids misdiagnosis of aggressive lymphoma but has no therapeutic or prognostic implications (Willemze 2019). Patients with CD8-positive LyP were less likely to develop a second lymphoma than those with CD8-negative types (Swallow 2024).

LyP versus primary cutaneous ALCL. pcALCL presents as a solitary or localized nodule, usually >2 cm, in the seventh decade, with a diffuse sheet of anaplastic large CD30-positive cells (Marques-Piubelli 2026). Ulcerated pcALCL can resemble LyP histologically, so clinical presentation decides the diagnosis (Drabent 2026).

Reactive CD30-positive infiltrates. Nodular scabies can contain activated CD30-positive large lymphocytes that raise concern for LyP. Arthropod bites more often mimic LyP or SMLPD than MF (Nasser Eldin 2026). LyP resembling pityriasis lichenoides et varioliformis acuta (PLEVA) shows interface change with deep nodular infiltrates at the dermal-subcutaneous junction and CD30-positive large cells (Drabent 2026). PLEVA with prominent CD30-positive cells has smaller, more numerous lesions without a waxing and waning course. A T-cell clone is found in up to 50% of pityriasis lichenoides, so clonality does not separate it from LyP or MF. Eosinophils favor LyP because PLEVA lacks them (Drabent 2026).

Subcutaneous panniculitis-like T-cell lymphoma

Definition and clinical features. SPTCL is a cytotoxic αβ T-cell lymphoma of the subcutis that presents with subcutaneous nodules and plaques, usually on the trunk and extremities (Willemze 2019; Swallow 2024). It makes up about 1% of primary cutaneous lymphomas, with a 5-year disease-specific survival of 87% (Willemze 2019). Median age at onset is 36 years, and about one-fifth of patients are younger than 20 years (Swallow 2024). Systemic symptoms are common, and hemophagocytic lymphohistiocytosis (HLH) is a frequent complication (Swallow 2024). About 19% of patients have an autoimmune disease, most often systemic lupus erythematosus (Drabent 2026).

Histology and phenotype. A mainly lobular infiltrate of small to medium atypical lymphocytes with scattered large cells rims individual adipocytes. Rimming may be focal and is not specific. Histiocytes, fat necrosis and karyorrhexis are almost always present. Neutrophils and eosinophils are rare, and plasma cells and lymphoid follicles are sparse (Drabent 2026). The cells are CD3-, CD8-, βF1-, TIA-1- and granzyme B-positive and CD4- and CD56-negative. CD5 and CD7 are the pan-T-cell antigens most often lost. TCRγδ and EBV are negative, and Ki-67 is increased (Drabent 2026; Willemze 2019; Moonla 2023).

Germline HAVCR2 variants and HLH. Germline HAVCR2 variants cause misfolding of TIM-3, with persistent immune activation, and predispose to SPTCL and HLH. In a meta-analysis of 224 patients with SPTCL with or without HLH, the pooled prevalence of germline HAVCR2 variants was 51.6% (95% CI 30.3–72.4) and of HLH or HLH-like illness 31.9%; p.Y82C was the most common variant (Moonla 2023). In pooled individual patient data, male sex and heterozygous or homozygous/compound heterozygous HAVCR2 variants were associated with HLH, and HLH-2004 scores correlated inversely with age (Moonla 2023). Children without HAVCR2 variants often have indolent disease that may regress (Drabent 2026).

SPTCL versus lupus erythematosus panniculitis. The parameters that separate them, led by Ki-67 hotspots of atypical CD8-positive cells (LeBlanc 2016), are tabulated in Follicular Disorders, Alopecia, Nail Unit Pathology and Panniculitis: Rosacea, Folliculitis, Hidradenitis Suppurativa, Scarring and Non-scarring Alopecia, Hair Shaft and Nail Disorders, Septal and Lobular Panniculitis.

Adult T-cell leukemia/lymphoma in skin. Skin lesions occur in all Shimoyama subtypes of HTLV-1-associated ATLL but are most common in the chronic and smoldering types. Patches, papules, plaques, nodules, tumors, purpura and erythroderma occur, often together, and mimic mycosis fungoides and Sézary syndrome. Hypercalcemia with a skin lymphoma prompts HTLV-1 serology (LeWitt 2025). Biopsies can show psoriasiform acanthosis, epidermotropism of atypical lymphocytes and a dense band-like dermal infiltrate, with CD25 highlighting the atypical cells and focal CD30 (Patel Housley 2025). Because another T-cell lymphoma can arise in an HTLV-1 carrier, HTLV-1 bZIP factor (HBZ) in situ hybridization on tissue confirms HTLV-1 integration in the tumor cells when the presentation is unusual (Cheverez-Ocasio 2026). Definition, subtypes and phenotype are taught in Mature T-Cell and NK-Cell Neoplasms: Nodal, Leukemic, Extranodal and Cutaneous T-Cell Lymphomas.

Primary cutaneous γδ T-cell lymphoma, CD8-positive AECTCL and peripheral T-cell lymphoma, NOS

Table. Aggressive primary cutaneous T-cell lymphomas.

Feature Primary cutaneous γδ T-cell lymphoma Primary cutaneous CD8-positive AECTCL Primary cutaneous peripheral T-cell lymphoma, NOS
Clinical Patches, plaques or nodules with ulceration or necrosis on the trunk and extremities; mucosal and extranodal sites common; nodes, spleen and marrow rarely involved Ulcerated, often necrotic plaques and tumors; may involve mucosa, palms and soles Rapidly growing solitary or disseminated tumors, often on the extremities, frequently ulcerated
Histology Epidermal, dermal and subcutaneous (panniculitic) patterns, often mixed; epidermal-predominant cases show epidermotropism and interface change Dense epidermotropic infiltrate of cells with irregular hyperchromatic nuclei; epidermal necrosis, with dermal necrosis in tumors Diffuse or nodular dermal infiltrate, often into the subcutis; epidermotropism absent or mild and focal
Phenotype CD3-positive, TCRγδ-positive, βF1-negative; CD4-negative; CD8 variable; CD56 in 40%–80%; CD2, CD45RA and cytotoxic proteins positive; EBV-negative CD3-positive, CD8-positive, CD4-negative, cytotoxic proteins positive, CD56-negative, αβ lineage, EBV-negative Frequently CD4/CD8 double-negative or double-positive; CD20 in about 18%
Outcome 5-year disease-specific survival 11%; HLH in up to about 50% in some series; epidermotropic cases fare better than dermal or subcutaneous cases 5-year disease-specific survival 31% in the registry series; median survival 23–32 months 5-year disease-specific survival 15% in the registry series
Source Willemze 2019; Muhsen 2022; Swallow 2024; Alberti-Violetti and Berti 2018 Willemze 2019; Swallow 2024; Hatipoğlu 2026 Willemze 2019; Hatipoğlu 2026

Genetics of AECTCL. AECTCL carries JAK2, NF-κB pathway and CDKN2A/B alterations (Hatipoğlu 2026).

CD8-positive MF and CD8-positive LyP. Fewer than 5% of MF cases are CD8-positive, most often hypopigmented MF in children. A CD8-positive phenotype alone does not establish an aggressive lymphoma. Clinical course separates CD8-positive MF, LyP type D and the acral CD8-positive disorder from AECTCL (Swallow 2024; Willemze 2019).

Indolent cutaneous T-cell lymphoproliferative disorders: CD4-positive small or medium T-cell, acral CD8-positive and IEI-associated

Table. Indolent cutaneous T-cell lymphoproliferative disorders (5th-edition terms).

Feature Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder IEI-associated T-cell lymphoproliferative disorders
Clinical Solitary plaque or tumor on the face, neck or upper trunk, without the patches and plaques of MF Solitary, slowly progressive papule or nodule, preferentially on the ear, less often the nose or foot Generalized indurated papules and nodules, often scaly or ulceronecrotic, often in children with inherited immunodeficiency and hypogammaglobulinemia
Histology Dense nodular to diffuse dermal infiltrate of small and medium pleomorphic CD4-positive cells with <30% large cells; admixed reactive CD8-positive T cells, B cells and histiocytes, including multinucleated giant cells; monotypic plasma cells in some cases Diffuse dermal infiltrate of clonal medium-sized cells separated from the epidermis by a grenz zone Granulomatous CD8-positive T-cell-rich dermal infiltrate
Phenotype CD3-positive, CD4-positive, CD8-negative; PD-1, BCL6 and CXCL13 positive (T-follicular helper markers); Ki-67 <5% to at most 20% CD3-positive, CD8-positive, CD4-negative, CD30-negative; variable loss of CD2, CD5 and CD7; TIA-1-positive with granzyme B and perforin negative; Golgi dot-like CD68; Ki-67 almost always <10%; EBV-negative EBV-negative by in situ hybridization
Ancillary studies and course Excellent prognosis; staging not recommended in typical cases; cases formerly called nodular cutaneous pseudo-T-cell lymphoma show the same features Excellent prognosis; staging not recommended in typical cases; cutaneous relapses occur and extracutaneous spread is exceptional Genetic diagnosis of the immunodeficiency, molecular testing for rubella virus and TCR rearrangement analysis when indicated; chronic course with limited progression
Source Willemze 2019; Hatipoğlu 2026 Willemze 2019; Swallow 2024 Goldman-Lévy 2026; Ho 2023

Separation of the acral disorder from aggressive CD8-positive lymphomas. The acral CD8-positive disorder has the histology of a high-grade lymphoma with an indolent course. Low proliferation, the TIA-1-only cytotoxic phenotype and the acral site separate it from AECTCL and CD8-positive MF (Willemze 2019; Hatipoğlu 2026).

Primary cutaneous B-cell lymphomas: recognition of the infiltrate in skin

Entity Infiltrate pattern Phenotype Source
PCMZL Nodular or diffuse, superficial and deep reticular dermis, often periadnexal, with a grenz zone; reactive or atrophic germinal centers surrounded by pale centrocyte-like marginal zone cells with follicular colonization; lymphoplasmacytoid and plasma cells CD20-positive, BCL2-positive, CD10-, CD23- and BCL6-negative; monotypic light chain; class-switched IgG, IgA or IgE in most cases; CD21 outlines colonized follicles Drabent 2026; Willemze 2019
PCFCL, diffuse large cell Predominance of large centrocytes with centroblasts not in confluent sheets; often abundant admixed T cells; head or trunk BCL6-positive, BCL2-negative, CD10-negative, IRF4/MUM1- and FOXP1-negative; IgM-negative; remnants of CD21/CD35 networks in some cases; usually no t(14;18) Willemze 2019; Hatipoğlu 2026
Primary cutaneous DLBCL, leg type Confluent sheets of centroblasts and immunoblasts with sparse perivascular T cells; tumors of one or both lower legs, 15% at other sites BCL2-, IRF4/MUM1-, FOXP1- and IgM-positive; MYC in 65%–80%; MYD88 mutation in about 60%–75% Willemze 2019; Hatipoğlu 2026
Reactive B-cell-rich lymphoid proliferation Preserved architecture, polymorphous infiltrate with plasma cells, eosinophils and histiocytes, reactive germinal centers with tingible body macrophages Polytypic light chains; no IGH monoclonality; low proliferation index Hatipoğlu 2026; Almeida-Silva 2026

Reactive T-cell-rich and B-cell-rich lymphoid proliferations (cutaneous lymphoid hyperplasia)

Definition and causes. Reactive lymphoid proliferations (formerly cutaneous pseudolymphoma or cutaneous lymphoid hyperplasia) are benign lymphoid infiltrates that mimic cutaneous lymphoma clinically and histologically. They present as solitary or grouped red-violaceous papules, plaques or nodules. Reported causes include drugs, biologic agents, arthropod bites, tattoos, vaccinations and Borrelia infection (Almeida-Silva 2026; Hatipoğlu 2026).

Findings that favor a reactive proliferation. Abrupt onset, a temporal link to a trigger, few lesions, no systemic symptoms and regression after the trigger is removed favor a reactive process. Histologic support comes from preserved skin architecture, a polymorphous infiltrate with plasma cells, eosinophils and histiocytes, reactive germinal centers and a low proliferation index (Almeida-Silva 2026). Progressive enlargement, ulceration, epidermotropism, cytologic atypia, monotonous cells, a high Ki-67 and a clone persisting on repeat biopsies favor lymphoma (Almeida-Silva 2026). Reactive proliferations may contain atypical cells, including CD30-positive cells. Reactive B-cell-rich proliferations lack IGH monoclonality and light-chain restriction (Hatipoğlu 2026).

Tattoo-associated lymphoid hyperplasia. In 58 patients with tattoo-induced lymphoid hyperplasia, red ink was the pigment most often involved. Onset followed tattooing by a median of 12 months (range 1 month to 41 years). Most infiltrates were mixed T- and B-cell infiltrates with T-cell predominance, some were purely T-cell, and none was purely B-cell (Ariasi 2026). Abundant pigment within the infiltrate, inflammation confined to pigmented areas and a polyclonal population favor a reactive process (Ariasi 2026). Tattoo pseudolymphoma typically shows a dense upper- and mid-dermal infiltrate, often top-heavy, with a preserved or partial grenz zone and pigment granules, commonly red or black; T-cell-predominant lesions remain polyclonal (Nasser Eldin 2026).

Drug-associated and biologic-associated proliferations. Drug-induced pseudolymphoma can show Pautrier-like collections, cerebriform lymphocytes and CD4- or CD8-predominant phenotypes. Clonal TCR rearrangement does not exclude a drug cause (Nasser Eldin 2026). Pseudolymphomas after TNF, IL-17 receptor and other biologics show a dense band-like or nodular dermal infiltrate of small mature lymphocytes, usually sparing the epidermis, and resolve after drug withdrawal (Almeida-Silva 2026).

Leukemia cutis, blastic plasmacytoid dendritic cell neoplasm and mature plasmacytoid dendritic cell proliferation in skin

Infiltrate Skin histology Key immunohistochemistry Source
Myeloid leukemia cutis Diffuse interstitial blasts between collagen bundles with a grenz zone, extending into the subcutis; high nuclear-to-cytoplasmic ratio, many mitoses and karyorrhexis Monocytic cases CD68-, CD43- and lysozyme-positive; MPO in myelomonoblastic cases; CD163 often negative; CD34 negative; Ki-67 90%–100% Drabent 2026
B- or T-lymphoblastic lymphoma in skin Monotonous blasts in dermis and subcutis with a grenz zone; fine chromatin; numerous mitoses; no inflammatory cells TdT-positive; PAX5 or CD79a more often than CD20 in B-lymphoblastic cases; CD10 often positive; CD99 almost always positive Drabent 2026
BPDCN Monotonous dermal infiltrate sparing the epidermis, often into the subcutis; medium-sized blasts with fine chromatin and irregular nuclei in sheets between collagen bundles CD4, CD56, CD123, TCL1 and TCF4 positive (CD123 with at least 1 other pDC marker); TdT often positive; CD68 positive in most; MPO and lysozyme negative Drabent 2026
Mature plasmacytoid dendritic cell proliferation associated with a myeloid neoplasm (5th edition) Aggregates of mature plasmacytoid dendritic cells with irregular nuclear contours and apoptotic cells; clinically macules, papules and rare nodules, mostly in adult men CD123 and other pDC markers; CD56 absent or low; aberrant pDC phenotype possible Goldman-Lévy 2026

Clinical context. Mature plasmacytoid dendritic cell proliferation occurs in patients with an established myeloid neoplasm, most often chronic myelomonocytic leukemia or AML, and its outcome follows the adverse course of that neoplasm (Goldman-Lévy 2026; Ho 2023). In neonates and infants, AML outnumbers ALL among leukemias in skin (up to 75%) and can present as "blueberry muffin baby"; aleukemic leukemia cutis may precede marrow disease (Drabent 2026).

Cutaneous plasma cell infiltrates

Entity Clinical setting Histology and ancillary findings Source
Cutaneous and systemic plasmacytosis Adults aged 30–50 years, mainly East Asian (Japanese) men; multiple red-brown macules, papules and plaques, with the axilla a characteristic site; superficial lymph nodes involved in about 58% Perivascular and periadnexal infiltrates of mature polyclonal plasma cells; polyclonal hypergammaglobulinemia in 88%–93%; elevated IL-6 in some cases; overlap with multicentric plasmacytic Castleman disease and IgG4-related disease Yao 2026; Xu 2025
IgG4-related skin disease Middle-aged and older men; erythematous papules, plaques and nodules; skin lesions may precede systemic disease by years Dense lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells (>10 per high-power field and an IgG4-to-IgG ratio >40% in the reported case); storiform fibrosis, obliterative phlebitis and eosinophils in IgG4-related disease; elevated serum IgG4. The IgG4-to-IgG ratio is usually <40% in sarcoidosis and other chronic inflammatory infiltrates Chen 2026
Primary cutaneous marginal zone lymphoma Trunk and arms of young adults; multifocal in most Monotypic plasma cells and class-switched immunoglobulin, with a marginal zone B-cell component Willemze 2019; Drabent 2026
Secondary syphilis Lichenoid or perivascular lesions; nodular and malignant forms mimic lymphoma, particularly with HIV coinfection Plasma cell-rich infiltrate with equal κ and λ expression, mixed CD20-positive B cells and CD3-positive T cells; Treponema pallidum immunohistochemistry Nasser Eldin 2026

ISCL point score for early mycosis fungoides

References

  1. Abdelhammed MH, Dodson LM, Diwan AH, et al. Delayed histiocytic foreign body reaction and granuloma formation following Argiform injection for soft tissue augmentation mimicking a lipomatous tumor on histopathology: a case report. Case Rep Dermatol Med. 2026;2026:7330965. doi:10.1155/crdm/7330965. PMID 42903457
  2. Abdul Rahman MF, Wong WL, Chew SH, et al. A cervical smear scare due to Monsel's solution: a case report. J Med Cases. 2020;11(10):324–326. doi:10.14740/jmc3556. PMID 34434339
  3. Abu-Dayeh A, Miller D, Giubellino A. Discoid lupus erythematosus in genital skin: a case report and review of the literature. J Cutan Pathol. 2026;53(11):1000–1006. doi:10.1111/cup.70145. PMID 42165750
  4. Agrawal S, Dhurat R, Ghate S, et al. Lichen simplex chronicus on the scalp: broom fibers on dermoscopy; gear wheel sign and hamburger sign on histopathology. Indian Dermatol Online J. 2020;11(3):401–403. doi:10.4103/idoj.idoj_350_19. PMID 32695702
  5. Ahmed A, Acharya S, Shukla S, et al. Beyond the Bottle: Niacin Deficiency and Chronic Alcoholism. Cureus. 2023;15(11):e49482. doi:10.7759/cureus.49482. PMID 38152783
  6. Ahmed A, Cahn B, Haber R. Wells syndrome: emerging triggers and treatments, an updated systematic review. Arch Dermatol Res. 2025;317(1):805. doi:10.1007/s00403-025-04305-9. PMID 40488888
  7. Ahmed AA, van de Sande W, Fahal AH. Mycetoma laboratory diagnosis: Review article. PLoS Negl Trop Dis. 2017;11(8):e0005638. doi:10.1371/journal.pntd.0005638. PMID 28837657
  8. Akanksha PC, Carol L, Sowmya K, et al. Povidone-iodine induced epidermal necrosis: a report of two cases. Indian Dermatol Online J. 2025;16(3):459–461. doi:10.4103/idoj.idoj_211_24. PMID 40395607
  9. Alanazi AF, Alharbe A, Asiree RH, et al. Idiopathic Localized Acquired Cutis Laxa in an Adult Male: A Case Report. Cureus. 2026;18(1):e100626. doi:10.7759/cureus.100626. PMID 41635354
  10. Alani O, Chau C, Patel D, et al. Staphylococcal scalded skin syndrome: a rare mimicker of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults. JAAD Case Rep. 2025;63:97–100. doi:10.1016/j.jdcr.2025.05.033. PMID 40791764
  11. Alberti-Violetti S, Berti E. Lymphocytic lobular panniculitis: a diagnostic challenge. Dermatopathology (Basel). 2018;5(1):30–33. doi:10.1159/000486754. PMID 29594104
  12. Alhalabi R, Salloum R, Alhalabi D, et al. Sclerema neonatorum in a premature newborn: a case report. Skin Health Dis. 2023;3(5):e255. doi:10.1002/ski2.255. PMID 37799354
  13. Almeida-Silva G, Tribolet de Abreu I, Monteiro F, et al. Biologics-induced cutaneous pseudolymphomas: a narrative review with an illustrative case of brodalumab-induced pseudolymphoma. Drugs Context. 2026;15:2025-10-5. doi:10.7573/dic.2025-10-5. PMID 41767544
  14. AlSulami M, Alshareef K, Aldossari AA, et al. Plantar ulcerative lichen planus as a therapeutic challenge: a review of literature. Cureus. 2025;17(7):e87444. doi:10.7759/cureus.87444. PMID 40772218
  15. Anavi BL, Stoyanova NS. Gouty tophus on the eyelid. Rom J Ophthalmol. 2026;70(2):322–325. doi:10.22336/rjo.2026.43. PMID 42572696
  16. Anderska A, Kaczmarska-Such A, Mazur E, et al. Porokeratoses: a rare group of dermatoses. Medicina (Kaunas). 2024;60(11):1876. doi:10.3390/medicina60111876. PMID 39597061
  17. Anderson HJ, Lee JB. A review of fixed drug eruption with a special focus on generalized bullous fixed drug eruption. Medicina (Kaunas). 2021;57(9):925. doi:10.3390/medicina57090925. PMID 34577848
  18. Anelli S, Mazzilli R, Zamponi V, et al. Glucagonoma and Glucagonoma Syndrome: An Updated Review. Clin Endocrinol (Oxf). 2025;103(4):417–426. doi:10.1111/cen.15300. PMID 40613421
  19. Arbache ST, Nogueira TG, Delgado L, et al. Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience. An Bras Dermatol. 2014;89(6):885–889. doi:10.1590/abd1806-4841.20143221. PMID 25387492
  20. Arenas R, Sánchez-Cardenas CD, Ramirez-Hobak L, et al. Sporotrichosis: From KOH to Molecular Biology. J Fungi (Basel). 2018;4(2):E62. doi:10.3390/jof4020062. PMID 29882883
  21. Ariasi C, Rogowska P, Damiani C, et al. Tattoo-induced cutaneous lymphoid hyperplasia: a case series and review of the literature. Dermatol Pract Concept. 2026;16(2). doi:10.5826/dpc.1602a6251. PMID 42190207
  22. Arriaga Escamilla D, Lakhani A, Antony S, et al. Dermatological Manifestations in Patients With Chronic Kidney Disease: A Review. Cureus. 2024;16(1):e52253. doi:10.7759/cureus.52253. PMID 38352109
  23. Babu A, Chellaswamy S, Muthukumar S, et al. Bullous lichen planus: case report and review. J Pharm Bioallied Sci. 2019;11(Suppl 2):S499–S506. doi:10.4103/jpbs.jpbs_58_19. PMID 31198396
  24. Bălăceanu-Gurău B, Tutunaru CV, Orzan OA. An Atypical Presentation of Reticular Erythematous Mucinosis: A Case Report and Comprehensive Literature Review. J Clin Med. 2025;14(6):2131. doi:10.3390/jcm14062131. PMID 40142939
  25. Balan RA, Lozneanu L, Grigoras A, et al. Spongiotic reaction patterns in autoimmune bullous dermatoses (review). Exp Ther Med. 2021;22(5):1334. doi:10.3892/etm.2021.10769. PMID 34630688
  26. Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129(1):92–96. doi:10.1001/archderm.1993.01680220104023. PMID 8420497
  27. Belda Junior W. Donovanosis. An Bras Dermatol. 2020;95(6):675-683. doi:10.1016/j.abd.2020.07.002. PMID 33069513
  28. Bernardeschi C, Foulet F, Ingen-Housz-Oro S, et al. Cutaneous Invasive Aspergillosis: Retrospective Multicenter Study of the French Invasive-Aspergillosis Registry and Literature Review. Medicine (Baltimore). 2015;94(26):e1018. doi:10.1097/md.0000000000001018. PMID 26131805
  29. Bertamino M, Goldberg DJ, Mughal MZ, et al. Pediatric ABCC6 deficiency: a genotypic and phenotypic analysis. Orphanet J Rare Dis. 2025;20(1):593. doi:10.1186/s13023-025-04102-7. PMID 41257790
  30. Bertanha L, Chiacchio ND. Nail clipping in onychomycosis. An Bras Dermatol. 2016;91(5):688–690. doi:10.1590/abd1806-4841.20164968. PMID 27828655
  31. Besekar SM, Jogdand SD, Naqvi WM. A Systematic Review of Case Reports of a Rare Dermatological Condition: Elastosis Perforans Serpiginosa. Cureus. 2023;15(6):e40296. doi:10.7759/cureus.40296. PMID 37448439
  32. Bhatnagar A, Kothari R, Kishore K, et al. Benign lichenoid keratosis: "a placid affair". Indian Dermatol Online J. 2023;14(6):893–894. doi:10.4103/idoj.idoj_605_22. PMID 38099014
  33. Borradori L, Van Beek N, Feliciani C, et al. Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2022;36(10):1689–1704. doi:10.1111/jdv.18220. PMID 35766904 (abstract)
  34. Botelho LFF, Hélène S, Proença CGC, et al. Transient neonatal zinc deficiency or acrodermatitis enteropathica?. An Bras Dermatol. 2024;99(5):763–765. doi:10.1016/j.abd.2023.08.018. PMID 38955663
  35. Brazel M, Desai A, Are A, et al. Staphylococcal Scalded Skin Syndrome and Bullous Impetigo. Medicina (Kaunas). 2021;57(11):1157. doi:10.3390/medicina57111157. PMID 34833375
  36. Brem CE, Goldberg LJ. Early Erythema Migrans: Do Not Count on Plasma Cells. Am J Dermatopathol. 2022;44(2):e23-e25. doi:10.1097/dad.0000000000002058. PMID 35076434
  37. Brito AC, Bittencourt MJS. Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update. An Bras Dermatol. 2018;93(4):495-506. doi:10.1590/abd1806-4841.20187321. PMID 30066754
  38. Brunetti T, Misciali C, Rapparini L, et al. Scalp biopsies for alopecia. Dermatopathology (Basel). 2026;13(3):44. doi:10.3390/dermatopathology13030044. PMID 42782841
  39. Bryan J, Skopis PK, Saikaly SK, et al. Comparing cases of type I cryoglobulinemia with histopathologic findings of vasculitis. JAAD Case Rep. 2022;23:160–161. doi:10.1016/j.jdcr.2022.02.014. PMID 35519798
  40. Buffet M, Grange PA, Gerhardt P, et al. Diagnosing Treponema pallidum in secondary syphilis by PCR and immunohistochemistry. J Invest Dermatol. 2007;127(10):2345-2350. doi:10.1038/sj.jid.5700888. PMID 17554371
  41. Cárdenas-Gonzalez RE, Ruelas MEH, Candiani JO. Lichen myxedematosus: a rare group of cutaneous mucinosis. An Bras Dermatol. 2019;94(4):462–469. doi:10.1590/abd1806-4841.20198478. PMID 31644623
  42. Caroppo F, Gnesotto L, Mioso G, et al. Pseudoporphyria induced by voriconazole in a 10-year-old boy: a case report and review of the literature. Acta Derm Venereol. 2023;103:adv10286. doi:10.2340/actadv.v103.10286. PMID 37249198
  43. Caruso A, Marchesini D, Manta A, et al. Junction-associated laminin-R/RPSA immunoreactivity in electrical marks: a morphological and immunohistochemical study. Int J Mol Sci. 2026;27(19):8872. doi:10.3390/ijms27198872. PMID 42884115
  44. Carvalho MLR, Magalhães GM, Leite HV. Update on specific dermatoses of pregnancy. Rev Assoc Med Bras (1992). 2023;69(Suppl 1):e2023S109. doi:10.1590/1806-9282.2023s109. PMID 37556628
  45. Cassisa A, Cima L. Cutaneous vasculitis: insights into pathogenesis and histopathological features. Pathologica. 2024;116(2):119–133. doi:10.32074/1591-951X-985. PMID 38767544
  46. Castrejón-Pérez AD, Welsh EC, Miranda I, et al. Cutaneous mucormycosis. An Bras Dermatol. 2017;92(3):304-311. doi:10.1590/abd1806-4841.20176614. PMID 29186239
  47. Cerqueira C, Sobreiro Silva J, Moreira Nogueira C, et al. Diffuse normolipemic plane xanthoma associated with monoclonal gammopathy. Cureus. 2025;17(7):e89071. doi:10.7759/cureus.89071. PMID 40895906
  48. Chalarca-Cañas D, Caviedes-Cleves MA, Correa-Londoño LA, et al. Tattoos: risks and complications, clinical and histopathological approach. An Bras Dermatol. 2024;99(4):491–502. doi:10.1016/j.abd.2023.07.004. PMID 38521707
  49. Chatterjee D, Bhattacharjee R, Saikia UN. Non-infectious granulomatous dermatoses: a pathologist's perspective. Indian Dermatol Online J. 2021;12(4):515–528. doi:10.4103/idoj.idoj_662_20. PMID 34430454
  50. Chen KH, Lin CY, Su SB, et al. Leprosy: A Review of Epidemiology, Clinical Diagnosis, and Management. J Trop Med. 2022;2022:8652062. doi:10.1155/2022/8652062. PMID 35832335
  51. Chen XY, Chen J, Lv L, et al. Case report: a case of primary IgG4-related skin disease presenting initially with skin papules and abscesses. Front Immunol. 2026;17:1850129. doi:10.3389/fimmu.2026.1850129. PMID 42454055
  52. Cheverez-Ocasio J, Medeiros LJ, Tashakori M. From serologic uncertainty to diagnostic clarity in unusual adult T-cell leukemia/lymphoma via HBZ in situ hybridization. J Hematop. 2026;19(1):28. doi:10.1007/s12308-026-00705-6. PMID 42230398
  53. Chewcharat A, Nigwekar SU. Ten tips on how to deal with calciphylaxis patients. Clin Kidney J. 2025;18(4):sfaf098. doi:10.1093/ckj/sfaf098. PMID 40600068
  54. Chiang YH, Winter S, Kalavala M. A new association of cutaneous leishmaniasis with guselkumab in a patient with chronic psoriasis. Skin Health Dis. 2026;6(4):605–608. doi:10.1093/skinhd/vzag080. PMID 42540059
  55. Chieng ACR, Sivagnanam B, Liew MH, et al. Pseudovasculitic Scurvy Mimicking Small Vessel Vasculitis: A Case Report. Reports (MDPI). 2026;9(2):114. doi:10.3390/reports9020114. PMID 42029462
  56. Ciccarese G, Facciorusso A, Mastrolonardo M, et al. Atypical Manifestations of Syphilis: A 10-Year Retrospective Study. J Clin Med. 2024;13(6):1603. doi:10.3390/jcm13061603. PMID 38541829
  57. Cohen PR, Paravar T, Lee RA. Epidermal multinucleated giant cells are not always a histopathologic clue to a herpes virus infection: multinucleated epithelial giant cells in the epidermis of lesional skin biopsies from patients with acantholytic dermatoses can histologically mimic a herpes virus infection. Dermatol Pract Concept. 2014;4(4):21-27. doi:10.5826/dpc.0404a03. PMID 25396080
  58. Cohen PR. Antineoplastic drugs-related medication-associated pseudoporphyria. JAAD Case Rep. 2023;42:66–68. doi:10.1016/j.jdcr.2023.08.019. PMID 38077162
  59. Couto M, Oura MJ, Tavares NT, et al. Pathway from lichen sclerosus to squamous cell carcinoma of the penis: the oncologist's perspective. Urol Case Rep. 2026;65:103318. doi:10.1016/j.eucr.2025.103318. PMID 41584786
  60. Cuestas D, Gómez A, Neri Morales C, et al. Acquired epidermodysplasia verruciformis syndrome in HIV-infected patients: a systematic review. Arch Dermatol Res. 2024;316(7):471. doi:10.1007/s00403-024-03016-x. PMID 39001899
  61. Currie M, Going JJ. Ducts in the human nipple: structure, epithelial immunophenotypes, and relationships with clear cells of nipple epidermis (Toker cells). BMC Proc. 2009;3(Suppl 5):S12. doi:10.1186/1753-6561-3-S5-S12
  62. Damiani L, Quadros M, Posser V, et al. Zoon vulvitis. An Bras Dermatol. 2017;92(5 Suppl 1):166–168. doi:10.1590/abd1806-4841.20175622. PMID 29267481
  63. Dang Y, Niu L, Wang D, et al. Eosinophilic fasciitis: a case report and literature review. Medicine (Baltimore). 2025;104(43):e45449. doi:10.1097/md.0000000000045449. PMID 41137258
  64. Danielson DT, Lagerstrom I, Wary Z, et al. Dermatologic lesions with eosinophilia in the head and neck. Head Neck Pathol. 2025;19(1):27. doi:10.1007/s12105-025-01757-3. PMID 39998691
  65. Daruish M, Ambrogio F, Foti C, et al. Tumid Lupus Erythematosus (TLE): A Review of a Rare Variant of Chronic Cutaneous Lupus Erythematosus (cCLE) with Emphasis on Differential Diagnosis. Diagnostics (Basel). 2024;14(7):780. doi:10.3390/diagnostics14070780. PMID 38611691
  66. Dayal S, Sahu P. Zoon balanitis: a comprehensive review. Indian J Sex Transm Dis AIDS. 2016;37(2):129–138. doi:10.4103/0253-7184.192128. PMID 27890945
  67. de Carvalho JF, de Araujo RPC. Polyarteritis nodosa and antiphospholipid syndrome: a systematic review of a rare and challenging overlap between vasculitis and thrombotic vasculopathy. Clin Rheumatol. 2026;45(8):4791–4800. doi:10.1007/s10067-026-08214-8. PMID 42377683
  68. Dermitzakis I, Chatzi D, Kyriakoudi SA, et al. Skin development and disease: a molecular perspective. Curr Issues Mol Biol. 2024;46(8):8239–8267. doi:10.3390/cimb46080487. PMID 39194704
  69. Devi B, Behera B, Dash M, et al. Botryomycosis. Indian J Dermatol. 2013;58(5):406. doi:10.4103/0019-5154.117322. PMID 24082199
  70. Dhar S, Pradhan S, Saha A, et al. Deep Fungal Infections of Skin and Role of Histopathology in Diagnosis. Indian J Dermatol. 2024;69(6):442-452. doi:10.4103/ijd.ijd_419_23. PMID 39678745
  71. Di Lernia V, Casanova DM, Goldust M, et al. Pemphigus vulgaris and bullous pemphigoid: update on diagnosis and treatment. Dermatol Pract Concept. 2020;10(3):e2020050. doi:10.5826/dpc.1003a50. PMID 32642305
  72. Dika E, Venturi F, Veronesi G. Reflectance confocal microscopy of large penis pigmentation: a clue for detection of genital melanosis. Skin Res Technol. 2023;29(5):e13347. doi:10.1111/srt.13347. PMID 37231933
  73. Doshi M, Sak L, Jimenez JC. Drug-induced hyperpigmentation confounding clinical assessment and management for advanced chronic venous insufficiency. J Vasc Surg Cases Innov Tech. 2026;12(4):102327. doi:10.1016/j.jvscit.2026.102327. PMID 42376058
  74. Drabent P, Welfringer A, Gru AA, et al. Cutaneous hematologic neoplasms in children: overview and update. Dermatopathology (Basel). 2026;13(2):24. doi:10.3390/dermatopathology13020024. PMID 42346176
  75. Dutta P, Chaudet KM, Nazarian RM, et al. Correlation between clinical and pathological features of cutaneous calciphylaxis. PLoS One. 2019;14(6):e0218155. doi:10.1371/journal.pone.0218155. PMID 31194797
  76. El Jalkh J, Obeid PM, Guermazi D, et al. Skin-Colored Papules on the Neck of a Postmenopausal Woman: A Diagnostic Challenge. Dermatopathology (Basel). 2025;12(2):15. doi:10.3390/dermatopathology12020015. PMID 40407483
  77. Engelman D, Yoshizumi J, Hay RJ, et al. The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies. Br J Dermatol. 2020;183(5):808-820. doi:10.1111/bjd.18943. PMID 32034956
  78. Eswaran H, Googe P, Vedak P, et al. Livedoid vasculopathy: a review with focus on terminology and pathogenesis. Vasc Med. 2022;27(6):593–603. doi:10.1177/1358863X221130380. PMID 36285834
  79. Ettinger M, Kimeswenger S, Deli I, et al. Darier disease: current insights and challenges in pathogenesis and management. J Eur Acad Dermatol Venereol. 2025;39(5):942–951. doi:10.1111/jdv.20448. PMID 39606894
  80. Fan Y, Willems L, Leboeuf C, et al. Skin Microvascular Thrombosis in Fusarium Infection in Two Early Biopsied Cases. Case Rep Dermatol. 2010;2(2):76-81. doi:10.1159/000313934. PMID 21113281
  81. Fantini F, Dainese E, Recalcati S. Late-onset focal dermal elastosis: Report of a case and review of the literature. Dermatol Reports. 2022;14(3):9337. doi:10.4081/dr.2022.9337. PMID 36199904
  82. Faria AR, Tarlé RG, Dellatorre G, et al. Vitiligo. Part 2: classification, histopathology and treatment. An Bras Dermatol. 2014;89(5):784–790. doi:10.1590/abd1806-4841.20142717. PMID 25184918
  83. Farladansky-Gershnabel S, Shechter-Maor G, Biron-Shental T. Pemphigoid gestationis: a rare pregnancy-associated autoimmune blistering disorder. Arch Gynecol Obstet. 2025;312(5):1547–1549. doi:10.1007/s00404-025-08146-9. PMID 40828303
  84. Ferea CR, Mihai SN, Balan G, et al. Sweet syndrome associated with myelodysplastic syndrome: a review of a multidisciplinary approach. Life (Basel). 2023;13(3):809. doi:10.3390/life13030809. PMID 36983964
  85. Fijałkowska A, Kądziela M, Żebrowska A. The spectrum of cutaneous manifestations in lupus erythematosus: a comprehensive review. J Clin Med. 2024;13(8):2419. doi:10.3390/jcm13082419. PMID 38673692
  86. Flamm A, Parikh K, Xie Q, et al. Histologic features of secondary syphilis: A multicenter retrospective review. J Am Acad Dermatol. 2015;73(6):1025-1030. doi:10.1016/j.jaad.2015.08.062. PMID 26464219
  87. Fortarezza F, Caroppo F, Meneghel A, et al. "Adnexotropic" lichen striatus: a potential histological mimicker of mycosis fungoides. Pathologica. 2026;118(1):53–55. doi:10.32074/1591-951x-1996. PMID 41954367
  88. Frank L, Brandt S, Wabitsch M. Subcutaneous fat necrosis in newborns: a systematic literature review of case reports and model of pathophysiology. Mol Cell Pediatr. 2022;9(1):18. doi:10.1186/s40348-022-00151-1. PMID 36427118
  89. Frantz R, Huang S, Are A, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management. Medicina (Kaunas). 2021;57(9):895. doi:10.3390/medicina57090895. PMID 34577817
  90. Frew JW. Hidradenitis suppurativa is an autoinflammatory keratinization disease: a review of the clinical, histologic, and molecular evidence. JAAD Int. 2020;1(1):62–72. doi:10.1016/j.jdin.2020.05.005. PMID 34409324
  91. Gamez-Siller P, Moreno-Davila H, Oscherwitz M, et al. Granulomatous filler reaction treated with adalimumab: a case report and literature review. An Bras Dermatol. 2025;100(6):501214. doi:10.1016/j.abd.2025.501214. PMID 41177077
  92. Garcia Garcia SC, Salas Alanis JC, Flores MG, et al. Coccidioidomycosis and the skin: a comprehensive review. An Bras Dermatol. 2015;90(5):610-619. doi:10.1590/abd1806-4841.20153805. PMID 26560205
  93. Garg S, Behera B, Gowda SK, et al. Lichen planus cheilitis: a brief review. Indian Dermatol Online J. 2025;16(4):539–544. doi:10.4103/idoj.idoj_672_24. PMID 40688151
  94. Garimella V, Mukosera GT, Liedl DA, et al. Venous abnormalities in biopsy-confirmed lipodermatosclerosis. Adv Skin Wound Care. 2026;39(3):141–144. doi:10.1097/ASW.0000000000000421. PMID 41649308 (abstract)
  95. Giorgio CMR, Nicoletti MM, Malaspina M, et al. Folliculotropic mycosis fungoides mimicking pityriasis rubra pilaris and lichen spinulosus: a dermoscopic and histopathologic study. Dermatol Pract Concept. 2026;16(2). doi:10.5826/dpc.1602a6442. PMID 42190205
  96. Golani S, Khan S, Saeed Z, et al. Sjögren's syndrome associated with erythema dyschromicum perstans: a rare dermatological manifestation. Cureus. 2025;17(5):e84234. doi:10.7759/cureus.84234. PMID 40524988
  97. Goldman-Lévy G, Barnhill R, Bastian BC, et al. WHO classification of skin tumours: key updates in the fifth edition. Histopathology. 2026;88(3):555–568. doi:10.1111/his.15562. PMID 41263762 (summarizes the WHO Classification of Skin Tumours, 5th edition)
  98. Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021;35(6):1251–1277. doi:10.1111/jdv.17183. PMID 34004067 (abstract)
  99. Gu SL, Jorizzo JL. Urticarial vasculitis. Int J Womens Dermatol. 2021;7(3):290–297. doi:10.1016/j.ijwd.2021.01.021. PMID 34222586
  100. Guillet C, Hauser X, Stillhard A, et al. Nodular vasculitis: retrospective study of an uncommon disease in a non-tuberculosis endemic country with focus on treatment modalities and efficacy. Dermatology. 2025;241(1):27–34. doi:10.1159/000542488. PMID 39557040
  101. Haldankar S, Rebello NE, Spadigam A, et al. Isolated oral pemphigus vegetans: a case report. J Oral Biol Craniofac Res. 2026;16(5):101527. doi:10.1016/j.jobcr.2026.101527. PMID 42701504
  102. Harouni M, Sadrolashrafi K, Mobini N. Clipping towards clarity: significant role of simple nail clipping in the diagnosis of nail unit melanoma. JAAD Case Rep. 2026;74:108–110. doi:10.1016/j.jdcr.2026.05.016. PMID 42381819
  103. Has C, Bauer JW, Bodemer C, et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol. 2020;183(4):614–627. doi:10.1111/bjd.18921. PMID 32017015 (abstract)
  104. Hassevoort K, Grant P, Thielman A, et al. Delayed diagnosis of scabies: a case report. Cureus. 2026;18(4):e107569. doi:10.7759/cureus.107569. PMID 42181397
  105. Hatipoğlu U, Seyhan M, Eminoglu H, et al. Primary cutaneous lymphomas and lymphoproliferative disorders: current insights for classification and management. Cancers (Basel). 2026;18(18):3038. doi:10.3390/cancers18183038. PMID 42795004
  106. Hayashida MZ, Seque CA, Pasin VP, et al. Disseminated cryptococcosis with skin lesions: report of a case series. An Bras Dermatol. 2017;92(5 Suppl 1):69-72. doi:10.1590/abd1806-4841.20176343. PMID 29267451
  107. Heng JK, Aw DC, Tan KB. Solar elastosis in its papular form: uncommon, mistakable. Case Rep Dermatol. 2014;6(1):124–128. doi:10.1159/000362589. PMID 24926253
  108. Hertl M, Jedlickova H, Karpati S, et al. Pemphigus. S2 guideline for diagnosis and treatment, guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2015;29(3):405–414. doi:10.1111/jdv.12772. PMID 25338479 (abstract)
  109. Hesseltine LC, Sulewski RJ. Combined 595-nm pulsed dye laser and picosecond laser toning for the treatment of extensive erythema ab igne: A case report. JAAD Case Rep. 2026;76:131–134. doi:10.1016/j.jdcr.2026.08.024. PMID 42781249
  110. Ho J, Collie CJ. What's new in dermatopathology 2023: WHO 5th edition updates. J Pathol Transl Med. 2023;57(6):337–340. doi:10.4132/jptm.2023.09.22. PMID 37840244
  111. Hoffmann J, Durani B, Hartschuh W. Grover's disease-like patterns in early pityriasis rubra pilaris. J Dtsch Dermatol Ges. 2025;23(2):231–233. doi:10.1111/ddg.15597. PMID 39601057
  112. Hofmann AG, Deinsberger J, Oszwald A, et al. The histopathology of leg ulcers. Dermatopathology (Basel). 2024;11(1):62–78. doi:10.3390/dermatopathology11010007. PMID 38390849
  113. Iorio L, Davanzo F, Cazzador D, et al. Cocaine- and levamisole-induced vasculitis: defining the spectrum of autoimmune manifestations. J Clin Med. 2024;13(17):5116. doi:10.3390/jcm13175116. PMID 39274328
  114. Jagasia MH, Greinix HT, Arora M, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2015;21(3):389–401.e1. doi:10.1016/j.bbmt.2014.12.001. PMID 25529383
  115. Jallow BJJ, Gassara G, Bajinka O, et al. Human myiasis in Sub-Saharan Africa: A systematic review. PLoS Negl Trop Dis. 2024;18(3):e0012027. doi:10.1371/journal.pntd.0012027. PMID 38547087
  116. Jarrett P, Werth VP. A review of cutaneous lupus erythematosus: improving outcomes with a multidisciplinary approach. J Multidiscip Healthc. 2019;12:419–428. doi:10.2147/jmdh.s179623. PMID 31213824
  117. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11. doi:10.1002/art.37715. PMID 23045170 (definitions as tabulated in reference 3)
  118. Joly P, Horvath B, Patsatsi A, et al. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2020;34(9):1900–1913. doi:10.1111/jdv.16752. PMID 32830877 (abstract)
  119. Joshi TP, Duvic M. Granuloma annulare: an updated review of epidemiology, pathogenesis, and treatment options. Am J Clin Dermatol. 2022;23(1):37–50. doi:10.1007/s40257-021-00636-1. PMID 34495491
  120. Joshi TP, Friske SK, Hsiou DA, et al. New practical aspects of Sweet syndrome. Am J Clin Dermatol. 2022;23(3):301–318. doi:10.1007/s40257-022-00673-4. PMID 35157247
  121. Ju HJ, Bae JM. Vitiligo and its mimics in childhood: a diagnostic framework for hypopigmented disorders. Ann Dermatol. 2026;38(5):360–374. doi:10.5021/ad.26.064. PMID 42845200
  122. Jung I, Joo EJ, Suh BS, et al. A case of generalized argyria presenting with muscle weakness. Ann Occup Environ Med. 2017;29:45. doi:10.1186/s40557-017-0201-0. PMID 29026613
  123. Junghetu MA, Tutunaru CV, Ianoși SL, et al. Acquired Reactive Perforating Collagenosis-A Rare Entity Occurring Within Common Disorders: A Systematic Review and Our Personal Experience. J Clin Med. 2026;15(1):391. doi:10.3390/jcm15010391. PMID 41517640
  124. Kalantari Y, Meier K, Ghoreschi K, et al. Sclerosing diseases of the skin. J Dtsch Dermatol Ges. 2025;23(10):1282–1300. doi:10.1111/ddg.15835. PMID 41030177
  125. Kamaguchi M, Iwata H. The diagnosis and blistering mechanisms of mucous membrane pemphigoid. Front Immunol. 2019;10:34. doi:10.3389/fimmu.2019.00034. PMID 30740099
  126. Kanaki T, Hadaschik E, Esser S, et al. Eosinophilic pustular folliculitis (EPF) in a patient with HIV infection. Infection. 2021;49(4):799–801. doi:10.1007/s15010-020-01543-z. PMID 33237446
  127. Karnan A. Peeling paint dermatosis. Pan Afr Med J. 2024;47:76. doi:10.11604/pamj.2024.47.76.42420. PMID 38708134
  128. Kashif M, Kumar H, Khaja M. An unusual presentation of eruptive xanthoma: A case report and literature review. Medicine (Baltimore). 2016;95(37):e4866. doi:10.1097/md.0000000000004866. PMID 27631252
  129. Kassa HL, Singh S, Douglas-Jones M, et al. Scurvy masquerading as IgA vasculitis. Pediatr Rheumatol Online J. 2024;22(1):56. doi:10.1186/s12969-024-00992-2. PMID 38760753
  130. Kassa T. A Review on Human Orf: A Neglected Viral Zoonosis. Res Rep Trop Med. 2021;12:153-172. doi:10.2147/rrtm.s306446. PMID 34267574
  131. Kavanoor Sridhar K, German GJ, Krajden S, et al. Primary subcutaneous candidiasis presenting as a chronic eschar-covered ulcer: a diagnostic challenge in an immunocompromised host. A case report and literature review. Case Rep Dermatol. 2026;18(1):380–388. doi:10.1159/000552323. PMID 42441161
  132. Kechichian E, Dupin N, Wetter DA, et al. Erythema multiforme. EClinicalMedicine. 2024;77:102909. doi:10.1016/j.eclinm.2024.102909. PMID 39583748
  133. Kempf W, Mitteldorf C, Cerroni L, et al. Classifications of cutaneous lymphomas and lymphoproliferative disorders: an update from the EORTC cutaneous lymphoma histopathology group. J Eur Acad Dermatol Venereol. 2024;38(8):1491–1503. doi:10.1111/jdv.19987. PMID 38581201 (abstract)
  134. Khodadadi RB, Yetmar ZA, Montagnon CM, et al. Majocchi's granuloma-A multicenter retrospective cohort study. JAAD Int. 2023;13:104-111. doi:10.1016/j.jdin.2023.08.010. PMID 37744668
  135. Kim HS, Myeong SY, Kang HY, et al. Comparative study on the age-related incidence of seborrheic keratosis and verruca plana in patients with verruca plana-like lesions. Sci Rep. 2024;14(1):5223. doi:10.1038/s41598-024-55617-1. PMID 38433172
  136. Kim KH, Kim KM, Woo SS, et al. Updated solution for diagnosis and management of calcinosis cutis: A retrospective review. Medicine (Baltimore). 2024;103(32):e39139. doi:10.1097/md.0000000000039139. PMID 39121273
  137. Kirmani N, Shegog E. Atypical case of pemphigus erythematosus in a previously healthy young woman: diagnostic delay and response to rituximab. Cureus. 2025;17(11):e97108. doi:10.7759/cureus.97108. PMID 41426874
  138. Klifto KM, Gurno CF, Grzelak MJ, et al. Surgical outcomes in adults with purpura fulminans: a systematic review and patient-level meta-synthesis. Burns Trauma. 2019;7:30. doi:10.1186/s41038-019-0168-x. PMID 31641673
  139. Kobkurkul P, Pattanaprichakul P, Sitthinamsuwan P, et al. Obesity-Associated Lymphedematous Mucinosis: An Emerging Variant of Pretibial Mucinosis - A Case Report and Literature Review. Case Rep Dermatol. 2026;18(1):654–660. doi:10.1159/cde/abvag013. PMID 42923860
  140. Koga H, Prost-Squarcioni C, Iwata H, et al. Epidermolysis bullosa acquisita: the 2019 update. Front Med (Lausanne). 2018;5:362. doi:10.3389/fmed.2018.00362. PMID 30687710
  141. Kolivras A, Dehavay F, Delplace D, et al. Coronavirus (COVID-19) infection-induced chilblains: a case report with histopathologic findings. JAAD Case Rep. 2020;6(6):489–492. doi:10.1016/j.jdcr.2020.04.011. PMID 32363225
  142. Koshy M, Flynn C, Kribis M, et al. Disseminated Acanthamoeba Infection with Necrotic Skin Lesions and Granulomatous Vasculitis, United States. Emerg Infect Dis. 2026;32(4):627-630. doi:10.3201/eid3204.251201. PMID 41987017
  143. Kruczek W, Frątczak A, Polak K, et al. Successful Trifarotene Treatment of a Typical Kyrle's Disease With Overview of Topical Therapies. Skin Res Technol. 2026;32(7):e70359. doi:10.1111/srt.70359. PMID 42480558
  144. Kumar A, Sachdeva R, Verma A. Bilateral Achilles tendon xanthomas in a 17-year-old female: a clinicoradiological case report. Clin Med Insights Case Rep. 2026;19:11795476251413415. doi:10.1177/11795476251413415. PMID 41589299
  145. Kumar L, Gupta LK, Balai M, et al. Generalized lichen nitidus successfully treated with cyclosporine. Indian Dermatol Online J. 2026;17(1):105–106. doi:10.4103/idoj.idoj_881_24. PMID 40924681
  146. Kutwin M, Karp P, Kądziela M, et al. The spectrum of cutaneous manifestations in dermatomyositis: a comprehensive review. J Clin Med. 2026;15(8):2874. doi:10.3390/jcm15082874. PMID 42074677
  147. Lacerda PN, Garcia LC, Mazeto IFDS, et al. Livedoid vasculopathy, calciphylaxis, and Martorell's hypertensive ulcer: update on ischemic ulcers due to impaired microcirculation of the lower limbs. An Bras Dermatol. 2025;100(2):215–227. doi:10.1016/j.abd.2024.09.004. PMID 39848831
  148. Ladas G, Cascone J, Badawi AH. Bullous pellagra in a patient with alcohol use disorder and gastric bypass. JAAD Case Rep. 2026;74:102–104. doi:10.1016/j.jdcr.2026.05.050. PMID 42381827
  149. Lastória JC, Abreu MA. Leprosy: a review of laboratory and therapeutic aspects--part 2. An Bras Dermatol. 2014;89(3):389-401. doi:10.1590/abd1806-4841.20142460. PMID 24937811 (cited as Lastória and Abreu 2014b)
  150. Lastória JC, Abreu MA. Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - part 1. An Bras Dermatol. 2014;89(2):205-218. doi:10.1590/abd1806-4841.20142450. PMID 24770495 (cited as Lastória and Abreu 2014a)
  151. Leasure AC, Turner N, Lim I. Facial hyperpigmentation and crusted papules on the hands. JAAD Case Rep. 2022;20:23–25. doi:10.1016/j.jdcr.2021.09.043. PMID 35036499
  152. LeBlanc RE, Tavallaee M, Kim YH, et al. Useful parameters for distinguishing subcutaneous panniculitis-like T-cell lymphoma from lupus erythematosus panniculitis. Am J Surg Pathol. 2016;40(6):745–754. doi:10.1097/PAS.0000000000000596. PMID 26796503 (abstract)
  153. Lee H. Mycosis fungoides and Sézary syndrome. Blood Res. 2023;58(S1):66–82. doi:10.5045/br.2023.2023023. PMID 37105561
  154. Leung AK, Barankin B, Lam JM, et al. Tinea versicolor: an updated review. Drugs Context. 2022;11:2022-9-2. doi:10.7573/dic.2022-9-2. PMID 36452877
  155. Lew R, Jacob J. Polymorphous light eruption: a common skin disease uncommonly recognized in the Hispanic population. Oxf Med Case Reports. 2014;2014(8):145–147. doi:10.1093/omcr/omu055. PMID 25988060
  156. LeWitt TM, Gru AA. A review of cutaneous manifestations of HTLV-associated adult T-cell leukemia/lymphoma. Front Med (Lausanne). 2025;12:1603102. doi:10.3389/fmed.2025.1603102. PMID 41080947
  157. Li BY, Hauptman M, Russell AJ, et al. Type B Digital Mucous Cysts Can Present with Cuticle Thickening as a Clinical Clue. Skin Appendage Disord. 2026. doi:10.1159/000552652. PMID 42428010
  158. Limandjaja GC, Niessen FB, Scheper RJ, et al. Hypertrophic scars and keloids: overview of the evidence and practical guide for differentiating between these abnormal scars. Exp Dermatol. 2021;30(1):146–161. doi:10.1111/exd.14121. PMID 32479693
  159. Linder KA, Kauffman CA. Current and New Perspectives in the Diagnosis of Blastomycosis and Histoplasmosis. J Fungi (Basel). 2020;7(1):12. doi:10.3390/jof7010012. PMID 33383637
  160. Liu S, Song Y, Wang A. Atypical cutaneous candidiasis mimicking tinea corporis in an otherwise healthy young man: a case report. Med Mycol Case Rep. 2026;52:100800. doi:10.1016/j.mmcr.2026.100800. PMID 42282935
  161. Llamas-Velasco M, Rozas-Muñoz E, Fernandez-Flores A, et al. Basic principles of skin biopsy optimization in dermatopathology. Dermatopathology (Basel). 2026;13(3):42. doi:10.3390/dermatopathology13030042. PMID 42782839
  162. Loh TY, Goldberg MS, Falsey RR, et al. Insight into the mechanisms of type III minocycline-induced pigmentation removal: A case of repeated immediate pigment clearing with the Q-switched 755-nm alexandrite laser over a 13-year period. JAAD Case Rep. 2019;5(10):865–867. doi:10.1016/j.jdcr.2019.07.030. PMID 31649974
  163. Lovegrove FE, Sauder MB, Mufti A, et al. Navigating bullous pemphigoid: consensus recommendations for diagnosis and management, a Canadian perspective. J Cutan Med Surg. 2025;29(6):661–674. doi:10.1177/12034754251351854. PMID 40665541
  164. Lyons AB, Harvey VM, Gusev J. Fluoroscopy-induced chronic radiation dermatitis (FICRD) after endovascular abdominal aortic aneurysm endoleak repair. JAAD Case Rep. 2015;1(6):403–405. doi:10.1016/j.jdcr.2015.09.022. PMID 27051793
  165. Machado RA, Oliveira LQ, Martelli-Júnior H, et al. Adverse reactions to the injection of face and neck aesthetic filling materials: a systematic review. Med Oral Patol Oral Cir Bucal. 2023;28(3):e278-e284. doi:10.4317/medoral.25713. PMID 36565218
  166. Maffeis L, Pugni L, Pietrasanta C, et al. Iatrogenic anetoderma of prematurity: a case report and review of the literature. Case Rep Dermatol Med. 2014;2014:781493. doi:10.1155/2014/781493. PMID 25374702
  167. Mahabal GD, George L, Peter DCV, et al. A study of epidermal elafin immunohistochemistry as a diagnostic biomarker of acute skin GVHD. Indian J Dermatol. 2026;71(5):354–359. doi:10.4103/ijd.ijd_219_25. PMID 42708167
  168. Mahmood MN. Direct immunofluorescence of skin and oral mucosa: guidelines for selecting the optimum biopsy site. Dermatopathology (Basel). 2024;11(1):52–61. doi:10.3390/dermatopathology11010006. PMID 38390848
  169. Malkud S, Mahajan P. Rhinoscleroma: An Unusual Presentation. Indian Dermatol Online J. 2018;9(3):191-193. doi:10.4103/idoj.idoj_134_17. PMID 29854642
  170. Marhraoui M, El Moustaoui M, Meziane M, et al. Extensive flexural and pan-ungual involvement in Hallopeau-type pemphigus vegetans: a case report. Cureus. 2026;18(8):e115333. doi:10.7759/cureus.115333. PMID 42802740
  171. Marques-Piubelli ML, Torres-Cabala CA, Miranda RN. Lymphomatoid papulosis: a practical review for pathologists. J Pathol Transl Med. 2026;60(4):388–397. doi:10.4132/jptm.2026.06.09. PMID 42452871
  172. Martin A, Gouveia BM, Rawson R, et al. Complex management of lentigo maligna in the setting of chrysiasis, argyriasis, and tattoo using in vivo reflectance confocal microscopy. J Dermatol. 2022;49(7):703–709. doi:10.1111/1346-8138.16390. PMID 35514028
  173. Martínez-Ortega JI, Mut Quej JE, Franco González S. Malassezia folliculitis: pathogenesis and diagnostic challenges. Cureus. 2024;16(11):e73429. doi:10.7759/cureus.73429. PMID 39664138
  174. Marwah M, Nadkarni N, Patil S. 'Ho-ver'ing over alopecia areata: histopathological study of 50 cases. Int J Trichology. 2014;6(1):13–18. doi:10.4103/0974-7753.136749. PMID 25114447
  175. Mashoudy KD, Kim S, Farhadi L, et al. Beyond the herald patch: exploring the complex landscape of pityriasis rosea. Am J Clin Dermatol. 2025;26(2):237–250. doi:10.1007/s40257-024-00915-7. PMID 39798062
  176. Matsukuma S, Matsunaga A, Takahashi O, et al. Lipomembranous fat necrosis: a distinctive and unique morphology (review). Exp Ther Med. 2022;24(6):759. doi:10.3892/etm.2022.11695. PMID 36561978
  177. Maurelli M, Gisondi P, Colato C, et al. Annually recurring erythema annulare centrifugum: a new case series with review of the literature. Case Rep Dermatol. 2021;13(2):282–288. doi:10.1159/000515999. PMID 34248533
  178. Mejía F, Seas C. Bacillary angiomatosis. Am J Trop Med Hyg. 2014;91(3):439. doi:10.4269/ajtmh.13-0561. PMID 25187668
  179. Metze D, Traupe H, Süßmuth K. Ichthyoses: a clinical and pathological spectrum from heterogeneous cornification disorders to inflammation. Dermatopathology (Basel). 2021;8(2):107–123. doi:10.3390/dermatopathology8020017. PMID 34066992
  180. Meza-Romero R, Navarrete-Dechent C, Downey C. Molluscum contagiosum: an update and review of new perspectives in etiology, diagnosis, and treatment. Clin Cosmet Investig Dermatol. 2019;12:373-381. doi:10.2147/ccid.s187224. PMID 31239742
  181. Micali G, Lacarrubba F, Verzì AE, et al. Scabies: Advances in Noninvasive Diagnosis. PLoS Negl Trop Dis. 2016;10(6):e0004691. doi:10.1371/journal.pntd.0004691. PMID 27311065
  182. Milanovic S, Draper E, Parke M, et al. Histopathologic features of nutritional deficiency dermatoses: a two-center series. JAAD Int. 2026;24:263–265. doi:10.1016/j.jdin.2025.10.018. PMID 41488564
  183. Mimouni N, Bari J, Karrati S, et al. Primary cutaneous aspergillosis due to Aspergillus flavus after nasal packing in a neutropenic patient with acute myeloid leukemia: a case report. Cureus. 2026;18(7):e113066. doi:10.7759/cureus.113066. PMID 42625907
  184. Misiakos EP, Bagias G, Patapis P, et al. Current concepts in the management of necrotizing fasciitis. Front Surg. 2014;1:36. doi:10.3389/fsurg.2014.00036. PMID 25593960
  185. Mocarska M, Muciek A, Dolinkiewicz J, et al. Netherton syndrome: a comprehensive literature review of pathogenesis, clinical manifestations, and therapeutic strategies. J Mother Child. 2025;29(1):106–113. doi:10.34763/jmotherandchild.20252901.d-25-00014. PMID 40899446
  186. Mokos M, Šitum M, Masnec IS. Dissecting cellulitis of the scalp: linking pathogenesis to therapy. Biomedicines. 2026;14(3):570. doi:10.3390/biomedicines14030570. PMID 41898217
  187. Mondal K, Augustine D, Sowmya SV. Foam cells in verruciform xanthoma: A pathognomonic histopathological attribute. J Oral Maxillofac Pathol. 2025;29(4):656–658. doi:10.4103/jomfp.jomfp_129_25. PMID 41584639
  188. Moonla C, Polprasert C, Komvilaisak P, et al. Germline HAVCR2 mutations and their relation to the clinical spectrum of subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis: results from a multicenter study and meta-analysis. Haematologica. 2023;108(10):2743–2752. doi:10.3324/haematol.2022.282419. PMID 37051767
  189. Morais KL, Miyamoto D, Maruta CW, et al. Diagnostic approach of eosinophilic spongiosis. An Bras Dermatol. 2019;94(6):724–728. doi:10.1016/j.abd.2019.02.002. PMID 31789265
  190. Morita TCAB, Criado PR, Criado RFJ, et al. Update on vasculitis: overview and relevant dermatological aspects for the clinical and histopathological diagnosis, part II. An Bras Dermatol. 2020;95(4):493–507. doi:10.1016/j.abd.2020.04.004. PMID 32527591. Cited as Morita et al. 2020b.
  191. Morita TCAB, Trés GFS, Criado RFJ, et al. Update on vasculitis: an overview and dermatological clues for clinical and histopathological diagnosis, part I. An Bras Dermatol. 2020;95(3):355–371. doi:10.1016/j.abd.2020.01.003. PMID 32307202. Cited as Morita et al. 2020a.
  192. Mormile I, Mosella F, Turco P, et al. Calcinosis Cutis and Calciphylaxis in Autoimmune Connective Tissue Diseases. Vaccines (Basel). 2023;11(5):898. doi:10.3390/vaccines11050898. PMID 37243003
  193. Mota L, Dinis-Oliveira RJ. Clinical and Forensic Aspects of the Different Subtypes of Argyria. J Clin Med. 2021;10(10):2086. doi:10.3390/jcm10102086. PMID 34068024
  194. Moulonguet I, Caucanas M, Goettmann S. Longitudinal melanonychia in children: clinical and histopathologic features and management with literature update. Dermatopathology (Basel). 2026;13(1):13. doi:10.3390/dermatopathology13010013. PMID 41892081
  195. Moulonguet I, Fraitag S. Panniculitis in children. Dermatopathology (Basel). 2021;8(3):315–336. doi:10.3390/dermatopathology8030037. PMID 34449587
  196. Muhsen IN, El Fakih R, Hamadani M, et al. Clinical, diagnostic and prognostic characteristics of primary cutaneous gamma delta T-cell lymphomas. Clin Hematol Int. 2022;4(1-2):1–10. doi:10.1007/s44228-022-00011-9. PMID 35950208
  197. Mumber HE, Perman MJ. Epidermolysis bullosa classification and current approach to diagnosis. Pediatr Dermatol. 2026;43(Suppl 2):5–15. doi:10.1111/pde.70143. PMID 42696398
  198. Murinello AG, Sá Damásio H, Guedes P, et al. Acute disseminated panniculitis associated with alpha-1 antitrypsin deficiency. Case Rep Dermatol. 2022;14(3):283–290. doi:10.1159/000526156. PMID 36824156
  199. Nanda A, Tedbirt B, Bodemer C, et al. European S2k guidelines on management of autoimmune blistering diseases in children and adolescents. J Eur Acad Dermatol Venereol. 2026;40(7):1137–1161. doi:10.1111/jdv.70308. PMID 41678328
  200. Nandakumar V, Ashique KT. An intriguing, solitary nodule on the nose. Indian Dermatol Online J. 2026;17(5):769–771. doi:10.4103/idoj.idoj_553_26. PMID 42646664
  201. Narasimhan M, Muthu P, Ramakrishnan R, et al. Tuberous xanthoma with cardiac failure in a child. J Family Med Prim Care. 2022;11(6):3290–3292. doi:10.4103/jfmpc.jfmpc_1416_21. PMID 36119308
  202. Nasser Eldin J, El Tayar E, Abbas O, et al. Inflammatory and infectious cutaneous entities resembling cutaneous T-cell lymphoma (CTCL): an integrated clinicopathological review. Dermatopathology (Basel). 2026;13(2):23. doi:10.3390/dermatopathology13020023. PMID 42346175
  203. Naumowicz M, Modzelewski S, Macko A, et al. A breakthrough in the treatment of necrobiosis lipoidica? Update on treatment, etiopathogenesis, diagnosis, and clinical presentation. Int J Mol Sci. 2024;25(6):3482. doi:10.3390/ijms25063482. PMID 38542454
  204. Navarro Triviño FJ, Velasco Amador JP, Rivera Ruiz I. Seborrheic dermatitis revisited: pathophysiology, diagnosis, and emerging therapies. A narrative review. Biomedicines. 2025;13(10):2458. doi:10.3390/biomedicines13102458. PMID 41153741
  205. Neumann AB, Daxbacher EL, Chiaratti FC, et al. Cutaneous involvement by cytomegalovirus in a renal transplant recipient as an indicator of severe systemic infection. An Bras Dermatol. 2016;91(1):80-83. doi:10.1590/abd1806-4841.20163989. PMID 26982783
  206. Ní Maolcatha S, Nic Dhonncha E, O'Connor C, et al. The lupus band test: a review of the sensitivity and specificity in the diagnosis of lupus erythematosus. Skin Health Dis. 2023;3(4):e205. doi:10.1002/ski2.205. PMID 37538339
  207. Niedźwiedź M, Skibińska M, Kurowski M, et al. Unmasking incontinentia pigmenti: a multimodal clinico-dermoscopic and pathologic correlation. Diagnostics (Basel). 2026;16(16):2544. doi:10.3390/diagnostics16162544. PMID 42650946
  208. Numata T, Harada K, Tsuboi R, et al. Erythema dyschromicum perstans: identical to ashy dermatosis or not? Case Rep Dermatol. 2015;7(2):146–150. doi:10.1159/000437414. PMID 26351421
  209. Obaidi N, Agee O, Yau I, et al. Frostbite: diagnosis, treatment, prognosis, and future directions. Mil Med Res. 2026;13(1):100007. doi:10.1016/j.mmr.2026.100007. PMID 41953050
  210. Obiakor B, Abegaze B, Feng AS, et al. Disease course, comorbidities, and treatment outcomes of lupus erythematosus panniculitis in adults and children: a retrospective review. JAAD Int. 2026;26:28–30. doi:10.1016/j.jdin.2026.03.001. PMID 42027982
  211. Ogrinc K, Maraspin V, Lusa L, et al. Acrodermatitis chronica atrophicans: clinical and microbiological characteristics of a cohort of 693 Slovenian patients. J Intern Med. 2021;290(2):335-348. doi:10.1111/joim.13266. PMID 33550695
  212. Ogunbiyi A. Pseudofolliculitis barbae; current treatment options. Clin Cosmet Investig Dermatol. 2019;12:241–247. doi:10.2147/CCID.S149250. PMID 31354326
  213. Ogunremi OO, Hopkins Z. Dapsone for Treatment of a Neutrophilic Predominant Variant of Polymorphous Light Eruption: A Case Report. Case Rep Dermatol. 2026;18(1):337–345. doi:10.1159/000552174. PMID 42375515
  214. Okinaka T, Fukumitsu K, Okamura N, et al. Minocycline-Induced Hyperpigmentation: Importance of Early Diagnosis. IDCases. 2023;34:e01901. doi:10.1016/j.idcr.2023.e01901. PMID 37841948. Corrected in: IDCases. 2024;40:e02129
  215. Osman S, Tarnari N, Ahsan A, et al. Cutaneous Larva Migrans (CLM) may not be easy to diagnose: a case report and narrative review. Oxf Med Case Reports. 2024;2024(4):omae025. doi:10.1093/omcr/omae025. PMID 38680772
  216. Özcan D, Seçkin D, Güleç AT, et al. Lichen planopilaris versus frontal fibrosing alopecia: histopathologically distinct diseases or not? An Bras Dermatol. 2026;101(2):501302. doi:10.1016/j.abd.2026.501302. PMID 41875727
  217. Özgün Geçer M, Kaya G. Clinical, histological, and immunohistochemical signatures of non-segmental vitiligo: a case-control analysis of Melan-A expression and CD8⁺ T-cell infiltration. Sci Rep. 2025;15(1):27425. doi:10.1038/s41598-025-11448-2. PMID 40721713
  218. Ozkok A. Cholesterol-embolization syndrome: current perspectives. Vasc Health Risk Manag. 2019;15:209–220. doi:10.2147/VHRM.S175150. PMID 31371977
  219. Palladino CN, Keller MK, Olsen GM, et al. Sebaceous gland necrosis induced by Demodex mites: a case report. JAAD Case Rep. 2026;72:184–187. doi:10.1016/j.jdcr.2026.03.003. PMID 42256364
  220. Palo S. 'Cutting through the roots': a critical appraisal of transverse and vertical sectioning techniques of scalp biopsy for primary alopecia. Indian J Dermatol. 2026;71(5):403–409. doi:10.4103/ijd.ijd_450_25. PMID 42708156
  221. Pampaloni F, Cedirian S, Melo DF, et al. Trichoscopy of scalp folliculotropic mycosis fungoides: a review of the literature. Dermatol Pract Concept. 2026;16(3). doi:10.5826/dpc.1603a6459. PMID 42858382
  222. Papadopoulou MM, Karampinis E, Sgouros D, et al. Dermoscopy of Acquired Perforating Dermatoses: A Case Series and Review of the Literature. Life (Basel). 2025;15(12):1786. doi:10.3390/life15121786. PMID 41465726
  223. Papp JR, Park IU, Fakile Y, et al. CDC Laboratory Recommendations for Syphilis Testing, United States, 2024. MMWR Recomm Rep. 2024;73(1):1-32. doi:10.15585/mmwr.rr7301a1. PMID 38319847
  224. Parisi R, Shah H, Navarini AA, et al. Acute generalized exanthematous pustulosis: clinical features, differential diagnosis, and management. Am J Clin Dermatol. 2023;24(4):557–575. doi:10.1007/s40257-023-00779-3. PMID 37156992
  225. Park SH, Ahn SW, Jang SH, et al. A comparative study on clinico-histopathological features of granulomatous rosacea and lupus miliaris disseminatus faciei. Ann Dermatol. 2024;36(1):58–61. doi:10.5021/ad.22.229. PMID 38325436
  226. Park YW, Kim DY, Yoon SY, et al. 'Clues' for the histological diagnosis of tinea: how reliable are they? Ann Dermatol. 2014;26(2):286-288. doi:10.5021/ad.2014.26.2.286. PMID 24882998
  227. Parvathy N, Joshi R, Bhattacharjee R, et al. Primary Localized Cutaneous Amyloidosis: A Histological and Immunohistochemical Appraisal. Indian Dermatol Online J. 2026;17(5):683–687. doi:10.4103/idoj.idoj_629_25. PMID 42377141
  228. Patel Housley P, Purvis CG, Gurram PR, et al. HTLV-1 associated primary cutaneous tumoral ATLL in a Floridian without travel to an endemic area. JAAD Case Rep. 2025;66:206–210. doi:10.1016/j.jdcr.2025.09.013. PMID 41322093
  229. Patel T, Morrison LK, Rady P, et al. Epidermodysplasia verruciformis and susceptibility to HPV. Dis Markers. 2010;29(3-4):199-206. doi:10.3233/dma-2010-0733. PMID 21178278
  230. Patel T, Singh G, Thesiya Y, et al. Plantar myrmecia wart: a rare case report with clinicopathologic correlation and literature review. Cureus. 2026;18(8):e113839. doi:10.7759/cureus.113839. PMID 42688925
  231. Perazzolli G, Banchetti E, Melis E, et al. Chilblain lupus: a rare form of cutaneous lupus erythematosus. A case report. SAGE Open Med Case Rep. 2026;14:2050313X261415591. doi:10.1177/2050313X261415591. PMID 41625144
  232. Pérez-Garza DM, Chavez-Alvarez S, Ocampo-Candiani J, et al. Erythema nodosum: a practical approach and diagnostic algorithm. Am J Clin Dermatol. 2021;22(3):367–378. doi:10.1007/s40257-021-00592-w. PMID 33683567
  233. Persson C, Coican A, Ferrer-Bruker S. Central centrifugal cicatricial alopecia in Black women: diagnostic challenges and molecular insights. Cureus. 2026;18(9):e116655. doi:10.7759/cureus.116655. PMID 42910370
  234. Phiske MM. An approach to acanthosis nigricans. Indian Dermatol Online J. 2014;5(3):239–249. doi:10.4103/2229-5178.137765. PMID 25165638
  235. Pignolo RJ, Ramaswamy G, Fong JT, et al. Progressive osseous heteroplasia: diagnosis, treatment, and prognosis. Appl Clin Genet. 2015;8:37–48. doi:10.2147/tacg.s51064. PMID 25674011
  236. Pimpinelli N, Olsen EA, Santucci M, et al. Defining early mycosis fungoides. J Am Acad Dermatol. 2005;53(6):1053–1063. doi:10.1016/j.jaad.2005.08.057. PMID 16310068 (algorithm as tabulated in Lee 2023)
  237. Plantier F, Lewis F. Genital disorders in children: what does a biopsy bring? Dermatopathology (Basel). 2026;13(1):12. doi:10.3390/dermatopathology13010012. PMID 41892079
  238. Polańska A, Bowszyc-Dmochowska M, Żaba RW, et al. Elastosis perforans serpiginosa: a review of the literature and our own experience. Postepy Dermatol Alergol. 2016;33(5):392–395. doi:10.5114/ada.2016.62849. PMID 27881947
  239. Pomerantz ER, Hackley MA, Lawlor CE, et al. A scoping literature review of pancreatic panniculitis. Cureus. 2025;17(1):e78000. doi:10.7759/cureus.78000. PMID 40007931
  240. Porro AM, Arai Seque C, Miyamoto D, et al. Hailey–Hailey disease: clinical, diagnostic and therapeutic update. An Bras Dermatol. 2024;99(5):651–661. doi:10.1016/j.abd.2023.12.003. PMID 38789364
  241. Porro AM, Caetano LV, Maehara LS, et al. Non-classical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG/IgA pemphigus. An Bras Dermatol. 2014;89(1):96–106. doi:10.1590/abd1806-4841.20142459. PMID 24626654
  242. Prieto-Torres L, Requena L, Rodríguez-Pinilla SM. Clinical, histopathological and molecular spectrum of cutaneous lesions in myelodysplastic syndrome and myeloproliferative neoplasms (MDS/MPN): an integrative review. Cancers (Basel). 2023;15(24):5888. doi:10.3390/cancers15245888. PMID 38136431
  243. Pritt BS, Aubry MC. Histopathology of viral infections of the lung. Semin Diagn Pathol. 2017;34(6):510-517. doi:10.1053/j.semdp.2017.06.005. PMID 28693907
  244. Prohic A, Poparic S, Cemerlic A, et al. Erythema Ab Igne with Histological Features of Keratosis Lichenoides Chronica. Case Rep Dermatol. 2021;13(1):184–189. doi:10.1159/000515259. PMID 34703425
  245. Promsena P, Iamsumang W, Rutnin S. Clinicopathological characteristics of lichenoid drug eruption: a 17-year retrospective study. Clin Cosmet Investig Dermatol. 2025;18:3203–3211. doi:10.2147/ccid.s560840. PMID 41340879
  246. Qiu X, Liu Y, Shao Y, et al. Clinical and molecular characteristics of Chinese patients with alkaptonuria: 4-year follow-up of a pediatric patient and literature review. Mol Genet Metab Rep. 2025;45:101276. doi:10.1016/j.ymgmr.2025.101276. PMID 41323097
  247. Qorbani A, Mubasher A, Sarantopoulos GP, et al. Exogenous Ochronosis (EO): Skin lightening cream causing rare caviar-like lesion with banana-like pigments; review of literature and histological comparison with endogenous counterpart. Autops Case Rep. 2020;10(4):e2020197. doi:10.4322/acr.2020.197. PMID 33344320
  248. Radonjic-Hoesli S, Brüggen MC, Feldmeyer L, et al. Eosinophils in skin diseases. Semin Immunopathol. 2021;43(3):393–409. doi:10.1007/s00281-021-00868-7. PMID 34097126
  249. Ravić Nikolić A, Miličić V, Jovović Dagović B, et al. A case of erythema dyschromicum perstans. Dermatol Pract Concept. 2022;12(2):e2022106. doi:10.5826/dpc.1202a106. PMID 35646435
  250. Reginatto FP, Villa DD, Cestari TF. Benign skin disease with pustules in the newborn. An Bras Dermatol. 2016;91(2):124–134. doi:10.1590/abd1806-4841.20164285. PMID 27192509
  251. Requena L, Requena C. Histopathology of the more common viral skin infections [in Spanish]. Actas Dermosifiliogr. 2010;101(3):201-216. doi:10.1016/j.ad.2009.07.022. PMID 20398595
  252. Riley C, Crawl-Bey A, Gibson G, et al. The diagnostic challenge of coma blisters. JAAD Case Rep. 2025;56:45–47. doi:10.1016/j.jdcr.2024.08.050. PMID 39845466
  253. Roberts BT, Kempton D, Konstantinov NK. Subungual hyperkeratosis as a diagnostic cue in crusted scabies. IDCases. 2026;45:e02711. doi:10.1016/j.idcr.2026.e02711. PMID 42569321
  254. Rodríguez-Cuadrado FJ, Nájera L, Suárez D, et al. Clinical, histopathologic, immunohistochemical, and electron microscopic findings in cutaneous monkeypox: A multicenter retrospective case series in Spain. J Am Acad Dermatol. 2023;88(4):856-863. doi:10.1016/j.jaad.2022.12.027. PMID 36581043
  255. Roje Z, Roje Z, Matić D, et al. Necrotizing fasciitis: literature review of contemporary strategies for diagnosing and management with three case reports: torso, abdominal wall, upper and lower limbs. World J Emerg Surg. 2011;6(1):46. doi:10.1186/1749-7922-6-46. PMID 22196774
  256. Rozo-Paz G, González-Devia D, Aguirre-Matallana DA, et al. Exceptional Response of Necrolytic Migratory Erythema to Octreotide in a Patient with Glucagonoma: A Case Report and Scoping Review. Case Rep Dermatol. 2026;18(1):411–425. doi:10.1159/000552556. PMID 42434589
  257. Rutland CD, Wang A, Zdravkovic S, et al. TRPS1 expression across the spectrum of Paget disease and morphologic mimics. Appl Immunohistochem Mol Morphol. 2026;34(3):155–165. doi:10.1097/PAI.0000000000001313. PMID 41725031
  258. Saal RC, Van Voorhees AS, Conran RM. Educational case: psoriasis. Acad Pathol. 2025;12(1):100154. doi:10.1016/j.acpath.2024.100154. PMID 39758588
  259. Saldanha MG, Queiroz A, Machado PRL, et al. Characterization of the Histopathologic Features in Patients in the Early and Late Phases of Cutaneous Leishmaniasis. Am J Trop Med Hyg. 2017;96(3):645-652. doi:10.4269/ajtmh.16-0539. PMID 28115669
  260. Samadi Takaldani AH, Negaresh M, Negaresh M, et al. Amiodarone-induced blue man syndrome: a case report. J Med Case Rep. 2023;17(1):248. doi:10.1186/s13256-023-03954-6. PMID 37291615
  261. Santos JB, Figueiredo AR, Ferraz CE, et al. Cutaneous tuberculosis: diagnosis, histopathology and treatment - part II. An Bras Dermatol. 2014;89(4):545-555. doi:10.1590/abd1806-4841.20142747. PMID 25054739
  262. Saoji VA, Saoji SV, Gadegone RW, et al. Primary cutaneous nocardiosis. Indian J Dermatol. 2012;57(5):404-406. doi:10.4103/0019-5154.100502. PMID 23112367
  263. Saravanan Y, Palaniappan V, Karthikeyan K. "Actinic" Conditions in Dermatology. Indian J Dermatol. 2026;71(4):296–305. doi:10.4103/ijd.ijd_803_24. PMID 42441198
  264. Scheinkman R, Aggarwal R, Summers R, et al. Arctic & Antarctic dermatology: a narrative review of cutaneous conditions of polar explorers and researchers. Arch Dermatol Res. 2025;317(1):664. doi:10.1007/s00403-025-04182-2. PMID 40323427
  265. Scotti B, Misciali C, Bardazzi F, et al. Hypertrophic lichen planus and hypertrophic skin lesions associated with histological lichenoid infiltrate: a case report and literature review. Dermatopathology (Basel). 2025;12(1):8. doi:10.3390/dermatopathology12010008. PMID 40136318
  266. Seguí M, Rodríguez-Jiménez P, Fraga J, et al. Pancreatic panniculitis revisited: a series of 34 patients. J Cutan Pathol. 2023;50(11):983–990. doi:10.1111/cup.14515. PMID 37605438 (abstract)
  267. Seidel A, Nunes DH, Fernandes C, et al. Skin infection by Mycobacterium marinum - diagnostic and therapeutic challenge. An Bras Dermatol. 2022;97(3):366-368. doi:10.1016/j.abd.2021.03.013. PMID 35428530
  268. Serra-Baldrich E, Flórez Á, Julià Manresa M, et al. The state of the art in chronic prurigo nodularis. Dermatol Ther (Heidelb). 2026;16(7):3659–3686. doi:10.1007/s13555-026-01804-z. PMID 42247108
  269. Sever M, Trčko K, Zidarič T, et al. Exploring genital lichen sclerosus: navigating from pathophysiology to precise diagnostic approaches. Biomedicines. 2025;13(9):2252. doi:10.3390/biomedicines13092252. PMID 41007812
  270. Seward AH, LaRocque JH. Cold-sensitive acral hand lesions. JAAD Case Rep. 2026;70:246–248. doi:10.1016/j.jdcr.2026.01.009. PMID 41938595
  271. Shin L, Gardner JT, Dao H. Updates in the diagnosis and management of linear IgA disease: a systematic review. Medicina (Kaunas). 2021;57(8):818. doi:10.3390/medicina57080818. PMID 34441024
  272. Shrestha A, Bam PK, Pandit A, et al. Eruptive xanthoma as a warning sign of uncontrolled hypertriglyceridemia presenting with acute pancreatitis and uncontrolled type II diabetes mellitus: A case report. Clin Case Rep. 2024;12(6):e8926. doi:10.1002/ccr3.8926. PMID 38799544
  273. Siddiqui R, Khan NA. Balamuthia mandrillaris: Morphology, biology, and virulence. Trop Parasitol. 2015;5(1):15-22. doi:10.4103/2229-5070.149888. PMID 25709948
  274. Singh G, Pathania Y, Goswami P, et al. Folliculitis decalvans: an uncommon case report with review of literature. Int J Appl Basic Med Res. 2025;15(1):63–65. doi:10.4103/ijabmr.ijabmr_414_24. PMID 40336766
  275. Singh SK, Manchanda K. Acroangiodermatitis (pseudo-Kaposi sarcoma). Indian Dermatol Online J. 2014;5(3):323–325. doi:10.4103/2229-5178.137791. PMID 25165656
  276. Smith LR, Moore S, Cardon B, et al. Bilateral Blistering Rash Following Gastric Bypass Procedure and Mushroom Soup Diet: Hepatitis C Virus-Seronegative Necrolytic Acral Erythema. Cureus. 2024;16(7):e63755. doi:10.7759/cureus.63755. PMID 39100037
  277. So N, Yip L, Orchard D. Paediatric hypotrichosis: a clinical and algorithmic approach to diagnosis. Australas J Dermatol. 2025;66(3):e109–e119. doi:10.1111/ajd.14429. PMID 39992008
  278. Søndergaard C, Nagarajah S, Shen J, et al. Calciphylaxis in chronic kidney disease: a systematic review of pathomechanisms and risk factors for calcific uremic arteriolopathy. Ren Fail. 2026;48(1):2710397. doi:10.1080/0886022x.2026.2710397. PMID 42572798
  279. Spigariolo CB, Giacalone S, Nazzaro G. Pigmented purpuric dermatoses: a complete narrative review. J Clin Med. 2021;10(11):2283. doi:10.3390/jcm10112283. PMID 34070260
  280. Steinhelfer L, Kühnel T, Jägle H, et al. Systemic therapy of necrobiotic xanthogranuloma: a systematic review. Orphanet J Rare Dis. 2022;17(1):132. doi:10.1186/s13023-022-02291-z. PMID 35331271
  281. Stephens MR, Moore DF, Dau J, et al. A case of generalized morphea profunda following SARS-CoV-2 infection. JAAD Case Rep. 2022;23:20–23. doi:10.1016/j.jdcr.2022.02.033. PMID 35308063
  282. Stewart AG, Stewart AGA. An Update on the Laboratory Diagnosis of Rickettsia spp. Infection. Pathogens. 2021;10(10):1319. doi:10.3390/pathogens10101319. PMID 34684267
  283. Stumpf MJ, Schahab N, Nickenig G, et al. Therapy of Pseudoxanthoma Elasticum: Current Knowledge and Future Perspectives. Biomedicines. 2021;9(12):1895. doi:10.3390/biomedicines9121895. PMID 34944710
  284. Sunderkötter CH, Zelger B, Chen KR, et al. Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheumatol. 2018;70(2):171–184. doi:10.1002/art.40375. PMID 29136340 (abstract)
  285. Sushantika S, Sethi J. Weeping Wound, Disgruntled Gut and Fading Hunger: Acrodermatitis Enteropathica in an Infant. Cureus. 2025;17(12):e100465. doi:10.7759/cureus.100465. PMID 41625893
  286. Swallow MA, Micevic G, Zhou A, et al. Clinical and histologic variants of CD8+ cutaneous T-cell lymphomas. Cancers (Basel). 2024;16(17):3087. doi:10.3390/cancers16173087. PMID 39272944
  287. Talhari C, Arriel K, Serra MS, et al. Acquired syphilis: update on clinical, diagnostic and therapeutic aspects. An Bras Dermatol. 2025;100(3):407-421. doi:10.1016/j.abd.2024.11.002. PMID 40210541
  288. Theodoridis A, Makrantonaki E, Zouboulis CC. Malignant atrophic papulosis (Köhlmeier-Degos disease): a review. Orphanet J Rare Dis. 2013;8:10. doi:10.1186/1750-1172-8-10. PMID 23316694
  289. Thesiya Y, Goswami P, Anandani G, et al. Pityriasis lichenoides et varioliformis acuta: diagnostic enigma unveiled with clinicopathologic insights into a rare dermatologic entity. Int J Appl Basic Med Res. 2026;16(2):147–149. doi:10.4103/ijabmr.ijabmr_56_26. PMID 42396363
  290. Tirumalae R. Psoriasiform dermatoses: microscopic approach. Indian J Dermatol. 2013;58(4):290–293. doi:10.4103/0019-5154.113945. PMID 23919000
  291. Tokura Y, Yunoki M, Kondo S, et al. What is "eczema"? J Dermatol. 2025;52(2):192–203. doi:10.1111/1346-8138.17439. PMID 39301836
  292. Traini DO, Palmisano G, Stefani AD, et al. In vivo microscopic features of acne vulgaris revealed via LC-OCT. Skin Res Technol. 2026;32(6):e70371. doi:10.1111/srt.70371. PMID 42290222
  293. Trevisan F, Werner B, Pinheiro RL. Nail clipping in onychomycosis and comparison with normal nails and ungual psoriasis. An Bras Dermatol. 2019;94(3):344–347. doi:10.1590/abd1806-4841.20198301. PMID 31365667
  294. Umar S, Ogah O, Yang J, et al. Perifollicular lymphocytic inflammation and fibrosis in dissecting cellulitis: evidence of a consistent histopathologic pattern. Clin Cosmet Investig Dermatol. 2026;19:614816. doi:10.2147/CCID.S614816. PMID 42483001
  295. Urosevic-Maiwald M, Hardenberg JB, Hafner J, et al. Cocaine/levamisole-induced, skin-limited ANCA-associated vasculitis with pyoderma gangrenosum-like presentation. Dermatopathology (Basel). 2022;9(3):207–211. doi:10.3390/dermatopathology9030026. PMID 35892479
  296. van Beek N, Holtsche MM, Atefi I, et al. State-of-the-art diagnosis of autoimmune blistering diseases. Front Immunol. 2024;15:1363032. doi:10.3389/fimmu.2024.1363032. PMID 38903493
  297. van Wyk RB, le Grange DL, Budding L. A retrospective review of leprosy diagnosed histopathologically from skin biopsy specimens in central South Africa. S Afr J Infect Dis. 2026;41(1):802. doi:10.4102/sajid.v41i1.802. PMID 42428785
  298. Vasconcellos BO, Fialho SCAV, Guimarães ICCDV, et al. Study of 138 vulvar lichen sclerosus patients and the malignant risk transformation. Rev Bras Ginecol Obstet. 2024;46:e-rbgo62. doi:10.61622/rbgo/2024rbgo62. PMID 39176197
  299. Vattigunta M, Jaller JA. Distinguishing verrucous herpes from neoplastic lesions: A clinical and histopathological approach. JAAD Case Rep. 2026;72:119-122. doi:10.1016/j.jdcr.2026.02.051. PMID 42183101
  300. Vijayasankar P, Karthikeyan K. Flaky paint dermatosis in kwashiorkor. Am J Trop Med Hyg. 2021;106(1):3. doi:10.4269/ajtmh.21-0487. PMID 34607303
  301. Villarreal CD, Alanis JC, Pérez JC, et al. Cutaneous graft-versus-host disease after hematopoietic stem cell transplant: a review. An Bras Dermatol. 2016;91(3):336–343. doi:10.1590/abd1806-4841.20164180. PMID 27438202
  302. Vu TN, Talasila S, Jeha GM, et al. Understanding the clinical spectrum of the cutaneous and acute hepatic porphyrias. Am J Clin Dermatol. 2026;27(4):745–764. doi:10.1007/s40257-026-01046-x. PMID 42213346
  303. Waikhom R, Taraphder A. Nephrogenic systemic fibrosis: a brief review. Indian J Dermatol. 2011;56(1):54–58. doi:10.4103/0019-5154.77554. PMID 21572794
  304. Wang C, Wang T, Gao L, et al. Giant condyloma acuminatum in a patient with HIV infection: a case report. AIDS Res Ther. 2026;23(1):78. doi:10.1186/s12981-026-00889-y. PMID 42231443
  305. Wang X, Ran Y, Jia S, et al. Human Disseminated Protothecosis: The Skin is the "Window"? Front Immunol. 2022;13:880196. doi:10.3389/fimmu.2022.880196. PMID 35774787
  306. Weiss EH, Ko CJ, Leung TH, et al. Neutrophilic dermatoses: a clinical update. Curr Dermatol Rep. 2022;11(2):89–102. doi:10.1007/s13671-022-00355-8. PMID 35310367
  307. Wickramasinghe WMSN, Jayasooriya PR, Mendis BRRN, et al. Comparative Clinicopathological Analysis of Oral Focal Mucinosis and Solitary Cutaneous Focal Mucinosis: A Case Series and Literature-Based Analysis. Dermatopathology (Basel). 2025;12(4):38. doi:10.3390/dermatopathology12040038. PMID 41283480
  308. Wijesinghe H, Gunathilaka N, Semege S, et al. Histopathology of Cutaneous Leishmaniasis Caused by Leishmania donovani in Sri Lanka. Biomed Res Int. 2020;2020:4926819. doi:10.1155/2020/4926819. PMID 32461993
  309. Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703–1714. doi:10.1182/blood-2018-11-881268. PMID 30635287. Erratum in: Blood. 2019;134(13):1112
  310. Witte M, Zillikens D, Schmidt E. Diagnosis of autoimmune blistering diseases. Front Med (Lausanne). 2018;5:296. doi:10.3389/fmed.2018.00296. PMID 30450358
  311. Wu X, Lin Z, Shen X, et al. Clinical and dermoscopic features of subungual hemorrhage: a retrospective study of 420 cases. Skin Res Technol. 2026;32(10):e70400. doi:10.1111/srt.70400. PMID 42928658
  312. Xu WT, Tan C. Subcorneal pustular dermatosis in a 54-year-old woman. CMAJ. 2023;195(27):E933. doi:10.1503/cmaj.230149. PMID 37460125
  313. Xu X, Ding W, Song H, et al. Unique skin nodules following COVID-19 vaccination: a case report of cutaneous plasmacytosis and review of the literature. Virol J. 2025;22(1):57. doi:10.1186/s12985-025-02653-6. PMID 40038708
  314. Yamada A, Unuma K, Arai N, et al. Recognizing pellagra with Casal's necklace: a fatal case of anorexia nervosa. Forensic Sci Med Pathol. 2026;22(3):1113–1118. doi:10.1007/s12024-026-01218-5. PMID 42334825
  315. Yan A, Madigan L, Korman A, et al. Morbilliform eruptions: differentiating low-risk drug eruptions, severe cutaneous adverse reactions, viral eruptions, and acute graft-versus-host disease. Am J Clin Dermatol. 2025;26(3):379–393. doi:10.1007/s40257-025-00924-0. PMID 39888589
  316. Yao Y, Liu F. Multicentric plasmacytic Castleman disease and IgG4-related disease manifested as cutaneous plasmacytosis: a report of two cases. An Bras Dermatol. 2026;101(4):501388. doi:10.1016/j.abd.2026.501388. PMID 42302536
  317. Yee SA, Langelier DM, Taylor K, et al. Radiation-induced morphoea in the setting of previous breast cancer: a case report. SAGE Open Med Case Rep. 2026;14:2050313X261463846. doi:10.1177/2050313x261463846. PMID 42428767
  318. Zhang AD, Lazar M, Akhundova E, et al. A scoping review on melasma treatments and their histopathologic correlates. Dermatopathology (Basel). 2025;12(2):13. doi:10.3390/dermatopathology12020013. PMID 40265344
  319. Zhu D, Lin Y, Li Y, et al. Tofacitinib for the management of refractory eosinophilic pustular folliculitis: a case report and literature review. Clin Cosmet Investig Dermatol. 2026;19:585317. doi:10.2147/CCID.S585317. PMID 41847261
  320. Zhu P, Qi RQ, Yang Y, et al. Clinical guideline for the diagnosis and treatment of cutaneous warts (2022). J Evid Based Med. 2022;15(3):284-301. doi:10.1111/jebm.12494. PMID 36117295
  321. Zou X, Tang Z, Zhang X, et al. Myxoid onychomatricoma with unusual CD99 expression: a report of a rare case and literature review. Clin Cosmet Investig Dermatol. 2026;19:642035. doi:10.2147/CCID.S642035. PMID 42802758
  322. Zou Z, Ma L. Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed cases. Indian J Dermatol. 2011;56(1):65–73. doi:10.4103/0019-5154.77556. PMID 21572796